<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC3004943/results/search/disease/results.xml">
   <result pre="Natl Acad Sci USA101151241512915477600 8FergusonNMCummingsDACauchemezSFraserCRileySet al.2005Strategies for containing an emerging" exact="influenza" post="pandemic in Southeast Asia.Nature43720921416079797 9LaiPCSoFMChanK-W2009Spatial Epidemiological Approaches in Disease"/>
   <result pre="Prog171156116511735454 29KatsumotoTHiranoAKurimuraTTakagiA1981In situ electron microscopical observation of cells infected with" exact="herpes simplex" post="virus.J Gen Virol522672786270236 30PriceRWRubensteinRKhanA1982Herpes simplex virus infection of isolated"/>
   <result pre="within mammalian cells.Adv Drug Deliv Rev1414971513 32LamVDucaKAYinJ2005Arrested spread of vesicular" exact="stomatitis" post="virus infections in vitro depends on interferon-mediated antiviral activity.Biotechnol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC3561042/results/search/disease/results.xml">
   <result pre="this endeavour is the basic reproductive number (R0) of an" exact="infectious disease," post="the mean number of secondary infections per primary infection"/>
   <result pre="population. The problem is further compounded for HIV and the" exact="hepatitis" post="C virus (HCV) that circulate in socially-marginalised groups such"/>
   <result pre="useful comments. References References 1GrasslyNC, FraserC (2008) Mathematical models of" exact="infectious disease" post="transmission. Nat Rev Microbiol6: 477–487.18533288 2Anderson RM, May RM"/>
   <result pre="App Prob19A: 27–43. 19DeufficS, BuffatL, PoynardT, ValleronAJ (1999) Modeling the" exact="hepatitis" post="C virus epidemic in France. Hepatology29: 1596–1601.10216148 20StrimmerK, PybusOG"/>
   <result pre="22VolzEM, Kosakovsky PondSL, WardMJ, Leigh BrownAJ, FrostSD (2009) Phylodynamics of" exact="infectious disease" post="epidemics. Genetics183: 1421–1430.19797047 23KoelleK, RasmussenDA (2012) Rates of coalescence"/>
   <result pre="SypsaV, TassopoulosNC, BoletisJ, KarafoulidouA, et al. (2006) Molecular epidemiology of" exact="hepatitis" post="C virus (HCV) in Greece: temporal trends in HCV"/>
   <result pre="TassopoulosNC, KetikoglouI, VafiadisI, et al. (2004) Reconstructing and predicting the" exact="hepatitis" post="C virus epidemic in Greece: increasing trends of cirrhosis"/>
   <result pre="the hepatitis C virus epidemic in Greece: increasing trends of" exact="cirrhosis" post="and hepatocellular carcinoma despite the decline in incidence of"/>
   <result pre="C virus epidemic in Greece: increasing trends of cirrhosis and" exact="hepatocellular carcinoma" post="despite the decline in incidence of HCV infection. J"/>
   <result pre="ParaskevisD, HoSY, ShapiroB, et al. (2009) The global spread of" exact="hepatitis" post="C virus 1a and 1b: a phylodynamic and phylogeographic"/>
   <result pre="PreissL, KonkleBA, et al. (2006) Correlates of spontaneous clearance of" exact="hepatitis" post="C virus among people with hemophilia. Blood107: 892–897.16204310 30VogtM,"/>
   <result pre="KlinglerC, SendlAF, et al. (1999) Prevalence and clinical outcome of" exact="hepatitis" post="C infection in children who underwent cardiac surgery before"/>
   <result pre="polymorphism near IL28B is associated with spontaneous clearance of acute" exact="hepatitis" post="C virus and jaundice. Gastroenterology139: 1586–1592.20637200 32ThomasDL, ThioCL, MartinMP,"/>
   <result pre="al. (2009) Genetic variation in IL28B and spontaneous clearance of" exact="hepatitis" post="C virus. Nature461: 798–801.19759533 33ThomasDL, AstemborskiJ, RaiRM, AnaniaFA, SchaefferM,"/>
   <result pre="RaiRM, AnaniaFA, SchaefferM, et al. (2000) The natural history of" exact="hepatitis" post="C virus infection: host, viral, and environmental factors. JAMA284:"/>
   <result pre="MillerRN, RabkinCS, Buskell-BalesZ, Straley-EasonKD, et al. (2000) 45-year follow-up of" exact="hepatitis" post="C virus infection in healthy young adults. Ann Intern"/>
   <result pre="and outcome among a large patient cohort with community-acquired acute" exact="hepatitis" post="C in Italy. Clin Infect Dis43: 1154–1159.17029134 36Kenny-WalshE (1999)"/>
   <result pre="Italy. Clin Infect Dis43: 1154–1159.17029134 36Kenny-WalshE (1999) Clinical outcomes after" exact="hepatitis" post="C infection from contaminated anti-D immune globulin. Irish Hepatology"/>
   <result pre="WongD, MillerRH, ShihJW, et al. (1991) A long-term study of" exact="hepatitis" post="C virus replication in non-A, non-B hepatitis. N Engl"/>
   <result pre="MelpolderJ, ShakilAO, et al. (1996) Routes of infection, viremia, and" exact="liver disease" post="in blood donors found to have hepatitis C virus"/>
   <result pre="viremia, and liver disease in blood donors found to have" exact="hepatitis" post="C virus infection. N Engl J Med334: 1691–1696.8637513 39BortolottiF,"/>
   <result pre="CammaC, CabibboG, ZancanL, et al. (2008) Long-term course of chronic" exact="hepatitis" post="C in children: from viral clearance to end-stage liver"/>
   <result pre="chronic hepatitis C in children: from viral clearance to end-stage" exact="liver disease." post="Gastroenterology134: 1900–1907.18439604 40AlterMJ, MargolisHS, KrawczynskiK, JudsonFN, MaresA, et al."/>
   <result pre="JudsonFN, MaresA, et al. (1992) The natural history of community-acquired" exact="hepatitis" post="C in the United States. The Sentinel Counties Chronic"/>
   <result pre="Kruszon-MoranD, NainanOV, McQuillanGM, GaoF, et al. (1999) The prevalence of" exact="hepatitis" post="C virus infection in the United States, 1988 through"/>
   <result pre="Med341: 556–562.10451460 42AlterHJ, SeeffLB (2000) Recovery, persistence, and sequelae in" exact="hepatitis" post="C virus infection: a perspective on long-term outcome. Semin"/>
   <result pre="RambautA, HolmesEC, et al. (2001) The epidemic behavior of the" exact="hepatitis" post="C virus. Science292: 2323–2325.11423661 45NelsonPK, MathersBM, CowieB, HaganH, Des"/>
   <result pre="CowieB, HaganH, Des JarlaisD, et al. (2011) Global epidemiology of" exact="hepatitis" post="B and hepatitis C in people who inject drugs:"/>
   <result pre="JarlaisD, et al. (2011) Global epidemiology of hepatitis B and" exact="hepatitis" post="C in people who inject drugs: results of systematic"/>
   <result pre="AlexanderWJ, et al. (1990) Risk factors for acute non-A, non-B" exact="hepatitis" post="in the United States and association with hepatitis C"/>
   <result pre="non-A, non-B hepatitis in the United States and association with" exact="hepatitis" post="C virus infection. JAMA264: 2231–2235.2170702 48WallingaJ, LipsitchM (2007) How"/>
   <result pre="Sci274: 599–604.17476782 49HaganH, PougetER, Des JarlaisDC, Lelutiu-WeinbergerC (2008) Meta-regression of" exact="hepatitis" post="C virus infection in relation to time since onset"/>
   <result pre="Epidemiol168: 1099–1109.18849303 50Raptopoulou-GigiM, OrphanouE, LallaTH, LitaA, GarifallosA (2001) Prevalence of" exact="hepatitis" post="C virus infection in a cohort of pregnant women"/>
   <result pre="risk factors and evaluation of a screening strategy for chronic" exact="hepatitis" post="C and B virus infections in healthy company employees."/>
   <result pre="AlbertiA, BernasconiE, ButiM, et al. (2011) A systematic review of" exact="hepatitis" post="C virus epidemiology in Europe, Canada and Israel. Liver"/>
   <result pre="2194–2197.1969502 55PageK, HahnJA, EvansJ, ShiboskiS, LumP, et al. (2009) Acute" exact="hepatitis" post="C virus infection in young adult injection drug users:"/>
   <result pre="ShermanSG, StrathdeeS, et al. (2005) Prospective evaluation of community-acquired acute-phase" exact="hepatitis" post="C virus infection. Clin Infect Dis40: 951–958.15824985 57ArmstrongGL, AlterMJ,"/>
   <result pre="951–958.15824985 57ArmstrongGL, AlterMJ, McQuillanGM, MargolisHS (2000) The past incidence of" exact="hepatitis" post="C virus infection: implications for the future burden of"/>
   <result pre="C virus infection: implications for the future burden of chronic" exact="liver disease" post="in the United States. Hepatology31: 777–782.10706572 58WilliamsIT, BellBP, KuhnertW,"/>
   <result pre="BellBP, KuhnertW, AlterMJ (2011) Incidence and transmission patterns of acute" exact="hepatitis" post="C in the United States, 1982–2006. Arch Intern Med171:"/>
   <result pre="perspective. Blood112: 2617–2626.18809775 60ChungH, UedaT, KudoM (2010) Changing trends in" exact="hepatitis" post="C infection over the past 50 years in Japan."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC6695746/results/search/disease/results.xml">
   <result pre="crises. Moreover, physicians should encourage patients to get immunized for" exact="influenza" post="every year. sickle cell disease vaso-occlusive crisis (VOC) climate"/>
   <result pre="main genetic forms that combine different structural hemoglobin variants or" exact="thalassemia" post="syndromes (hemoglobin S HbS, hemoglobin C HbC, β-thalassemia): HbSS"/>
   <result pre="hemoglobin C HbC, β-thalassemia): HbSS (68%), HbSC (25%), and Sβ" exact="thalassemia" post="(7%) [10]. Identifying a link between environmental factors and"/>
   <result pre="weeks before returning to the north. The weekly series of" exact="influenza" post="outbreaks clearly showed the occurrence of several infectious episodes"/>
   <result pre="of interest. Data showed that except for the year 2008," exact="influenza" post="outbreaks occurred every year. The magnitude of the epidemics"/>
   <result pre="and 2014 also recorded important epidemics. The timing of the" exact="influenza" post="outbreaks was also variable across years; although in most"/>
   <result pre="autoregressive parameters of order 1, 3 and 4 and the" exact="influenza" post="series (lag 1). The value of the influenza variable"/>
   <result pre="and the influenza series (lag 1). The value of the" exact="influenza" post="variable estimator translates one new hospitalization case for VOC"/>
   <result pre="without prior emergency visit), the associated factors were different and" exact="influenza" post="was the only explanatory series that correlated significantly with"/>
   <result pre="explains, in part, the increase in hospitalizations for VOC during" exact="influenza" post="epidemics [16]. The question of vaccination also arises here."/>
   <result pre="insurance in France. The vaccine coverage of SCD patients against" exact="influenza" post="in France is not exactly known, but it is"/>
   <result pre="A study in the UK showed an immunization against viral" exact="influenza" post="of 12% in adults and 8% in children [17]."/>
   <result pre="device or to defective measures was substantial. The integration of" exact="chikungunya" post="and Zika epidemics as explanatory series of VOC would"/>
   <result pre="quite clear, but so far there has been only one" exact="chikungunya" post="epidemic and one Zika epidemic in French Guiana, which"/>
   <result pre="does not allow a time series analysis. The impact of" exact="dengue fever" post="should also be tested, but so far the two"/>
   <result pre="seemed, however, that graphically there were no correlations between the" exact="dengue fever" post="series and the two VOC series. In conclusion, patients"/>
   <result pre="crises. Moreover, physicians should encourage patients to get immunized for" exact="influenza" post="vaccine every year. Improving the influenza vaccine coverage and"/>
   <result pre="to get immunized for influenza vaccine every year. Improving the" exact="influenza" post="vaccine coverage and optimizing pneumococcal vaccine coverage could reduce"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC6964091/results/search/disease/results.xml">
   <result pre="540 doi: 10.1186/s12992-019-0540-4 : Research Spatial and temporal distribution of" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies in"/>
   <result pre="temporal analysis indicates that the risk of emerging and re-emerging" exact="infectious disease" post="epidemics has risen [1, 8]. This could partly be"/>
   <result pre="WHO Health Emergencies Programme from the website https://www.afro.who.int/health-topics/disease-outbreaks/outbreaks-and-other-emergencies-updates. Data on" exact="infectious disease" post="epidemics, disasters and other emergencies were compiled from the"/>
   <result pre="are published weekly in the DON website (https://www.who.int/csr/don/archive/year/2016/en/). Data on" exact="infectious disease" post="epidemics and other health emergencies were compiled from the"/>
   <result pre="the period 2016 to 2018. Assembly of the data for" exact="infectious disease" post="epidemics and other public health emergencies Most of the"/>
   <result pre="events by country for the period 2016–2018. Results Over 260" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies were"/>
   <result pre="one epidemic per year (Fig. 1). These data demonstrate that" exact="infectious disease" post="epidemics continue to emerge and re-emerge predictably in certain"/>
   <result pre="1). Table 1 Prioritization of countries, based on frequency of" exact="infectious disease" post="epidemics, 2016–2018 Discussion This analysis demonstrates that the entire"/>
   <result pre="suggests that there is an increase in the frequency of" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies in"/>
   <result pre="greater scale of epidemics. Some of the changes in the" exact="infectious disease" post="transmission patterns are likely a consequence of climate change,"/>
   <result pre="Ebola virus disease epidemic [1]). Second, several epidemics of meningococcal" exact="meningitis" post="recently occurred outside the meningitis belt, showing a high"/>
   <result pre="Second, several epidemics of meningococcal meningitis recently occurred outside the" exact="meningitis" post="belt, showing a high likelihood that the areas at"/>
   <result pre="constituting a dual threat. We explored the dual occurrence of" exact="infectious disease" post="epidemics, disasters and humanitarian crises. A comparison of data"/>
   <result pre="epidemics, disasters and humanitarian crises. A comparison of data on" exact="infectious disease" post="epidemics, disasters and other potential public health emergencies suggest"/>
   <result pre="emergencies suggest that certain countries have a high frequency of" exact="infectious disease" post="epidemics, as well as, a high frequency of other"/>
   <result pre="Africa highlight the negative compounding effects of humanitarian crisis and" exact="infectious disease" post="epidemics, suggesting obvious benefits of cross linkages and the"/>
   <result pre="Niche Modeling for Filoviruses: A risk map for ebola and" exact="marburg virus disease" post="outbreaks in uganda. PLoS Curr. 2017;5:9. 33.NyakarahukaLShoemakerTRBalinandiSChemosGKwesigaBet al.Marburg virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7098263/results/search/disease/results.xml">
   <result pre="Comput Biol201286e100255222761556 25PoonAFYImpacts and shortcomings of genetic clustering methods for" exact="infectious disease" post="outbreaksVirus Evol201622vew031vew03128058111 26RatmannOvan SighemABezemerDGavryushkinaAJurriaansSWensingASources of HIV infection among men"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7102705/results/search/disease/results.xml">
   <result pre="affected to date, with multiple health and socio-economic consequences. This" exact="infectious disease" post="of poverty was first discovered in Uganda in 1947;"/>
   <result pre="1 ). Figure 1 Reported and active transmission of Zika" exact="viral disease" post="countries. Zika is caused by an arthropod-borne virus &quot;arbovirus&quot;"/>
   <result pre="the flavivirus family that also includes dengue, West Nile and" exact="yellow fever." post="Zika virus (ZIKV) can be transmitted through blood and"/>
   <result pre="economic impacts. In comparison, Brazil reported 4000 cases of fetal" exact="microcephaly" post="during pregnancy yet had only 150 cases total in"/>
   <result pre="and tools for early detection and rapid confirmation of ZIKV-linked" exact="microcephaly" post="and early warning systems to provide timely evidence-based information"/>
   <result pre="guidelines for outbreak surveillance and response in humanitarian emergencies, global" exact="infectious disease" post="surveillance, epidemic preparedness and response, Global Alert and Response"/>
   <result pre="and 2016, Brazil recorded the highest number of cases of" exact="microcephaly" post="(more than 3800), which was over 30 times more"/>
   <result pre="in any year since 2010 (Fig. 1). Zika and dengue" exact="viral disease" post="impact implications on global maternal–child health burden Both Zika"/>
   <result pre="determinants and to confirm the association between Zika virus infections," exact="microcephaly" post="and related neurological aberrations suspected in fetal and childhood"/>
   <result pre="). Table 1 Key comparative characteristics between Zika and dengue" exact="viral disease" post="threats and epidemics. Table 1 Characteristics Zika Dengue References"/>
   <result pre="arthralgiaJoints pain and conjunctivitis, Rash, headaches, Guillain–Barre syndrome, increasing congenital" exact="microcephaly" post="or birth defects or neurological disorders in babies/newborns, stillbirths"/>
   <result pre="behind the eyesMuscle and severe abdominal joint painSwollen glands or" exact="rash" post="nausea, vomitingComplications include fluid accumulation, respiratory distress, severe bleeding,Restlessness"/>
   <result pre="&amp;gt;2 million &amp;gt;652,212 cases of dengue hemorrhagic fever67–136 million cases" exact="dengue fever" post="Global cumulative deaths – NA 22,000 deaths mainly among"/>
   <result pre="inequities, poverty and the maternal–child health burden in most emerging" exact="infectious disease" post="epidemic-prone countries. Discussion Zika and dengue viral diseases have"/>
   <result pre="biological risk factors, including poor community engagement and lack of" exact="viral disease" post="surveillance–response systems, have several related implications [6], [8]. Table"/>
   <result pre="socio-economic challenges in sub-Saharan Africa. Tackling emerging or re-emerging vector-borne" exact="viral disease" post="requires more proactive and concrete efforts and commitment in"/>
   <result pre="with MERS-CoV and dengue in Saudi Arabia, H1N1 and H7N9" exact="avian influenza" post="in China [2], [5], [9], [17], [26], [28]. Additionally,"/>
   <result pre="MERS-CoV and dengue in Saudi Arabia, H1N1 and H7N9 avian" exact="influenza" post="in China [2], [5], [9], [17], [26], [28]. Additionally,"/>
   <result pre="urgent need to improve investment in Zika, dengue and other" exact="infectious disease" post="research and development on evidence-informed and sustainable policies making"/>
   <result pre="and macular atrophy in a child with microcephalyLancetJanuary201610.1016/S0140-6736(16)00006-4pii: S0140-6736(16)00006-4 8Villamil-GómezW.E.González-CamargoO.Rodriguez-AyubiJ.Zapata-SerpaD.Rodriguez-MoralesA.J.Dengue," exact="chikungunya" post="and Zika co-infection in a patient from ColombiaJ Infect"/>
   <result pre="policies and programsJ Prev Infect Control1120152 27RothA.MercierA.LepersC.HoyD.DuituturagaS.BenyonE.Concurrent outbreaks of dengue," exact="chikungunya" post="and Zika virus infections – an unprecedented epidemic wave"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7119083/results/search/disease/results.xml">
   <result pre="that now officially named SARS-CoV-2 is 80–89% similar to bat" exact="severe acute respiratory syndrome" post="related coronaviruses found in Chinese horseshoe bats [2], [3]."/>
   <result pre="[2], [3]. In addition, it is about 79% akin to" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) and 50% related to Middle East respiratory"/>
   <result pre="one week after symptom onset, and some progress to develop" exact="acute respiratory distress syndrome." post="The median time from presentation to mechanical ventilation is"/>
   <result pre="outcomes, but resulted in devastating steroid induced complications [14]. As" exact="respiratory failure" post="is the predominant complication of COVID-19, attention to the"/>
   <result pre="high-flow nasal oxygen (HFNO) may prevent intubation in severe hypoxemic" exact="respiratory failure" post="[23]. Within the ICU, and with HCW protected by"/>
   <result pre="non-invasive ventilation (NIV) and HFNO use during SARS-CoV and 2009" exact="influenza" post="epidemic was not clearly associated with an increased risk"/>
   <result pre="unclear and mortality benefit of HFNO and NIV in severe" exact="pneumonia" post="is unproven, we do not currently recommend their use"/>
   <result pre="pressure airflow. Based on the experience of SARS-CoV and H1N1" exact="influenza" post="outbreaks, seriously ill patients are referred to specialised units"/>
   <result pre="SARS-CoV-2 to date have not yet shown signs of severe" exact="respiratory failure" post="and some have been discharged from hospital after the"/>
   <result pre="procurement. Painful lessons were learned from the recent SARS-CoV and" exact="influenza" post="epidemics. It is time to apply what we have"/>
   <result pre="2019 novel coronavirus in Wuhan, ChinaLancet39510223202049750631986264 2ChanJ.F.YuanS.KokK.H.ToK.K.ChuH.YangJ.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="for virus origins and receptor bindingLancet39510224202056557432007145 4LiW.WongS.K.LiF.KuhnJ.H.HuangI.C.ChoeH.Animal origins of the" exact="severe acute respiratory syndrome" post="coronavirus: insight from ACE2-S-protein interactionsJ Virol80920064211421916611880 5El-KafrawyS.A.CormanV.M.TolahA.M.Al MasaudiS.B.HassanA.M.MullerM.A.Enzootic patterns"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 7PhanL.T.NguyenT.V.LuongQ.C.NguyenT.V.NguyenH.T.LeH.Q.Importation and human-to-human"/>
   <result pre="2 is a functional receptor for the SARS coronavirusNature4266965200345045414647384 11ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="13WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA202010.1001/jama.2020.1585 14GriffithJ.F.AntonioG.E.KumtaS.M.HuiD.S.WongJ.K.JoyntG.M.Osteonecrosis of hip and knee in"/>
   <result pre="Wuhan, ChinaJAMA202010.1001/jama.2020.1585 14GriffithJ.F.AntonioG.E.KumtaS.M.HuiD.S.WongJ.K.JoyntG.M.Osteonecrosis of hip and knee in patients with" exact="severe acute respiratory syndrome" post="treated with steroidsRadiology2351200516817515703312 15TelemanM.D.BoudvilleI.C.HengB.H.ZhuD.LeoY.S.Factors associated with transmission of severe"/>
   <result pre="respiratory syndrome treated with steroidsRadiology2351200516817515703312 15TelemanM.D.BoudvilleI.C.HengB.H.ZhuD.LeoY.S.Factors associated with transmission of" exact="severe acute respiratory syndrome" post="among health-care workers in SingaporeEpidemiol Infect1325200479780315473141 16ChenW.Q.LingW.H.LuC.Y.HaoY.T.LinZ.N.LingL.Which preventive measures"/>
   <result pre="health care workers from SARS?BMC Public Health920098119284644 17BoothT.F.KournikakisB.BastienN.HoJ.KobasaD.StadnykL.Detection of airborne" exact="severe acute respiratory syndrome" post="(SARS) coronavirus and environmental contamination in SARS outbreak unitsJ"/>
   <result pre="lessons learnedAntiviral Res1002201340741923994190 20JiangS.HuangL.ChenX.WangJ.WuW.YinS.Ventilation of wards and nosocomial outbreak of" exact="severe acute respiratory syndrome" post="among healthcare workersChin Med J (Engl)116920031293129714527351 21VariaM.WilsonS.SarwalS.McGeerA.GournisE.GalanisE.Investigation of a"/>
   <result pre="workersChin Med J (Engl)116920031293129714527351 21VariaM.WilsonS.SarwalS.McGeerA.GournisE.GalanisE.Investigation of a nosocomial outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in Toronto, CanadaCMAJ1694200328529212925421 22GomersallC.D.JoyntG.M.HoO.M.IpM.YapF.DerrickJ.L.Transmission of SARS to healthcare"/>
   <result pre="respiratory failure: a meta-analysis of randomized controlled trialsCMAJ18972017E260E26728246239 24FowlerR.A.GuestC.B.LapinskyS.E.SibbaldW.J.LouieM.TangP.Transmission of" exact="severe acute respiratory syndrome" post="during intubation and mechanical ventilationAm J Respir Crit Care"/>
   <result pre="acute respiratory infection: a cohort study in patients with 2009" exact="influenza" post="A/H1N1vJ Crit Care275201243443922762937 26ReynoldsM.G.AnhB.H.ThuV.H.MontgomeryJ.M.BauschD.G.ShahJ.J.Factors associated with nosocomial SARS-CoV transmission"/>
   <result pre="Health6200620716907978 27HeuerJ.F.CrozierT.A.HowardG.QuintelM.Can breathing circuit filters help prevent the spread of" exact="influenza" post="A (H1N1) virus from intubated patients?GMS Hyg Infect Control812013Doc0923967395"/>
   <result pre="procedures for intensive care unit and hospital preparations for an" exact="influenza" post="epidemic or mass disasterChapter 7Intensive Care Med36Suppl 12010S55S6420213422 37ChristianM.D.SprungC.L.KingM.A.DichterJ.R.KissoonN.DevereauxA.V.Triage:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7120695/results/search/disease/results.xml">
   <result pre="as a global pandemic. Abstract Mathematical models when applied to" exact="infectious disease" post="data can provide extremely useful insights into the possible"/>
   <result pre="with early investigations exemplified by Bernoulli (1) (in relation to" exact="smallpox" post="inoculation), Ross (2) (in relation to malaria transmission), and"/>
   <result pre="(in relation to smallpox inoculation), Ross (2) (in relation to" exact="malaria" post="transmission), and Kermack and McKendrick (3) (in relation to"/>
   <result pre="of the complex biological and epidemiological systems that underlie emerging" exact="infectious disease" post="threats and thus enabling better prospects for their control."/>
   <result pre="given what little might be known about a particular emerging" exact="infectious disease" post="problem. A more reasonable approach is to have a"/>
   <result pre="mean (and variances) for influenza, SARS coronavirus (SARS CoV), and" exact="smallpox" post="have been estimated to be about 1.3 days (0.5"/>
   <result pre="parameters, respectively. A simple example concerns crude analysis of the" exact="smallpox" post="outbreaks that resulted from importations into Europe from abroad"/>
   <result pre="possible to derive a reasonable estimate of the transmissibility of" exact="smallpox" post="based on an equivalent regression model (31) (Fig. 1)."/>
   <result pre="(Fig. 1). Fig. 1. Fitting a linear regression model to" exact="infectious disease" post="data showing the strong relationship between the extent to"/>
   <result pre="data showing the strong relationship between the extent to which" exact="smallpox" post="outbreaks expanded as delays in the public health response"/>
   <result pre="order of 104 spores, whilst that for Francisella tularensis or" exact="smallpox" post="virus has been estimated to be of the order"/>
   <result pre="of 10 cells/virions or so. Moving on to more complex" exact="infectious disease" post="models, there is an extensive ecological and epidemiological modelling"/>
   <result pre="a range of public health interventions, in this case for" exact="smallpox" post="(c), (see text). To better understand these, first imagine"/>
   <result pre="epidemic data at the start of outbreaks, as in the" exact="smallpox" post="example above. However, common sense tells us that epidemics"/>
   <result pre="with assessing vaccination programmes for vaccine-preventable childhood diseases such as" exact="measles" post="and mumps) then disease mortality has to be factored"/>
   <result pre="and health-care systems. Clearly, the severity of diseases such as" exact="smallpox" post="with a case fatality ratio estimated to be in"/>
   <result pre="set of consequences compared to a disease such as pandemic" exact="influenza" post="with its usually much lower estimates for the case"/>
   <result pre="final attack size or R0. Therefore, for diseases such as" exact="smallpox" post="(R0 in the range 3–6), SARS CoV (R0 about"/>
   <result pre="in the range 3–6), SARS CoV (R0 about 3–4) and" exact="measles" post="(with one of the highest estimated R0’s for an"/>
   <result pre="measles (with one of the highest estimated R0’s for an" exact="infectious disease," post="variously reported to be in the range 12 to"/>
   <result pre="example, that maybe only about 60% of individuals infected with" exact="influenza" post="actually develop reportable clinical symptoms, whilst by comparison cases"/>
   <result pre="actually develop reportable clinical symptoms, whilst by comparison cases of" exact="smallpox" post="and SARS CoV are rarely, if ever considered, to"/>
   <result pre="+ R = 1. Typically, for a new or emerging" exact="infectious disease" post="initial conditions are given such that no people are"/>
   <result pre="between 1 and 3 for diseases such as pandemic influenza," exact="pneumonic plague" post="or SARS CoV, a one off introduction of a"/>
   <result pre="1 and 3 for diseases such as pandemic influenza, pneumonic" exact="plague" post="or SARS CoV, a one off introduction of a"/>
   <result pre="different infectiousness, I1, I2, I3, and so forth. Thus for" exact="influenza" post="it might be appropriate to have an I1 class"/>
   <result pre="both prodromal and infectious periods, since in the case of" exact="smallpox" post="both are infectious (signified by the two dotted lines"/>
   <result pre="the former, according to our knowledge and analysis of previous" exact="smallpox" post="outbreaks (30, 40). Some Problems with Data and the"/>
   <result pre="symptom onset because of the extremely short infectious period of" exact="influenza" post="and the rapid rise and fall of viral titres"/>
   <result pre="overall, or chronic or recurring such as influenza, HIV, or" exact="tuberculosis" post="can theoretically be much harder to control by these"/>
   <result pre="by these means than diseases such as SARS CoV or" exact="smallpox" post="(18). In this respect, the eradication of SARS CoV"/>
   <result pre="can be a relatively long time in the course of" exact="influenza" post="compared to smallpox (Fig. 5). Depending on the natural"/>
   <result pre="relatively long time in the course of influenza compared to" exact="smallpox" post="(Fig. 5). Depending on the natural history of the"/>
   <result pre="can be more or less feasible. For diseases such as" exact="smallpox" post="or SARS CoV that possibly have a better marked"/>
   <result pre="overcome to some extent; for example, in the case of" exact="influenza" post="this has been achieved by rigorous statistical analysis of"/>
   <result pre="explored in Fig. 7, which relates to observational data on" exact="pneumonic plague" post="(31), which is transmissible person to person at relatively"/>
   <result pre="in Fig. 7, which relates to observational data on pneumonic" exact="plague" post="(31), which is transmissible person to person at relatively"/>
   <result pre="occurring from a primary case. Fig. 7. Offspring distribution for" exact="pneumonic plague." post="Data are the vertical bars; the geometric distribution (solid"/>
   <result pre="4, the higher the estimate of R0 for a particular" exact="infectious disease" post="the higher the proportion of the population that needs"/>
   <result pre="is to bring RE below one. For a pandemic of" exact="influenza" post="with an R0 value of 1.6, for example, this"/>
   <result pre="little as around 37% of the population (43), but for" exact="smallpox" post="with an R0 value in the range of 3–6"/>
   <result pre="2c shows an extension of the earlier SEPIR structure for" exact="smallpox" post="to allow for a whole range of public health"/>
   <result pre="disease of similar natural history. For diseases such as smallpox," exact="pneumonic plague," post="SARS CoV, and bacterial meningitis, for example, the finding"/>
   <result pre="For diseases such as smallpox, pneumonic plague, SARS CoV, and" exact="bacterial meningitis," post="for example, the finding of potentially infected contacts can"/>
   <result pre="health-care facilities (see later for a discussion of transmission of" exact="pneumonic plague" post="in different settings and contexts). Alternatively, or more likely"/>
   <result pre="facilities (see later for a discussion of transmission of pneumonic" exact="plague" post="in different settings and contexts). Alternatively, or more likely"/>
   <result pre="analysis was performed [e.g. as in the case of the" exact="smallpox" post="studies referred to earlier (20, 23)]. Introducing Better Descriptions"/>
   <result pre="matrices can be estimated by attempting to fit models to" exact="infectious disease" post="data where this has been stratified by age group"/>
   <result pre="disproportionate contribution of children to overall disease transmission. For pandemic" exact="influenza" post="it is thought such effects are likely to be"/>
   <result pre="such effects are likely to be important, since, for seasonal" exact="influenza" post="at least, children do seem to be particularly implicated"/>
   <result pre="do seem to be particularly implicated in transmission (47–49). For" exact="smallpox" post="and SARS CoV on the other hand this is"/>
   <result pre="hand this is much less certain. In the case of" exact="smallpox" post="it would seem from the limited historical observations available"/>
   <result pre="limited historical observations available on populations that had not experienced" exact="smallpox" post="for some considerable time (and so no older members"/>
   <result pre="considered here more simply in terms of metapopulation models. Taking" exact="pneumonic plague" post="again as an example it is clear from historical"/>
   <result pre="here more simply in terms of metapopulation models. Taking pneumonic" exact="plague" post="again as an example it is clear from historical"/>
   <result pre="9). Fig. 9. The contexts in which the transmission of" exact="pneumonic plague" post="was observed to occur. The most frequent context for"/>
   <result pre="Fig. 9. The contexts in which the transmission of pneumonic" exact="plague" post="was observed to occur. The most frequent context for"/>
   <result pre="in itself probably accounts for the fact that outbreaks of" exact="pneumonic plague" post="(with a low overall reproductive potential) were readily brought"/>
   <result pre="itself probably accounts for the fact that outbreaks of pneumonic" exact="plague" post="(with a low overall reproductive potential) were readily brought"/>
   <result pre="complexity can be constructed to tackle problems related to (re-)emerging" exact="infectious disease" post="problems and their control. Before embarking on model development"/>
   <result pre="Only in this way can an outbreak of an emerging" exact="infectious disease" post="really be better understood at the time when the"/>
   <result pre="attempt at a new analysis of the mortality caused by" exact="smallpox" post="and of the advantages of inoculation to prevent it."/>
   <result pre="Press 9HethcoteHThe mathematics of infectious diseasesSIAM Rev20004259965310.1137/S0036144500371907 10GrasslyNCFraserCMathematical models of" exact="infectious disease" post="transmissionNat Rev Microbiol2008647748718533288 11CauchemezSCarratFViboudCValleronAJBoëllePYA Bayesian MCMC approach to study"/>
   <result pre="reproduction numbers in an emerging epidemicPLoS ONE20072e75810.1371/journal.pone.000075817712406 15GaniRLeachSTransmission potential of" exact="smallpox" post="in contemporary populationsNature200141474875110.1038/414748a11742399 16FergusonNMKeelingMJEdmundsWJGaniRGrenfellBTAndersonRMLeachSPlanning for smallpox outbreaksNature200342568168510.1038/nature0200714562094 17RileySFraserCDonnellyCAGhaniACAbu-RaddadLJHedleyAJLeungGMHoLMLamTHThachTQChauPChanKPLoSVLeungPYTsangTHoWLeeKHLauEMFergusonNMAndersonRMTransmission dynamics"/>
   <result pre="ONE20072e75810.1371/journal.pone.000075817712406 15GaniRLeachSTransmission potential of smallpox in contemporary populationsNature200141474875110.1038/414748a11742399 16FergusonNMKeelingMJEdmundsWJGaniRGrenfellBTAndersonRMLeachSPlanning for" exact="smallpox" post="outbreaksNature200342568168510.1038/nature0200714562094 17RileySFraserCDonnellyCAGhaniACAbu-RaddadLJHedleyAJLeungGMHoLMLamTHThachTQChauPChanKPLoSVLeungPYTsangTHoWLeeKHLauEMFergusonNMAndersonRMTransmission dynamics of the etiological agent of SARS"/>
   <result pre="Kong: impact of public health interventionsScience20033001961196610.1126/science.108647812766206 18FraserCRileySAndersonRMFergusonNMFactors that make an" exact="infectious disease" post="outbreak controllableProc Natl Acad Sci USA20041016146615110.1073/pnas.030750610115071187 19FergusonNMCummingsDACauchemezSFraserCRileySMeeyaiAIamsirithawornSBurkeDSStrategies for containing"/>
   <result pre="controllableProc Natl Acad Sci USA20041016146615110.1073/pnas.030750610115071187 19FergusonNMCummingsDACauchemezSFraserCRileySMeeyaiAIamsirithawornSBurkeDSStrategies for containing an emerging" exact="influenza" post="pandemic in Southeast AsiaNature200543720921410.1038/nature0401716079797 20RileySFergusonNMSmallpox transmission and control: spatial"/>
   <result pre="early detection of SARSEmerg Infect Dis20061211011310.3201/eid1201.05059316494726 22FergusonNMCummingsDAFraserCCajkaJCCooleyPCBurkeDSStrategies for mitigating an" exact="influenza" post="pandemicNature200644244845210.1038/nature0479516642006 23HallIMEganJRBarrassIGaniRLeachSComparison of smallpox outbreak control strategies using a"/>
   <result pre="Infect Dis20061211011310.3201/eid1201.05059316494726 22FergusonNMCummingsDAFraserCCajkaJCCooleyPCBurkeDSStrategies for mitigating an influenza pandemicNature200644244845210.1038/nature0479516642006 23HallIMEganJRBarrassIGaniRLeachSComparison of" exact="smallpox" post="outbreak control strategies using a spatial metapopulation modelEpidemiol Infect20071351133114417222358"/>
   <result pre="spatial metapopulation modelEpidemiol Infect20071351133114417222358 24PitzerVELeungGMLipsitchMEstimating variability in the transmission of" exact="severe acute respiratory syndrome" post="to household contacts in Hong Kong, ChinaAm J Epidemiol200716635536310.1093/aje/kwm08217493952"/>
   <result pre="30FennerFHendersonDAAritaIJezekZLadnyiIDSmallpox and Its Eradication1988GenevaWorld Health Organization 31GaniRLeachSEpidemiologic determinants for modeling" exact="pneumonic plague" post="outbreaksEmerg Infect Dis20041060861410.3201/eid1004.03050915200849 32StuartAOrdKArnoldSKendall’s Advanced Theory of Statistics, Vol."/>
   <result pre="and Its Eradication1988GenevaWorld Health Organization 31GaniRLeachSEpidemiologic determinants for modeling pneumonic" exact="plague" post="outbreaksEmerg Infect Dis20041060861410.3201/eid1004.03050915200849 32StuartAOrdKArnoldSKendall’s Advanced Theory of Statistics, Vol."/>
   <result pre="outbreakAm J Epidemiol200315811011710.1093/aje/kwg10312851223 41GaniRHughesHFlemingDGriffinTMedlockJLeachSPotential impact of antiviral drug use during" exact="influenza" post="pandemicEmerg Infect Dis2005111355136210.3201/eid1209.04134416229762 42MaJEarnDGenerality of the final size formula"/>
   <result pre="infectious diseaseJ R Soc Interface200851001100710.1098/rsif.2008.001318319209 47VynnyckyEEdmundsWJAnalyses of the 1957 (Asian)" exact="influenza" post="pandemic in the United Kingdom and the impact of"/>
   <result pre="school closuresEpidemiol Infect200813616617917445311 48CauchemezSValleronAJBoëllePYFlahaultAFergusonNMEstimating the impact of school closure on" exact="influenza" post="transmission from Sentinel dataNature200845275075410.1038/nature0673218401408 49HalloranMEFergusonNMEubankSLonginiIMJrCummingsDALewisBXuSFraserCVullikantiAGermannTCWagenerDBeckmanRKadauKBarrettCMackenCABurkeDSCooleyPModeling targeted layered containment of"/>
   <result pre="transmission from Sentinel dataNature200845275075410.1038/nature0673218401408 49HalloranMEFergusonNMEubankSLonginiIMJrCummingsDALewisBXuSFraserCVullikantiAGermannTCWagenerDBeckmanRKadauKBarrettCMackenCABurkeDSCooleyPModeling targeted layered containment of an" exact="influenza" post="pandemic in the United StatesProc Natl Acad Sci USA200810546394410.1073/pnas.070684910518332436"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7144339/results/search/disease/results.xml">
   <result pre="emergence of and outbreaks of several infectious diseases including Japanese" exact="encephalitis" post="(JE), malaria, and dengue fever in Nepal [3,4]. These"/>
   <result pre="of several infectious diseases including Japanese encephalitis (JE), malaria, and" exact="dengue fever" post="in Nepal [3,4]. These diseases contribute significantly to socioeconomic"/>
   <result pre="to socioeconomic burden in Nepal, with an increasing impact from" exact="dengue fever" post="in recent years. Several studies on spatiotemporal epidemiology of"/>
   <result pre="future due to climate change. Dengue fever is an infectious" exact="viral disease" post="from tropical and subtropical regions which is transmitted to"/>
   <result pre="DENV-2, DENV-3 and DENV-4) [6,7]. A dramatic increase in global" exact="dengue fever" post="in recent years has put half of the world’s"/>
   <result pre="each year [5]. Since there is no specific treatment for" exact="dengue fever," post="it is now considered to be one of the"/>
   <result pre="at different governmental levels to help manage the outbreaks of" exact="dengue fever." post="Some independent research has been conducted to evaluate the"/>
   <result pre="been conducted to evaluate the spatial and temporal spread of" exact="dengue fever" post="in Nepal [9,21]. These studies have provided the basis"/>
   <result pre="of the disease and the efficacy of control strategies. Since" exact="dengue fever" post="exhibits long-distance dispersal (LDD) through its mosquito vector, the"/>
   <result pre="the efficacy of potential outbreak interventions. Some control measures for" exact="dengue fever" post="have been effective in partially reducing the disease burden,"/>
   <result pre="efficacy of control strategies. Environmental and demographic factors that influence" exact="dengue fever" post="outbreaks should also be thoroughly considered while developing management"/>
   <result pre="and severe dengue [Internet]. Who. 2016. Recuperat: http://www.who.int/mediacentre/factsheets/fs117/en/. 6HalsteadSM.Dengue and" exact="dengue hemorrhagic fever." post="In Handbook of zoonoses, second edition, section B: viral"/>
   <result pre="second edition, section B: viral zoonoses. 2017. doi:10.1201/9780203752463. 7GublerDJ.Dengue and" exact="dengue hemorrhagic fever." post="Clin Microbiol Rev. 1998. doi: 10.1128/cmr.11.3.480 8PandeyBD, RaiSK, MoritaK,"/>
   <result pre="Coll J. 2004;6(2):157–159.16295753 9AcharyaBK, CaoC, LakesT, et al.Spatiotemporal analysis of" exact="dengue fever" post="in Nepal from 2010 to 2014. BMC Public Health."/>
   <result pre="in Nepal. BMC Res Notes; 2018; doi:10.1186/s13104-018-3514-3. 11collab: EDCDUpdates on" exact="dengue fever." post="Epidemiol Dis Control Div. 2019: 1–2[cited 2019 Dec 3]."/>
   <result pre="21DhimalM, GautamI, KreßA, et al.Spatio-temporal distribution of dengue and lymphatic" exact="filariasis" post="vectors along an altitudinal transect in central Nepal. PLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7180007/results/search/disease/results.xml">
   <result pre="called severe respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a deadly" exact="pneumonia" post="outbreak in Wuhan, China [1,2]. It is thought to"/>
   <result pre="epidemics caused by Middle East respiratory syndrome coronavirus (MERS-CoV) and" exact="severe acute respiratory syndrome" post="(SARS) in Middle East (2009) and Guangdong, China (2002-03),"/>
   <result pre="with increasing resilience (S5-S9). While combating the impact of COVID-19" exact="pneumonia" post="(Figure 1), the health care regulatory authorities should communicate"/>
   <result pre="the region under the primary threat. The outbreak of COVID-19" exact="pneumonia" post="imposed a serious threat to the residents of the"/>
   <result pre="coronaviruses.Nat Rev Microbiol. 2019;17:181-92. 10.1038/s41579-018-0118-930531947 4ZhongNSZhengBJLiYMPoonLLMXieZHChanKHet al.Epidemiology and cause of" exact="severe acute respiratory syndrome" post="(SARS) in Guangdong, People’s Republic of China, in February"/>
   <result pre="6ZakiAMVan BoheemenSBestebroerTMOsterhausADMEFouchierRAMIsolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia.N Engl J Med. 2012;367:1814-20. 10.1056/NEJMoa121172123075143 7World"/>
   <result pre="epidemiology of human infections with middle east respiratory syndrome and" exact="severe acute respiratory syndrome" post="coronaviruses among healthcare personnel.PLoS One. 2016;11:e0149988. 10.1371/journal.pone.014998826930074 11HuiDSIAzharEMadaniTANtoumiFKockRDarOet al.The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7182292/results/search/disease/results.xml">
   <result pre="serum samples collected from patients presenting with clinical symptoms of" exact="dengue fever" post="and 152 mosquito pools. RESULTS: We detected the Asian"/>
   <result pre="during an outbreak. DENV-2 is the most frequent cause of" exact="dengue fever" post="epidemics worldwide and is usually associated with severe disease"/>
   <result pre="samples were collected from patients presenting with clinical symptoms of" exact="dengue fever" post="between February 2014 and December 2015. Furthermore, 778 mosquitoes"/>
   <result pre="Venezuela (1994), and Mexico (1995) epidemics, detected in cases of" exact="dengue hemorrhagic fever," post="were closely related to Asian II genotype strains from"/>
   <result pre="the Asian II genotype8. Interestingly, the Asian II genotype caused" exact="meningitis" post="in patients from Minas Gerais, in the southeast region"/>
   <result pre="in addition to the prevalent Asian/American genotype. Successive epidemics of" exact="dengue fever," post="with co-circulation of DENV-1, DENV-2, and DENV-4, have been"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7197577/results/search/disease/results.xml">
   <result pre="a literature review on viral epidemics and pandemics, including the" exact="severe acute respiratory syndrome" post="(SARS), the Middle East respiratory syndrome (MERS), influenza H1N1,"/>
   <result pre="acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS)," exact="influenza" post="H1N1, and the novel severe acute respiratory syndrome coronavirus"/>
   <result pre="Middle East respiratory syndrome (MERS), influenza H1N1, and the novel" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) with the goal of identifying the"/>
   <result pre="7  Stein et al, 201032 478 Headache: 51, seizure: 41," exact="meningitis" post="or encephalitis: 5  Khandaker et al, 201233 506 Seizure:"/>
   <result pre="and a transtentorial brain herniation syndrome associated with pandemic swine" exact="influenza" post="A (H1N1) virus infection. J Clin Neurosci. 2011;18(9):1245-1248.21742505 3.AkinsPT,"/>
   <result pre="J Clin Neurosci. 2011;18(9):1245-1248.21742505 3.AkinsPT, BelkoJ, UyekiTM, AxelrodY, LeeKK, SilverthornJH1N1" exact="encephalitis" post="with malignant edema and review of neurologic complications from"/>
   <result pre="from influenza. Neurocrit Care. 2010;13(3):396-406.20811962 4.LyonJB, RemigioC, MilliganT, DelineCAcute necrotizing" exact="encephalopathy" post="in a child with H1N1 influenza infection. Pediatr Radiol."/>
   <result pre="RemigioC, MilliganT, DelineCAcute necrotizing encephalopathy in a child with H1N1" exact="influenza" post="infection. Pediatr Radiol. 2010;40(2):200-205.20020117 5.UmapathiT, KorAC, VenketasubramanianNet al..Large artery"/>
   <result pre="infection. Pediatr Radiol. 2010;40(2):200-205.20020117 5.UmapathiT, KorAC, VenketasubramanianNet al..Large artery ischaemic" exact="stroke" post="in severe acute respiratory syndrome (SARS). J Neurol. 2004;251(10):1227-1231.15503102"/>
   <result pre="Radiol. 2010;40(2):200-205.20020117 5.UmapathiT, KorAC, VenketasubramanianNet al..Large artery ischaemic stroke in" exact="severe acute respiratory syndrome" post="(SARS). J Neurol. 2004;251(10):1227-1231.15503102 6.IshikawaT, FujioY, MoritaM, TakiyamaY, NakanoI[An"/>
   <result pre="FujioY, MoritaM, TakiyamaY, NakanoI[An adult case of acute cerebellitis after" exact="influenza" post="A infection with a cerebellar corical lesion on MRI]."/>
   <result pre="Neurol Med. 2016;2016:3502683. 27239356 9.Sivadon-TardyV, OrlikowskiD, PorcherRet al..Guillain-Barré syndrome and" exact="influenza" post="virus infection. Clin Infect Dis. 2009;48(1):48-56.19025491 10.D'SilvaD, HewagamaS, DohertyR,"/>
   <result pre="Dis. 2009;48(1):48-56.19025491 10.D'SilvaD, HewagamaS, DohertyR, KormanTM, ButteryJMelting muscles: novel H1N1" exact="influenza" post="A associated rhabdomyolysis. Pediatr Infect Dis J. 2009;28(12):1138-1139.19841604 11.JangH,"/>
   <result pre="neuroinvasive potential of SARS-CoV2 may play a role in the" exact="respiratory failure" post="of COVID-19 patients. J Med Virol. published online: February"/>
   <result pre="GarciaMN, MurrayKO, MunozFMCentral nervous system manifestations in pediatric patients with" exact="influenza" post="A H1N1 infection during the 2009 pandemic. Pediatr Neurol."/>
   <result pre="19.FrobertE, SarretC, BillaudGet al..Pediatric neurological complications associated with the A(H1N1)pdm09" exact="influenza" post="infection. J Clin Virol. 2011;52(4):307-313.21920811 20.EkstrandJJ, HerbenerA, RawlingsJet al..Heightened"/>
   <result pre="WinterK, DuBrayKet al..A population-based study of neurologic manifestations of severe" exact="influenza" post="A(H1N1)pdm09 in California. Clin Infect Dis. 2012;55(4):514-520.22573853 22.JainS, KamimotoL,"/>
   <result pre="Dis. 2012;55(4):514-520.22573853 22.JainS, KamimotoL, BramleyAMet al..Hospitalized patients with 2009 H1N1" exact="influenza" post="in the United States, April-June 2009. N Engl J"/>
   <result pre="2009;361(20):1935-1944.19815859 23.TokuhiraN, ShimeN, InoueMet al..Mechanically ventilated children with 2009 pandemic" exact="influenza" post="A/H1N1. Pediatr Crit Care Med. 2012;13(5):e294-e298.22805157 24.Dominguez-CheritG, LapinskySE, MaciasAEet"/>
   <result pre="Med. 2012;13(5):e294-e298.22805157 24.Dominguez-CheritG, LapinskySE, MaciasAEet al..Critically ill patients with 2009" exact="influenza" post="A(H1N1) in Mexico. JAMA. 2009;302(17):1880-1887.19822626 25.KumarA, ZarychanskiR, PintoRet al..Critically"/>
   <result pre="JAMA. 2009;302(17):1880-1887.19822626 25.KumarA, ZarychanskiR, PintoRet al..Critically ill patients with 2009" exact="influenza" post="A(H1N1) infection in Canada. JAMA. 2009;302(17):1872-1879.19822627 26.ArcherBN, TimothyGA, CohenCet"/>
   <result pre="Canada. JAMA. 2009;302(17):1872-1879.19822627 26.ArcherBN, TimothyGA, CohenCet al..Introduction of 2009 pandemic" exact="influenza" post="A virus subtype H1N1 into South Africa: clinical presentation,"/>
   <result pre="MaoYet al..Clinical features of the initial cases of 2009 pandemic" exact="influenza" post="A (H1N1) virus infection in China. N Engl J"/>
   <result pre="2009;361(26):2507-2517.20007555 29.LibsterR, BugnaJ, CovielloSet al..Pediatric hospitalizations associated with 2009 pandemic" exact="influenza" post="A (H1N1) in Argentina. N Engl J Med. 2010;362(1):45-55.20032320"/>
   <result pre="al..Factors associated with death or hospitalization due to pandemic 2009" exact="influenza" post="A(H1N1) infection in California. JAMA. 2009;302(17):1896-1902.19887665 31.KediaS, StroudB, ParsonsJet"/>
   <result pre="2009;302(17):1896-1902.19887665 31.KediaS, StroudB, ParsonsJet al..Pediatric neurological complications of 2009 pandemic" exact="influenza" post="A (H1N1). Arch Neurol. 2011;68(4):455-462.21149805 32.SteinM, TasherD, GlikmanDet al..Hospitalization"/>
   <result pre="Arch Neurol. 2011;68(4):455-462.21149805 32.SteinM, TasherD, GlikmanDet al..Hospitalization of children with" exact="influenza" post="A(H1N1) virus in Israel during the 2009 outbreak in"/>
   <result pre="Pediatr Adolesc Med. 2010;164(11):1015-1022.21041594 33.KhandakerG, ZurynskiY, ButteryJet al..Neurologic complications of" exact="influenza" post="A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology. 2012;79(14):1474-1481.22993280 34.ArabiYM,"/>
   <result pre="ChauTN, TsangOet al..Outcomes and prognostic factors in 267 patients with" exact="severe acute respiratory syndrome" post="in Hong Kong. Ann Intern Med. 2003;139(9):715-723.14597455 43.TsaiLK, HsiehST,"/>
   <result pre="Kong. Ann Intern Med. 2003;139(9):715-723.14597455 43.TsaiLK, HsiehST, ChangYCNeurological manifestations in" exact="severe acute respiratory syndrome." post="Acta Neurol Taiwan. 2005;14(3):113-119. 16252612 44.LeungCW, ChiuWKClinical picture, diagnosis,"/>
   <result pre="2005;14(3):113-119. 16252612 44.LeungCW, ChiuWKClinical picture, diagnosis, treatment and outcome of" exact="severe acute respiratory syndrome" post="(SARS) in children. Paediatr Respir Rev. 2004;5(4):275-288.15531251 45.LienTC, SungCS,"/>
   <result pre="Rev. 2004;5(4):275-288.15531251 45.LienTC, SungCS, LeeCHet al..Characteristic features and outcomes of" exact="severe acute respiratory syndrome" post="found in severe acute respiratory syndrome intensive care unit"/>
   <result pre="features and outcomes of severe acute respiratory syndrome found in" exact="severe acute respiratory syndrome" post="intensive care unit patients. J Crit Care. 2008;23(4):557-564.19056023 46.MaoL,"/>
   <result pre="al..Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study. Lancet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7202122/results/search/disease/results.xml">
   <result pre="disease (COVID-19) patients and from the avian (H7N9) and H1N1" exact="influenza" post="epidemics. We discuss the potential role for portable point-of-care"/>
   <result pre="and assessment of pulmonary status in patients during the 2013" exact="avian influenza" post="A (H7N9) epidemic.4,5 Similarly, lung ultrasound may aid in"/>
   <result pre="assessment of pulmonary status in patients during the 2013 avian" exact="influenza" post="A (H7N9) epidemic.4,5 Similarly, lung ultrasound may aid in"/>
   <result pre="from COVID-19 patients and from the avian (H7N9) and H1N1" exact="influenza" post="epidemics. We also discuss the potential role for portable"/>
   <result pre="y (3 cases &amp;gt;65 y) with fever, radiographic features of" exact="pneumonia" post="by computed tomography, and normal or decreased white blood"/>
   <result pre="consolidationsNormal lung ultrasound initiallyUltrasound findings occur in the absence of" exact="shortness" post="of breath/dyspnea and occur before malaise Thomas et al8"/>
   <result pre="which seems to be highly consistent with other cases of" exact="viral pneumonia" post="(Figure D and F; Supplemental Digital Content 3, Video"/>
   <result pre="seems to be highly consistent with other cases of viral" exact="pneumonia" post="(Figure D and F; Supplemental Digital Content 3, Video"/>
   <result pre="prior epidemics, including the subpleural consolidations described on ultrasound in" exact="influenza" post="A (H1N1) and subpleural consolidations and B lines described"/>
   <result pre="A (H1N1) and subpleural consolidations and B lines described in" exact="avian influenza" post="A (H7N9).5,6,9 In contrast, normal lungs have an A-line"/>
   <result pre="(H1N1) and subpleural consolidations and B lines described in avian" exact="influenza" post="A (H7N9).5,6,9 In contrast, normal lungs have an A-line"/>
   <result pre="IN PRIOR EPIDEMICS: WHAT IS THE SAME? During the 2009" exact="influenza" post="A (H1N1) pandemic, in which patients’ conditions rapidly deteriorated"/>
   <result pre="radiographs, 63% of whom were subsequently diagnosed with viral (H1N1)" exact="pneumonia" post="and 38% of whom were diagnosed with bacterial pneumonia.9"/>
   <result pre="of 96% and outperformed chest radiography for the detection of" exact="viral pneumonia" post="in symptomatic patients.5 The avian influenza A (H7N9) epidemics"/>
   <result pre="96% and outperformed chest radiography for the detection of viral" exact="pneumonia" post="in symptomatic patients.5 The avian influenza A (H7N9) epidemics"/>
   <result pre="for the detection of viral pneumonia in symptomatic patients.5 The" exact="avian influenza" post="A (H7N9) epidemics of 2013–2014 and 2016 saw large"/>
   <result pre="the detection of viral pneumonia in symptomatic patients.5 The avian" exact="influenza" post="A (H7N9) epidemics of 2013–2014 and 2016 saw large"/>
   <result pre="demonstrated the effectiveness of POCUS in the early identification of" exact="pneumonia" post="secondary to the H7N9 virus.4,5 In both patients who"/>
   <result pre="to the H7N9 virus.4,5 In both patients who eventually developed" exact="acute respiratory distress syndrome" post="(ARDS) as a result of the infection, serial lung"/>
   <result pre="with previously documented findings in viral pulmonary infections such as" exact="measles" post="and H1N1.4,5 Thus, ultrasonography has repeatedly proven to be"/>
   <result pre="Lung ultrasound can help clinicians to differentiate between a possible" exact="pneumonia" post="and alternative causes of dyspnea while awaiting confirmatory testing"/>
   <result pre="dynamic air bronchograms may suggest the development of a superimposed" exact="bacterial pneumonia." post="In addition to other clinical parameters, such ultrasound findings"/>
   <result pre="for additional PEEP and recruitment maneuvers. Although less common in" exact="viral pneumonia," post="the size, location, and appearance of any pleural effusions"/>
   <result pre="Material LINK LINK LINK LINK LINK FOOTNOTES GLOSSARY ARDS =" exact="acute respiratory distress syndrome" post="COVID-19 = coronavirus disease 2019 PEEP = positive end-expiratory"/>
   <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version).Mil Med Res. 2020;7:4.32029004 2.collab: Radiology ACR. ACR"/>
   <result pre="ultrasound: present and future.Lung India. 2015;32:250–257.25983411 4.TsaiNWNgaiCWMokKLTsungJWLung ultrasound imaging in" exact="avian influenza" post="A (H7N9) respiratory failure.Crit Ultrasound J. 2014;6:6.24949191 5.Yu-Kun ZhangJLJian-pingYYingZJunCLung"/>
   <result pre="present and future.Lung India. 2015;32:250–257.25983411 4.TsaiNWNgaiCWMokKLTsungJWLung ultrasound imaging in avian" exact="influenza" post="A (H7N9) respiratory failure.Crit Ultrasound J. 2014;6:6.24949191 5.Yu-Kun ZhangJLJian-pingYYingZJunCLung"/>
   <result pre="5.Yu-Kun ZhangJLJian-pingYYingZJunCLung ultrasonography for the diagnosis of 11 patients with" exact="acute respiratory distress syndrome" post="due to bird flu H7N9 infection.Virol J. 2015;12:176.26503117 6.collab:"/>
   <result pre="#COVID diagnosis. Sore throat, headache (strong!), Dry cough but not" exact="shortness" post="of breath. No lung US abnormalities. Will keep a"/>
   <result pre="Less sore throat, cough &amp;amp; headache (thank God!), still no" exact="shortness" post="of breath or pleuritic chest pain. #POCUS update: small"/>
   <result pre="diagnosis. No sore throat/headache. Yesterday was cough day, still no" exact="shortness" post="of breath/chest pain. Diarrhea started, lucky cough got better."/>
   <result pre="the ultrasonic manifestations of peripulmonary lesions of non-critical novel coronavirus" exact="pneumonia" post="(COVID-19).SSRN. 2020 February 26 [Epub ahead of print]. 8.ThomasAHaljanGMitraALung"/>
   <result pre="15, 2020. 11.AgarwalPPCintiSKazerooniEAChest radiographic and CT findings in novel swine-origin" exact="influenza" post="A (H1N1) virus (S-OIV) infection.AJR Am J Roentgenol. 2009;193:1488–1493.19933638"/>
   <result pre="J Roentgenol. 2009;193:1488–1493.19933638 12.collab: World Health Organization. Human infection with" exact="avian influenza" post="A (H7N9) virus – China.2017Available at: www.who.int/csr/don/26-october-2017-ah7n9-china/en/. Accessed May"/>
   <result pre="Roentgenol. 2009;193:1488–1493.19933638 12.collab: World Health Organization. Human infection with avian" exact="influenza" post="A (H7N9) virus – China.2017Available at: www.who.int/csr/don/26-october-2017-ah7n9-china/en/. Accessed May"/>
   <result pre="15.TsungJWKesslerDOShahVPProspective application of clinician-performed lung ultrasonography during the 2009 H1N1" exact="influenza" post="A pandemic: distinguishing viral from bacterial pneumonia.Crit Ultrasound J."/>
   <result pre="print]. 17.PratGGuinardSBizienNet al.Can lung ultrasonography predict prone positioning response in" exact="acute respiratory distress syndrome" post="patients?J Crit Care. 2016;32:36–41.26806842 18.WangXTDingXZhangHMChenHSuLXLiuDWcollab: Chinese Critical Ultrasound Study"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7203543/results/search/disease/results.xml">
   <result pre="the past ten years, only 15% of PLWH achieved viral" exact="suppression" post="[6]. The COVID-19 outbreak further intensifies existing challenges while"/>
   <result pre="For PLWH in care, maintaining HIV treatment and achieving viral" exact="suppression" post="were also challenging during the COVID-19 outbreak. For instance,"/>
   <result pre="vulnerable populations such as communities affected by HIV during another" exact="infectious disease" post="epidemic. This may also be an opportunity to engage"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7225630/results/search/disease/results.xml">
   <result pre="reminded of what it is like to live with rampant" exact="infectious disease," post="without effective drugs or vaccines. Researchers have piled in"/>
   <result pre="and MERS-CoV, two related viruses that have caused epidemics of" exact="respiratory disease." post="A crucial question was whether SARS-CoV-2 resembled either of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7229974/results/search/disease/results.xml">
   <result pre="outbreaks of other viral infections, including the 1918 Spanish H1N1" exact="influenza" post="A pandemic and, more recently, the 2003 Avian H5N1"/>
   <result pre="influenza A pandemic and, more recently, the 2003 Avian H5N1" exact="influenza" post="A epidemic, the 2003 SARS-CoV-1 epidemic, the 2009-2010 H1N1"/>
   <result pre="influenza A epidemic, the 2003 SARS-CoV-1 epidemic, the 2009-2010 H1N1" exact="influenza" post="pandemic, the 2012 Middle East Respiratory Syndrome (MERS)-CoV epidemic,"/>
   <result pre="SARS-CoV-2 viral loads, and normalization of temperature and resolution of" exact="acute respiratory distress syndrome" post="(ARDS) [7]. Duan and colleagues presented a series of"/>
   <result pre="collection and biologic qualification (number, volume and frequency of donations," exact="infectious disease" post="markers and pathogen inactivation) and treatment and disease characteristics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7245250/results/search/disease/results.xml">
   <result pre="are less than 5 years of age. Cough, vomiting, sterile" exact="pyuria" post="and diarrhea is very common in KD patients. The"/>
   <result pre="than 5 years of age. Cough, vomiting, sterile pyuria and" exact="diarrhea" post="is very common in KD patients. The exact etiology"/>
   <result pre="exact etiology of KD is not fully described, but the" exact="infectious disease," post="especially the ones that are caused by the respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7256497/results/search/disease/results.xml">
   <result pre="and lymphopenia.5 These symptoms are common among other types of" exact="influenza" post="and bacterial common cold. Wearing masks will also prevent"/>
   <result pre="symptoms are common among other types of influenza and bacterial" exact="common cold." post="Wearing masks will also prevent those types of infections"/>
   <result pre="COVID-19 can be screened out of all other types of" exact="influenza" post="and common cold comparatively easily. By referring fewer people"/>
   <result pre="be screened out of all other types of influenza and" exact="common cold" post="comparatively easily. By referring fewer people to the clinics"/>
   <result pre="Association.202010.1016/j.jfma.2020.04.013In press 4AghamohammadiM.AlizargarJ.HsiehN.-C.S-FVWuProphylactic anticoagulant therapy for reducing the risk of" exact="stroke" post="and other thrombotic events in COVID-19 patientsJournal of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7257617/results/search/disease/results.xml">
   <result pre="to the absence in the population of prior immunity to" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), as occurred in fully susceptible populations"/>
   <result pre="epidemics. In particular, S hankset al. [2] report that the" exact="measles" post="mortality rate in a fully susceptible population during the"/>
   <result pre="mortality rate in a fully susceptible population during the 1846" exact="measles" post="epidemic was higher in adults and in children aged"/>
   <result pre="older than 20 years are still more likely to suffer from" exact="measles" post="complications, despite not being fully susceptible [3]. Moreover, S"/>
   <result pre="mortality in adults is not a unique feature of first-contact" exact="measles" post="epidemics. Other reasons, rather than absence of prior immunity,"/>
   <result pre="to the absence in the population of prior immunity to" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), as occurred in fully susceptible populations"/>
   <result pre="epidemics. In particular, S hankset al. [2] report that the" exact="measles" post="mortality rate in a fully susceptible population during the"/>
   <result pre="mortality rate in a fully susceptible population during the 1846" exact="measles" post="epidemic was higher in adults and in children aged"/>
   <result pre="older than 20 years are still more likely to suffer from" exact="measles" post="complications, despite not being fully susceptible [3]. Moreover, S"/>
   <result pre="mortality in adults is not a unique feature of first-contact" exact="measles" post="epidemics. As regards West Nile virus infection [5], severe"/>
   <result pre="As regards West Nile virus infection [5], severe fever with" exact="thrombocytopenia" post="syndrome [6] and Plasmodium falciparum malaria [7], several factors"/>
   <result pre="[5], severe fever with thrombocytopenia syndrome [6] and Plasmodium falciparum" exact="malaria" post="[7], several factors such as pathogen features, transmission dynamics"/>
   <result pre="which reported that the different age-related mortality during the 1918" exact="influenza" post="pandemic could be related to previous exposures to the"/>
   <result pre="Respir J2020; 55: 2000749. doi:10.1183/13993003.00749-2020.32241833 2ShanksGD, WallerM, BriemH, et al.Age-specific" exact="measles" post="mortality during the late 19th–early 20th centuries. Epidemiol Infect2015;"/>
   <result pre="et al.Epidemiological and clinical features of laboratory-diagnosed severe fever with" exact="thrombocytopenia" post="syndrome in China, 2011–17: a prospective observational study. Lancet"/>
   <result pre="SmithA, SmithV, et al.Risk factors for mortality from imported falciparum" exact="malaria" post="in the United Kingdom over 20 years: an observational"/>
   <result pre="study. BMJ2012; 344: e2116. doi:10.1136/bmj.e211622454091 8ZhouP, YangXL, WangXG, et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="CristianiL, PierangeliA, et al.A single centre study of viral community-acquired" exact="pneumonia" post="in children: no evidence of SARS-CoV-2 from October 2019"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7265527/results/search/disease/results.xml">
   <result pre="UKLondon pmcid: 726552716585 doi: 10.1038/s41467-020-16585-y : Article Modeling mitigation of" exact="influenza" post="epidemics by baloxavir DuZhanwei1NugentCiara2GalvaniAlison P.3http://orcid.org/0000-0002-3754-5034KrugRobert M.4http://orcid.org/0000-0002-5828-8874MeyersLauren Ancellaurenmeyers@austin.utexas.edu125[1], 0000 0004"/>
   <result pre="worldwide. Antivirals can reduce death tolls. Baloxavir, the recently approved" exact="influenza" post="antiviral, inhibits initiation of viral mRNA synthesis, whereas oseltamivir,"/>
   <result pre="impact. Consequently, scaling up early baloxavir treatment would substantially reduce" exact="influenza" post="morbidity and mortality every year. The development of antivirals"/>
   <result pre="a mathematical model that describes how Baloxavir antiviral-induced inhibition of" exact="influenza" post="virus replication in infected individuals affects the spread of"/>
   <result pre="the scaling up and acceleration of treatment would avert substantial" exact="influenza" post="morbidity and mortality every year. Subject terms Diseases Health"/>
   <result pre="Introduction Influenza A and B viruses cause a highly contagious" exact="respiratory disease" post="in humans that kills 290,000–650,000 people worldwide every year1."/>
   <result pre="worldwide every year1. Vaccination is the primary means for controlling" exact="influenza" post="transmission but is hampered by the variable efficacy and"/>
   <result pre="after they develop symptoms. Prior to 2018, the only approved" exact="influenza" post="antivirals were viral neuraminidase inhibitors2,3. Of these, only oseltamivir"/>
   <result pre="shorten symptoms. In addition to reducing the duration of symptoms," exact="influenza" post="antivirals can reduce infectiousness by shortening the period of"/>
   <result pre="that scaling up and accelerating baloxavir treatment would substantially reduce" exact="influenza" post="morbidity and mortality every year. Results and discussion Impact"/>
   <result pre="discussion Impact of antiviral treatment on the cell-to-cell proliferation of" exact="influenza" post="Our within-host model assumes that infected patients have an"/>
   <result pre="recent clinical trial8 that measured the viral loads of 1014" exact="influenza" post="virus-infected patients after treatment with oseltamivir, baloxavir, or a"/>
   <result pre="data, and, like the clinical data, shows that baloxavir inhibits" exact="influenza" post="virus replication more effectively than oseltamivir (Fig. 1). Within"/>
   <result pre="are estimated via approximate Bayesian computation38,39 fitting of stochastic population-level" exact="influenza" post="transmission model (Supplementary Section 1) to US seasonal influenza"/>
   <result pre="population-level influenza transmission model (Supplementary Section 1) to US seasonal" exact="influenza" post="incidence data12. Parameters for distributions of time between infection"/>
   <result pre="dose. Impact of baloxavir treatment on the transmission dynamics of" exact="influenza" post="We incorporated this viral replication model into a stochastic"/>
   <result pre="this viral replication model into a stochastic individual-based model of" exact="influenza" post="transmission that tracks the daily evolution of infectiousness with"/>
   <result pre="viral load, treatment status, and baseline transmission rates estimated from" exact="influenza" post="surveillance data12,13 (Supplementary Table 2). Consistent with previous studies14,15,"/>
   <result pre="days. Fig. 2 Early antiviral treatment reduces the infectiousness of" exact="influenza" post="virus. Reduction of infectiousness by treatment with a baloxavir"/>
   <result pre="accelerating antiviral treatment, we fit our model to the 2017–2018" exact="influenza" post="epidemic in the United States, a severe epidemic which"/>
   <result pre="within 48 h after symptoms onset reduces the expected number of" exact="influenza" post="infections throughout the virus season by 38% or 26%,"/>
   <result pre="Baloxavir treatment is predicted to reduce the overall burden of" exact="influenza" post="more than oseltamivir treatment across all treatment rates. If"/>
   <result pre="are fit to incidence data from the 2016–2017 and 2018–2019" exact="influenza" post="seasons in the United States (Supplementary Figs. 4 and"/>
   <result pre="~1.08 (95% CI 1.05, 1.10). Fig. 3 Mitigation of seasonal" exact="influenza" post="with mass antiviral treatment. a Observed incidence of influenza"/>
   <result pre="seasonal influenza with mass antiviral treatment. a Observed incidence of" exact="influenza" post="virus (red) based on US surveillance data from the"/>
   <result pre="virus (red) based on US surveillance data from the 2017–2018" exact="influenza" post="season compared with typical model simulations without any antiviral"/>
   <result pre="in Table 1. Using our model based on the 2017–2018" exact="influenza" post="season, we consider the population-level impacts of treatment initiation"/>
   <result pre="and antiviral treatment can significantly mitigate the burden of seasonal" exact="influenza" post="in the United States. Using an influenza transmission model"/>
   <result pre="burden of seasonal influenza in the United States. Using an" exact="influenza" post="transmission model fitted to a recent clinical trial and"/>
   <result pre="onset. Consequently, efforts to accelerate the diagnosis and treatment of" exact="influenza" post="infections with antivirals such as baloxavir, including potentially cost-saving"/>
   <result pre="of 20–30% of infected patients may be attainable in future" exact="influenza" post="epidemics. Influenza A viruses also cause periodic widespread pandemics"/>
   <result pre="with oseltamivir and baloxavir that we have estimated for seasonal" exact="influenza" post="epidemics should extend to pandemics, although the herd effect"/>
   <result pre="oseltamivir (Supplementary Fig. 6). Seminal studies of the mitigation of" exact="influenza" post="pandemics suggest that oseltamivir-based interventions can only partially mitigate"/>
   <result pre="scaling up and acceleration of baloxavir treatment would avert substantial" exact="influenza" post="morbidity and mortality every year. Even modest baloxavir treatment"/>
   <result pre="baloxavir treatment rates can potentially spare millions of people from" exact="influenza" post="virus infections during epidemics, thereby substantially reducing hospitalizations, morbidity,"/>
   <result pre="as telemedicine and the development of rapid, sensitive assays for" exact="influenza" post="virus infection. Methods Our hierarchical method includes three steps"/>
   <result pre="1): (i) fitting a within-host model of antiviral-induced inhibition of" exact="influenza" post="virus replication to clinical trial data to estimate the"/>
   <result pre="fitting a between-host model of person-to-person virus transmission to seasonal" exact="influenza" post="surveillance data to estimate influenza transmission rates, and (3)"/>
   <result pre="person-to-person virus transmission to seasonal influenza surveillance data to estimate" exact="influenza" post="transmission rates, and (3) incorporate both sets of estimates"/>
   <result pre="and accelerating antiviral treatment during emerging epidemics. Within-host model of" exact="influenza" post="A replication dynamics We applied a published model that"/>
   <result pre="replication dynamics We applied a published model that includes viral" exact="suppression" post="by both the immune response and antiviral treatment10,11, as"/>
   <result pre="most of the patients in the trial were infected by" exact="influenza" post="A viruses, ~10% were infected by influenza B viruses."/>
   <result pre="were infected by influenza A viruses, ~10% were infected by" exact="influenza" post="B viruses. When we consider the reduced efficacy of"/>
   <result pre="viruses. When we consider the reduced efficacy of baloxavir against" exact="influenza" post="B viruses relative to influenza A viruses42, the predictions"/>
   <result pre="reduced efficacy of baloxavir against influenza B viruses relative to" exact="influenza" post="A viruses42, the predictions are relatively unchanged (Supplementary Fig."/>
   <result pre="placebo and treatment throughout the entire period of viremia. Between-host" exact="influenza" post="transmission models Using approximate Bayesian computation38,39, we fit a"/>
   <result pre="to incidence time series for the 2016–2017, 2017–2018, and 2018–2019" exact="influenza" post="seasons in the United States to estimate seasonal transmission"/>
   <result pre="product of CDC-reported ILINet activity and WHO lab percent positive" exact="influenza" post="tests12,13. We then incorporated viral replication dynamics and antiviral"/>
   <result pre="product of a population-wide scaling factor Φ estimated from seasonal" exact="influenza" post="incidence data and the individual’s infectiousness at time t"/>
   <result pre="the assumptions and robustness of the model with respect to" exact="influenza" post="virus type. Estimating epidemiological quantities from simulation data R0:"/>
   <result pre="CDC reported estimated for number of infections during the 2017–2018" exact="influenza" post="season12,13. DALYs averted To estimate the DALYs averted by"/>
   <result pre="cases, we estimate the years averted owing to alleviation of" exact="influenza" post="symptoms using baloxavir or oseltamivir8 (Supplementary Section 5). Reporting"/>
   <result pre="Food and Drug Administration. FDA approves new drug to treat" exact="influenza" post="(FDA, 2018). 5.PlotchSJBouloyMKrugRMTransfer of 5′-terminal cap of globin mRNA"/>
   <result pre="(FDA, 2018). 5.PlotchSJBouloyMKrugRMTransfer of 5′-terminal cap of globin mRNA to" exact="influenza" post="viral complementary RNA during transcription in vitroProc. Natl Acad."/>
   <result pre="transcription in vitroProc. Natl Acad. Sci. USA1979761618162210.1073/pnas.76.4.1618287003 6.PlotchSJBouloyMUlmanenIKrugRMA unique cap(m7GpppXm)-dependent" exact="influenza" post="virion endonuclease cleaves capped RNAs to generate the primers"/>
   <result pre="transcriptionCell19812384785810.1016/0092-8674(81)90449-96261960 7.ReichSet al.Structural insight into cap-snatching and RNA synthesis by" exact="influenza" post="polymeraseNature201451636136610.1038/nature1400925409151 8.HaydenFGet al.Baloxavir marboxil for uncomplicated influenza in adults"/>
   <result pre="RNA synthesis by influenza polymeraseNature201451636136610.1038/nature1400925409151 8.HaydenFGet al.Baloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescentsN. Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 9.JohnTJSamuelRHerd immunity"/>
   <result pre="for ILI, national summary. CDChttps://gis.cdc.gov/grasp/fluview/fluportaldashboard.html (2018). 14.HandelABrownJStallknechtDRohaniPA multi-scale analysis of" exact="influenza" post="A virus fitness trade-offs due to temperature-dependent virus persistencePLoS"/>
   <result pre="between and within scales: environmental persistence and within-host fitness of" exact="avian influenza" post="virusesProc. Biol. Sci.20142812013305110.1098/rspb.2013.305124898369 16.Centers for Disease Control and Prevention."/>
   <result pre="and within scales: environmental persistence and within-host fitness of avian" exact="influenza" post="virusesProc. Biol. Sci.20142812013305110.1098/rspb.2013.305124898369 16.Centers for Disease Control and Prevention."/>
   <result pre="Biol. Sci.20142812013305110.1098/rspb.2013.305124898369 16.Centers for Disease Control and Prevention. Archived estimated" exact="influenza" post="illnesses, medical visits, hospitalizations, and deaths in the United"/>
   <result pre="illnesses, medical visits, hospitalizations, and deaths in the United States—2017–2018" exact="influenza" post="season (CDC, 2019). 17.Centers for Disease Control and Prevention."/>
   <result pre="life year (DALY) (WHO, 2020). 22.SahPMedlockJFitzpatrickMCSingerBHGalvaniAPOptimizing the impact of low-efficacy" exact="influenza" post="vaccinesProc. Natl Acad. Sci. USA20181155151515610.1073/pnas.180247911529712866 23.GranwehrBPIn acute uncomplicated influenza,"/>
   <result pre="Med.2018169JC6310.7326/ACPJC-2018-169-12-06330557416 24.MontoASWebsterRGInfluenza pandemics: history and lessons learnedTextb. Influenza20132203310.1002/9781118636817.ch2 25.LonginiIMContaining pandemic" exact="influenza" post="at the sourceScience20053091083108710.1126/science.111571716079251 26.LonginiIMJrHalloranMENizamAYangYContaining pandemic influenza with antiviral agentsAm."/>
   <result pre="learnedTextb. Influenza20132203310.1002/9781118636817.ch2 25.LonginiIMContaining pandemic influenza at the sourceScience20053091083108710.1126/science.111571716079251 26.LonginiIMJrHalloranMENizamAYangYContaining pandemic" exact="influenza" post="with antiviral agentsAm. J. Epidemiol.200415962363310.1093/aje/kwh09215033640 27.GermannTCKadauKLonginiIMJrMackenCAMitigation strategies for pandemic"/>
   <result pre="influenza with antiviral agentsAm. J. Epidemiol.200415962363310.1093/aje/kwh09215033640 27.GermannTCKadauKLonginiIMJrMackenCAMitigation strategies for pandemic" exact="influenza" post="in the United StatesProc. Natl. Acad. Sci. USA20061035935594010.1073/pnas.060126610316585506 28.ColizzaVBarratABarthelemyMValleronA-JVespignaniAModeling"/>
   <result pre="case and containment interventionsPLoS Med.20074e1310.1371/journal.pmed.004001317253899 29.FergusonNMet al.Strategies for mitigating an" exact="influenza" post="pandemicNature200644244845210.1038/nature0479516642006 30.KamalMAet al.Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology"/>
   <result pre="mitigating an influenza pandemicNature200644244845210.1038/nature0479516642006 30.KamalMAet al.Interdisciplinary pharmacometrics linking oseltamivir pharmacology," exact="influenza" post="epidemiology and health economics to inform antiviral use in"/>
   <result pre="drug-disease model describing the effect of oseltamivir neuraminidase inhibition on" exact="influenza" post="virus progressionAntimicrob. Agents Chemother.2015595388539510.1128/AAC.00069-1526100715 37.MeyersLAPourbohloulBNewmanMEJSkowronskiDMBrunhamRCNetwork theory and SARS: predicting"/>
   <result pre="40.JiangHet al.Preliminary epidemiologic assessment of human infections with highly pathogenic" exact="avian influenza" post="A (H5N6) virus, ChinaClin. Infect. Dis.20176538338810.1093/cid/cix33428407105 41.LesslerJet al.Incubation periods"/>
   <result pre="al.Preliminary epidemiologic assessment of human infections with highly pathogenic avian" exact="influenza" post="A (H5N6) virus, ChinaClin. Infect. Dis.20176538338810.1093/cid/cix33428407105 41.LesslerJet al.Incubation periods"/>
   <result pre="infections: a systematic reviewLancet Infect. Dis.2009929130010.1016/S1473-3099(09)70069-619393959 42.KoszalkaPTilmanisDRoeMVijaykrishnaDHurtABaloxavir marboxil susceptibility of" exact="influenza" post="viruses from the Asia-Pacific, 2012–2018Antiviral Res.2019164919610.1016/j.antiviral.2019.02.00730771405 43.Keeling, M. J."/>
   <result pre="mortality over a seasonal baselineEpidemiology20122382983810.1097/EDE.0b013e31826c2dda22992574 45.FoxSJMillerJCMeyersLASeasonality in risk of pandemic" exact="influenza" post="emergencePLoS Comput. Biol.201713e100574910.1371/journal.pcbi.100574929049288 46.Xiang, Y., Gubian, S., Suomela, B."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7279053/results/search/disease/results.xml">
   <result pre="In Italy, we have been currently experiencing the effects of" exact="severe acute respiratory syndrome" post="(SARS)-CoV-2 global spread, started at the end of 2019"/>
   <result pre="reviewed by He et al,9 a newborn presenting vomiting and" exact="diarrhea" post="as first symptoms was tested positive for SARS-CoV-2, showing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7283747/results/search/disease/results.xml">
   <result pre="but closely resembles SARS CoV‐1, which was responsible for the" exact="severe acute respiratory syndrome" post="(SARS) outbreak in 2002. SARS CoV‐1 and 2 share"/>
   <result pre="he noticed a series of patients showing signs of a" exact="severe acute respiratory syndrome" post="or SARS‐like illness which was subsequently reported to the"/>
   <result pre="all emerging infectious diseases.1 Geographic hotspots, or maps reflecting zoonotic" exact="infectious disease" post="risk have been identified in South American, Africa and"/>
   <result pre="to SARS‐CoV‐1.8 SARS‐CoV‐2 is more closely related to two bat‐derived" exact="severe acute respiratory syndrome" post="(SARS)‐like coronaviruses, bat‐SL‐CoVZC45 and bat‐SL‐CoVZXC21, collected in 2018 in"/>
   <result pre="efficacy.26 Animal models demonstrated an analogous effect. Prior immunization with" exact="severe acute respiratory syndrome" post="(SARS)‐associated coronavirus (SARS‐Cove) nucleocapsid protein caused severe pneumonia in"/>
   <result pre="acute respiratory syndrome (SARS)‐associated coronavirus (SARS‐Cove) nucleocapsid protein caused severe" exact="pneumonia" post="in mice infected with SARS‐CoV.27 Demonstrations of safety and"/>
   <result pre="AllenJ. Infection control for the otolaryngologist in the era of" exact="severe acute respiratory syndrome." post="J Otolaryngol. 2003;32(5):281‐287.14974856 8ZhouP, YangXL, WangXG, et al. A"/>
   <result pre="syndrome. J Otolaryngol. 2003;32(5):281‐287.14974856 8ZhouP, YangXL, WangXG, et al. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="10LiJY, YouZ, WangQ, et al. The epidemic of 2019‐novel‐coronavirus (2019‐nCoV)" exact="pneumonia" post="and insights for emerging infectious diseases in the future."/>
   <result pre="cross‐neutralizing human monoclonal antibody protection against lethal human and zoonotic" exact="severe acute respiratory syndrome" post="coronavirus challenge. J Virol. 2008;82(7):3220‐3235.18199635 17PetherickA. Developing antibody tests"/>
   <result pre="Safety and immunogenicity from a phase I trial of inactivated" exact="severe acute respiratory syndrome" post="coronavirus vaccine. Antivir Ther. 2007;12(7):1107‐1113.18018769 25LurieN, SavilleM, HatchettR, HaltonJ."/>
   <result pre="Immunol. 2003;16(1):69‐86.12725690 27YasuiF, KaiC, KitabatakeM, et al. Prior immunization with" exact="severe acute respiratory syndrome" post="(SARS)‐associated coronavirus (SARS‐CoV) nucleocapsid protein causes severe pneumonia in"/>
   <result pre="acute respiratory syndrome (SARS)‐associated coronavirus (SARS‐CoV) nucleocapsid protein causes severe" exact="pneumonia" post="in mice infected with SARS‐CoV. J Immunol. 2008;181(9):6337‐6348.18941225 28MitsukiYY,"/>
   <result pre="antibody neutralization affects in vitro and in vivo fitness of" exact="severe acute respiratory syndrome" post="coronavirus. J Infect Dis. 2010;201(6):946–955. 20144042 30ter MeulenJ, van"/>
   <result pre="PLoS Med. 2006;3(7):e23716796401 31CoughlinMM, PrabhakarBS. Neutralizing human monoclonal antibodies to" exact="severe acute respiratory syndrome" post="coronavirus: target, mechanism of action, and therapeutic potential. Rev"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7298473/results/search/disease/results.xml">
   <result pre="areas with a low infection rate. The most widely distributed" exact="viral disease" post="of cereals, Barley yellow dwarf luteovirus, of the Luteoviridae"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7300792/results/search/disease/results.xml">
   <result pre="for Sonar‐Global, a European Commission social science network responding to" exact="infectious disease" post="outbreaks and antimicrobial resistance. His email is d.napier@ucl.ac.uk. References"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7309422/results/search/disease/results.xml">
   <result pre="4]. However, epidemics with respiratory virus such as not only" exact="influenza" post="but also human corona viruses are prevalent in the"/>
   <result pre="several months during the cold season and then disappear whereas" exact="influenza" post="remains prevalent in tropical regions throughout the whole year"/>
   <result pre="of this ratio, we excluded malignancies (group C), neoplasia (D)," exact="diabetes mellitus" post="2 (E-11.9), arterial hypertension (I-10) and ischemic heart diseases"/>
   <result pre="success [9]. However, pandemics with new viruses such as the" exact="influenza" post="H1N1v can circulate independent of typical respiratory viral seasons"/>
   <result pre="This might be the only one published exception of an" exact="influenza" post="summer epidemic. The next few months will provide a"/>
   <result pre="the COVID-19 outbreak in ChinaInfection20204815115310.1007/s15010-020-01409-432185635 5.HeraudJMNjouomRRoussetDKadjoHCaroVNdiayeMNVictoirKCollardJMOrelleAYekwaELEkazaERazanajatovoNHAdamouLBiscornetLEnoufVvan der WerfSDiopOMSpatiotemporal circulation of" exact="influenza" post="viruses in 5 African countries during 2008–2009: a collaborative"/>
   <result pre="the Institut Pasteur International NetworkJ Infect Dis2012206S51310.1093/infdis/jis54123169972 6.MostJWeissGConsecutive infections with" exact="influenza" post="A and B virus in children during the 2014–2015"/>
   <result pre="A and B virus in children during the 2014–2015 seasonal" exact="influenza" post="epidemicJ Infect Dis20162141139114110.1093/infdis/jiw10427095422 7.MoriyamaMHugentoblerWJIwasakiASeasonality of respiratory viral infectionsAnnu Rev"/>
   <result pre="7.MoriyamaMHugentoblerWJIwasakiASeasonality of respiratory viral infectionsAnnu Rev Virol202010.1146/annurev-virology-012420-02244532196426 8.MartinRConseilALongstaffAKodoJSiegertJDuguetAMLobato de FariaPHaringhuizenGEspinJCokerRPandemic" exact="influenza" post="control in Europe and the constraints resulting from incoherent"/>
   <result pre="BallegooijenWMNunesBRizzoCPopoviciFSanta-OlallaPHrubaFParmakovaKBaguelinMvan HoekAJDesenclosJCBernillonPCamaraALWallingaJAsikainenTWhitePJEdmundsWJDifferent transmission patterns in the early stages of the" exact="influenza" post="A(H1N1)v pandemic: a comparative analysis of 12 European countriesEpidemics2011312513310.1016/j.epidem.2011.03.00521624784"/>
   <result pre="analysis of 12 European countriesEpidemics2011312513310.1016/j.epidem.2011.03.00521624784 11.AndreasenVViboudCSimonsenLEpidemiologic characterization of the 1918" exact="influenza" post="pandemic summer wave in Copenhagen: implications for pandemic control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7309641/results/search/disease/results.xml">
   <result pre="Europe PMC, consistent with existing copyright protections.aids-publish-ahead-of-print-10.1097.qad.0000000000002555.pdf Infection caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), agent of corona virus disease 2019"/>
   <result pre="increased risk of hospitalization, more prolonged hospitalization and death following" exact="influenza" post="infection [4]. Since the beginning of the 21st Century,"/>
   <result pre="and interferon beta against MERS-CoV. Nat Commun2020; 11:222.31924756 13.ChenXPLiGHTangXPXiongYChenXJCaoYLack of" exact="severe acute respiratory syndrome" post="in 19 AIDS patients hospitalized together. J Acquir Immune"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7316359/results/search/disease/results.xml">
   <result pre="Sciences : Microbiology : Virology: Viral Evolution Dynamic interactions of" exact="influenza" post="viruses in Hong Kong during 1998-2018 Dynamic interactions of"/>
   <result pre="influenza viruses in Hong Kong during 1998-2018 Dynamic interactions of" exact="influenza" post="viruses http://orcid.org/0000-0002-7555-9728YangWanConceptualizationFormal analysisFunding acquisitionInvestigationMethodologyWriting – original draftWriting – review"/>
   <result pre="cause substantial morbidity and mortality every year worldwide. Currently, two" exact="influenza" post="A subtypes, A(H1N1) and A(H3N2), and type B viruses"/>
   <result pre="via cross-immunity and antigenic mutations that allow immune escape impact" exact="influenza" post="epidemic dynamics at the population level. Here we develop"/>
   <result pre="to study the evolutionary and epidemiological dynamics of the three" exact="influenza" post="types/subtypes in Hong Kong, a city of global public"/>
   <result pre="Hong Kong, a city of global public health significance for" exact="influenza" post="epidemic and pandemic control. Utilizing long-term influenza surveillance data"/>
   <result pre="health significance for influenza epidemic and pandemic control. Utilizing long-term" exact="influenza" post="surveillance data since 1998, we are able to estimate"/>
   <result pre="changes in population immunity in response to antigenic mutations in" exact="influenza" post="viruses, and key epidemiological parameters over the last 20"/>
   <result pre="rates, and viral genetic and antigenic changes. Author summary Three" exact="influenza" post="viruses, A(H1N1), A(H3N2) and B currently co-circulate in humans"/>
   <result pre="key ecological interactions and intricate balance that allow the three" exact="influenza" post="viruses to co-circulate. Our model-inference system only requires (sub)typed"/>
   <result pre="in routine surveillance, and thus could be adapted to study" exact="influenza" post="transmission worldwide. Funding http://dx.doi.org/10.13039/100000002National Institutes of Health 1R03AI135926-01A1http://orcid.org/0000-0002-7555-9728YangWan http://dx.doi.org/10.13039/100000002National"/>
   <result pre="a combined outcome of viral antigenic changes, interactions among co-circulating" exact="influenza" post="viruses, transmission and host immune response. Influenza viruses undergo"/>
   <result pre="immunity and cause new epidemics [3–6]. In addition, currently two" exact="influenza" post="A subtypes, A(H1N1) and A(H3N2), and influenza B co-circulate"/>
   <result pre="addition, currently two influenza A subtypes, A(H1N1) and A(H3N2), and" exact="influenza" post="B co-circulate in humans; and infection of a certain"/>
   <result pre="of a certain type/subtype can result in partial immunity to" exact="influenza" post="strains of the same type/subtype as well as strains"/>
   <result pre="[16–18]. The latter cross-reactive immunity—termed cross-immunity—leads to epidemiological interactions among" exact="influenza" post="viruses that, along with viral antigenic changes, shape influenza"/>
   <result pre="among influenza viruses that, along with viral antigenic changes, shape" exact="influenza" post="phylodynamics and epidemic dynamics [19–31]. Improving understanding of interactions"/>
   <result pre="phylodynamics and epidemic dynamics [19–31]. Improving understanding of interactions among" exact="influenza" post="viruses and the resulting impact on epidemic dynamics will"/>
   <result pre="and epidemiological processes, in this study, we utilized a long-term" exact="influenza" post="incidence surveillance dataset collected in Hong Kong since 1998"/>
   <result pre="seasonal epidemics in temperate regions, in the subtropics and tropics," exact="influenza" post="epidemics can occur at any time of the year"/>
   <result pre="provides a unique opportunity to study the interplay of different" exact="influenza" post="types/subtypes at the population level. These highly diverse epidemic"/>
   <result pre="S1 Fig). Three major challenges exist. First, the seasonality of" exact="influenza" post="in part shapes the epidemic dynamics and thus should"/>
   <result pre="in a naïve population. We thus first estimate, for each" exact="influenza" post="type/subtype, the average R0 in each week of the"/>
   <result pre="dataset and infer how major antigenic evolution and cross-immunity affect" exact="influenza" post="transmission dynamics therein over the last 20 years. Our"/>
   <result pre="Our results reveal intricate ecological interactions among the three co-circulating" exact="influenza" post="types/subtypes and their impacts on long-term influenza epidemic dynamics."/>
   <result pre="the three co-circulating influenza types/subtypes and their impacts on long-term" exact="influenza" post="epidemic dynamics. Results Overall influenza epidemic characteristics and seasonal"/>
   <result pre="and their impacts on long-term influenza epidemic dynamics. Results Overall" exact="influenza" post="epidemic characteristics and seasonal cycles in Hong Kong During"/>
   <result pre="epidemics). Fig 1 shows the superimposed annual cycle for each" exact="influenza" post="type/subtype in Hong Kong during the study period and"/>
   <result pre="with similar magnitudes (Fig 1B and 1C). In comparison, for" exact="influenza" post="B, major epidemics tended to occur in winter months"/>
   <result pre="peak in the winter (Fig 1G). Fig 1 Seasonality of" exact="influenza" post="epidemics in Hong Kong. Upper panel: infection rate time"/>
   <result pre="Kong. Upper panel: infection rate time series for the three" exact="influenza" post="viruses (A). Middle panel: annual cycles for A(H1N1) (B),"/>
   <result pre="for A(H1N1) (E), A(H3N2) (F), and B (G). Model-fits to" exact="influenza" post="epidemic dynamics in Hong Kong (1998–2018) Fig 2 shows"/>
   <result pre="shows the model-fits to the epidemic curves of the three" exact="influenza" post="types/subtypes. Despite the highly irregular epidemic timing and intensity,"/>
   <result pre="1 summarizes the estimates of key epidemiological parameters for each" exact="influenza" post="(sub)type. Weekly estimates are shown in Fig 2 (susceptibility),"/>
   <result pre="thus a key epidemiological parameter shaping the long-term dynamics of" exact="influenza" post="epidemics. However, it remains difficult to estimate due to"/>
   <result pre="strength of cross-immunity may modulate the ecological completion among co-circulating" exact="influenza" post="viruses. Here we estimated the pair-wise cross-immunity strength, relative"/>
   <result pre="interesting features seem to characterize the interactions between the three" exact="influenza" post="types/subtypes. First, interactions are asymmetric (i.e., cij ≠ cji)"/>
   <result pre="Third, cross-immunity appears to mediate ecologic competition among the three" exact="influenza" post="types/subtypes, with B &quot;controlling&quot; A(H1N1) and the latter further"/>
   <result pre="of punctuated antigenic changes Analyses of the antigenic evolution of" exact="influenza" post="have shown that major antigenic changes occur in a"/>
   <result pre="substantial increases in population susceptibility and in turn surge of" exact="influenza" post="epidemic [4,26,50]. To capture such punctuated antigenic changes, our"/>
   <result pre="that are potentially due to major antigenic evolution in the" exact="influenza" post="virus. We then used the major increases in population"/>
   <result pre="are consistent with reported estimates based on antigenic testing of" exact="influenza" post="virus isolates [4,50]. Further, interestingly, for A(H3N2), such potential"/>
   <result pre="1/13/18 0 6.2 6.4 gamma 56.29 Discussion Cross-immunity among different" exact="influenza" post="viruses has been reported and its resulting potential interactions"/>
   <result pre="been modeled; however, to date, its strength and impact on" exact="influenza" post="transmission dynamics at the population level remains unclear. Utilizing"/>
   <result pre="we have quantified the strength of cross-immunity among the two" exact="influenza" post="A subtypes and B currently co-circulating in humans and"/>
   <result pre="in population susceptibility representing population-level response to antigenic innovations in" exact="influenza" post="viruses over the last 20 years as well as"/>
   <result pre="20 years as well as identified key variations among three" exact="influenza" post="types/subtypes. These estimates, along with other key epidemiological variable"/>
   <result pre="the evolutionary and epidemiological dynamics of influenza. Comparing transmissibility of" exact="influenza" post="in Hong Kong and elsewhere Influenza epidemics in subtropical"/>
   <result pre="to 2.0, similar to previous estimates in other regions for" exact="influenza" post="overall [51]. Few studies have estimated R0 for individual"/>
   <result pre="influenza overall [51]. Few studies have estimated R0 for individual" exact="influenza" post="types/subtypes, especially for inter-pandemic seasons. Here we estimate that"/>
   <result pre="the model-inference system is effective in controlling for the elusive" exact="influenza" post="seasonality in Hong Kong and allows for estimation of"/>
   <result pre="studies could apply the same strategy to study the diverse" exact="influenza" post="dynamics in other subtropical/tropical regions or other infections with"/>
   <result pre="of evidence have suggested cross protection offered by infection of" exact="influenza" post="viruses of the same type/subtype as well as across"/>
   <result pre="during inter-pandemic seasons. Thus, to understand the co-circulation pattern of" exact="influenza" post="viruses, we need to take into account other key"/>
   <result pre="Nevertheless, the relative lengths of immunity period for the three" exact="influenza" post="types/subtypes were consistent. A recent cohort-specific analysis [54] further"/>
   <result pre="to its complement types/subtypes) allows the two less frequently circulating" exact="influenza" post="types/subtypes to coexist in humans. Estimating timing and frequency"/>
   <result pre="data alone. The rationale is that punctuated antigenic innovations in" exact="influenza" post="viruses would lead to surge in population susceptibility and"/>
   <result pre="14 years in B [4], based on antigenic analysis of" exact="influenza" post="virus isolates. Consistently, we estimate that antigenic innovations occurred"/>
   <result pre="an inexpensive alternative to support detection of evolutionary changes in" exact="influenza" post="viruses, especially since these estimates reflect changes in population"/>
   <result pre="and tropical regions with similar diverse epidemics, better delineation of" exact="influenza" post="seasonality in these climates is needed. Third, we assumed"/>
   <result pre="we assumed that the probability of seeking medical attention for" exact="influenza" post="is comparable to other illnesses and, for simplicity, we"/>
   <result pre="differences in health seeking behavior among patients infected by different" exact="influenza" post="(sub)types. Based on this assumption, the estimated annual attack"/>
   <result pre="to 42% in 2005. There is large uncertainty in estimated" exact="influenza" post="attack rates. Recent estimates ranged from 3–11% symptomatic infections"/>
   <result pre="revealed in great detail the epidemiological interactions among the three" exact="influenza" post="types/subtypes, the antigenic innovations for each type/subtype, and their"/>
   <result pre="type/subtype, and their combined impact on the transmission dynamics of" exact="influenza" post="over the last two decades in Hong Kong, a"/>
   <result pre="Hong Kong, a city of global public health significance for" exact="influenza" post="epidemic and pandemic control. The intricate epidemiological interactions among"/>
   <result pre="influenza epidemic and pandemic control. The intricate epidemiological interactions among" exact="influenza" post="viruses and key underlying population features underscore the importance"/>
   <result pre="features underscore the importance of monitoring population immunity to different" exact="influenza" post="viruses, incidence rates, and viral genetic and antigenic changes."/>
   <result pre="proven powerful for estimating key evolutionary and epidemiological characteristics of" exact="influenza" post="viruses based on type/subtype-specific incidence data and could be"/>
   <result pre="on type/subtype-specific incidence data and could be extended to study" exact="influenza" post="epidemic dynamics in other regions with limited antigenic data."/>
   <result pre="The Centre for Health Protection in Hong Kong monitors seasonal" exact="influenza" post="activity through a sentinel surveillance network of approximately 50"/>
   <result pre="Public Health Laboratory Services Branch thereof conducts laboratory testing for" exact="influenza" post="viruses in samples submitted mainly from local hospitals and"/>
   <result pre="obtained weekly records of ILI consultation rate and concurrent (sub)type-specific" exact="influenza" post="detection rate from the week ending 04 Jan 1998"/>
   <result pre="To obtain a more specific measure of the incidence of" exact="influenza" post="virus infections in the community, we multiplied the weekly"/>
   <result pre="presenting ILI to all patient-visits and does not measure true" exact="influenza" post="incidence rate in the catchment population. Previously, we showed"/>
   <result pre="rule, the incidence rate, or probability of a person contracting" exact="influenza" post="during a given week, p(i), is: p ( i"/>
   <result pre="than temperate regions but plausible given the year-round circulation of" exact="influenza" post="and low vaccination rates in Hong Kong. Estimating the"/>
   <result pre="rates in Hong Kong. Estimating the empirical seasonal cycle of" exact="influenza" post="epidemic As discussed in the Introduction, the seasonality of"/>
   <result pre="influenza epidemic As discussed in the Introduction, the seasonality of" exact="influenza" post="epidemics in Hong Kong is weaker than in temperate"/>
   <result pre="models have been developed [19–29,70–73] to study the interplay of" exact="influenza" post="viruses. The central idea behind these models is that"/>
   <result pre="able to generate evolutionary dynamics similar to that observed for" exact="influenza" post="and is commonly used as the backbone for more"/>
   <result pre="population susceptibility due to potential punctuated antigenic changes in the" exact="influenza" post="virus. To tackle this issue, we further incorporated space"/>
   <result pre="combinations for the three type/subtypes. Cross-immunity has been observed for" exact="influenza" post="strains of the same subtype as well as across"/>
   <result pre="Estimates of R0 are shown in D-F for the three" exact="influenza" post="types/subtypes and strength of cross-immunity shown in G-L. (PDF)"/>
   <result pre="arrows show the epidemic dynamics for each of the three" exact="influenza" post="viruses (H1, H3, or B): susceptible (S) individuals can"/>
   <result pre="recover (R) from the infection; due to warning immunity and" exact="influenza" post="virus evolution, recovered individuals can lose prior immunity and"/>
   <result pre="10.1038/nrmicro261321747392 4BedfordT, SuchardMA, LemeyP, DudasG, GregoryV, et al. (2014) Integrating" exact="influenza" post="antigenic dynamics with molecular evolution. Elife3: e0191410.7554/eLife.0191424497547 5BahlJ, NelsonMI,"/>
   <result pre="et al. (2011) Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humans. Proc Natl Acad Sci"/>
   <result pre="et al. (2004) Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science305: 371–376. 10.1126/science.109721115218094 7PicaN, PaleseP (2013) Toward a"/>
   <result pre="virus. Science305: 371–376. 10.1126/science.109721115218094 7PicaN, PaleseP (2013) Toward a universal" exact="influenza" post="virus vaccine: prospects and challenges. Annu Rev Med64: 189–202."/>
   <result pre="Geelhoed-MierasMM, van AmerongenG, VerburghRJ, et al. (2011) Vaccination against seasonal" exact="influenza" post="A/H3N2 virus reduces the induction of heterosubtypic immunity against"/>
   <result pre="influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against" exact="influenza" post="A/H5N1 virus infection in ferrets. J Virol85: 2695–2702. 10.1128/JVI.02371-1021228239"/>
   <result pre="JongeneelenM, et al. (2009) Antibody recognition of a highly conserved" exact="influenza" post="virus epitope. Science324: 246–251. 10.1126/science.117149119251591 10EkiertDC, FriesenRH, BhabhaG, KwaksT,"/>
   <result pre="al. (2011) A highly conserved neutralizing epitope on group 2" exact="influenza" post="A viruses. Science333: 843–850. 10.1126/science.120483921737702 11EpsteinSL (2006) Prior H1N1"/>
   <result pre="et al. (2009) Serum cross-reactive antibody response to a novel" exact="influenza" post="A (H1N1) virus after vaccination with seasonal influenza vaccine."/>
   <result pre="a novel influenza A (H1N1) virus after vaccination with seasonal" exact="influenza" post="vaccine. MMWR Morb Mortal Wkly Rep58: 521–524. 19478718 16DreyfusC,"/>
   <result pre="Viruses. Science337: 1343–1348. 10.1126/science.122290822878502 17StanekovaZ, VareckovaE (2010) Conserved epitopes of" exact="influenza" post="A virus inducing protective immunity and their prospects for"/>
   <result pre="infections and viral hierarchies are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. Eur J Immunol46:"/>
   <result pre="model. Eur J Immunol46: 685–686. 19AndreasenV (2003) Dynamics of annual" exact="influenza" post="A epidemics with immuno-selection. Journal of mathematical biology46: 504–536."/>
   <result pre="10.1016/j.tpb.2003.10.00214766191 22CasagrandiR, BolzoniL, LevinSA, AndreasenV (2006) The SIRC model and" exact="influenza" post="A. Mathematical Biosciences200: 152–169. 10.1016/j.mbs.2005.12.02916504214 23ChungKW, LuiR (2016) Dynamics"/>
   <result pre="Mathematical Biosciences200: 152–169. 10.1016/j.mbs.2005.12.02916504214 23ChungKW, LuiR (2016) Dynamics of two-strain" exact="influenza" post="model with cross-immunity and no quarantine class. Journal of"/>
   <result pre="GrenfellB, PascualM (2006) Epochal evolution shapes the phylodynamics of interpandemic" exact="influenza" post="A (H3N2) in humans. Science314: 1898–1903. 10.1126/science.113274517185596 27KoelleK, RasmussenDA"/>
   <result pre="The effects of a deleterious mutation load on patterns of" exact="influenza" post="A/H3N2's antigenic evolution in humans. Elife4: e0736110.7554/eLife.0736126371556 28KucharskiA, GogJR"/>
   <result pre="(2009) Incorporating demographic stochasticity into multi-strain epidemic models: application to" exact="influenza" post="A. Journal of the Royal Society Interface6: 989–996. 30MagalP,"/>
   <result pre="RuanSG (2010) Sustained oscillations in an evolutionary epidemiological model of" exact="influenza" post="A drift. P R Soc A466: 965–992. 31NunoM, ChowellG,"/>
   <result pre="33FengS, ChiuSS, ChanELY, KwanMYW, WongJSC, et al. (2018) Effectiveness of" exact="influenza" post="vaccination on influenza-associated hospitalisations over time among children in"/>
   <result pre="GrenfellBT, LipsitchM (2010) Absolute humidity and the seasonal onset of" exact="influenza" post="in the continental United States. Plos Biol8: e100031610.1371/journal.pbio.100031620186267 38AxelsenJB,"/>
   <result pre="e100031610.1371/journal.pbio.100031620186267 38AxelsenJB, YaariR, GrenfellBT, StoneL (2014) Multiannual forecasting of seasonal" exact="influenza" post="dynamics reveals climatic and evolutionary drivers. Proc Natl Acad"/>
   <result pre="of filtering methods for the modeling and retrospective forecasting of" exact="influenza" post="epidemics. PLoS Comput Biol10: e100358310.1371/journal.pcbi.100358324762780 43YangW, ShamanJ (2014) A"/>
   <result pre="FieldingR (2010) Situational awareness and health protective responses to pandemic" exact="influenza" post="A (H1N1) in Hong Kong: a cross-sectional study. Plos"/>
   <result pre="AnsartS, CoriA, ValleronAJ (2011) Transmission parameters of the A/H1N1 (2009)" exact="influenza" post="virus pandemic: a review. Influenza Other Respir Viruses5: 306–316."/>
   <result pre="ZhuH, JiangCQ, et al. (2015) Estimating the life course of" exact="influenza" post="A(H3N2) antibody responses from cross-sectional data. Plos Biol13: e100208210.1371/journal.pbio.100208225734701"/>
   <result pre="CobeyS, TakahashiS, MillerJC, LipsitchM (2011) Predicting the epidemic sizes of" exact="influenza" post="A/H1N1, A/H3N2, and B: a statistical method. PLoS Med8:"/>
   <result pre="et al. (2004) Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science305: 371–376. 10.1126/science.109721115218094 51BiggerstaffM, CauchemezS, ReedC, GambhirM, FinelliL"/>
   <result pre="53CowlingBJ, PereraRA, FangVJ, ChanKH, WaiW, et al. (2014) Incidence of" exact="influenza" post="virus infections in children in Hong Kong in a"/>
   <result pre="of infectious diseases220: 820–829. 10.1093/infdis/jiz20131053844 55NextStrain.org (2019) Real-time tracking of" exact="influenza" post="A/H1N1pdm evolution. https://nextstrain.org/flu/seasonal/h1n1pdm/ha/12y?c=cTiter&amp;amp;f_country=hong_kong 56TokarsJI, OlsenSJ, ReedC (2018) Seasonal Incidence"/>
   <result pre="10.1093/infdis/jiy44330016464 58LeeSS, LeungEH, WongNS (2013) Concerns for low coverage of" exact="influenza" post="vaccination in middle-aged adults. Human vaccines &amp;amp; immunotherapeutics9: 1989–1990.23792553"/>
   <result pre="https://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2016.htm 61WuJT, LeungK, PereraRA, ChuDK, LeeCK, et al. (2014) Inferring" exact="influenza" post="infection attack rate from seroprevalence data. PLoS Pathog10: e100405410.1371/journal.ppat.100405424699693"/>
   <result pre="e3834610.1371/journal.pone.003834622675456 63LauEHY, CowlingBJ, HoLM, LeungGM (2008) Optimizing use of multistream" exact="influenza" post="sentinel surveillance data. Emerging infectious diseases14: 1154–1157. 10.3201/eid1407.08006018598647 64CowlingBJ,"/>
   <result pre="10.3201/eid1407.08006018598647 64CowlingBJ, WongIO, HoLM, RileyS, LeungGM (2006) Methods for monitoring" exact="influenza" post="surveillance data. International journal of epidemiology35: 1314–1321. 10.1093/ije/dyl16216926216 65ShamanJ,"/>
   <result pre="epidemiology35: 1314–1321. 10.1093/ije/dyl16216926216 65ShamanJ, KarspeckA, YangW, TameriusJ, LipsitchM (2013) Real-time" exact="influenza" post="forecasts during the 2012–2013 season. Nat Commun4: 283710.1038/ncomms383724302074 66WongJY,"/>
   <result pre="10.1093/aje/kws31423459950 67YangW, LipsitchM, ShamanJ (2015) Inference of seasonal and pandemic" exact="influenza" post="transmission dynamics. Proc Natl Acad Sci U S A112:"/>
   <result pre="CowlingBJ, et al. (2011) Epidemiological characteristics of 2009 (H1N1) pandemic" exact="influenza" post="based on paired sera from a longitudinal community cohort"/>
   <result pre="13396–13400. 10.1073/pnas.151669811226460003 71GogJR (2008) The impact of evolutionary constraints on" exact="influenza" post="dynamics. Vaccine26: C15–C24. 10.1016/j.vaccine.2008.04.00818773528 72NuñoM, FengZ, MartchevaM, Castillo-ChavezC (2005)"/>
   <result pre="https://kingaa.github.io/sbied/mif/mif.html 76FergusonNM, GalvaniAP, BushRM (2003) Ecological and immunological determinants of" exact="influenza" post="evolution. Nature422: 428–433. 10.1038/nature0150912660783 77YaariR, KatrielG, HuppertA, AxelsenJB, StoneL"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7326430/results/search/disease/results.xml">
   <result pre="Wu Pushing past the tipping points in containment trajectories of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) epidemics: A simple arithmetic rationale for"/>
   <result pre="Handling editor: Jianhong Wu Main text Most cases of the" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) are relatively mild or even asymptomatic"/>
   <result pre="if current measures were maintained, may well have achieved 80%" exact="suppression" post="of transmission (Fig. 1B and C). If sustained, current"/>
   <result pre="weeks (Fig. 1B and C). While these levels of transmission" exact="suppression" post="may sound very high, several countries (notably China (Tang"/>
   <result pre="Cameron, Barfod, Sergeant, &amp;amp; Greiner, 2007) or human pathogens like" exact="malaria" post="(Feachem et al., 2019). It is also encouraging that"/>
   <result pre="to reduce COVID-19 mortality and healthcare demandWHO collaborating centre for" exact="infectious disease" post="modelling, MRC centre for global infectious disease analysis2020Abdul Latif"/>
   <result pre="collaborating centre for infectious disease modelling, MRC centre for global" exact="infectious disease" post="analysis2020Abdul Latif Jameel Institute for Disease and Emergency Analytics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7332278/results/search/disease/results.xml">
   <result pre="aimed to examine whether the ongoing COVID-19 epidemic, caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), is associated with an increase in"/>
   <result pre="cases per month; 365% increase ([31–719]; p=0.0053), concomitant with the" exact="influenza" post="A H1N1 pandemic. Interpretation Our study further suggests that"/>
   <result pre="Research Agency. Introduction The rapid spread of COVID-19 caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) has led to a global pandemic.1"/>
   <result pre="to reports of an increased incidence of paediatric shock and" exact="myocarditis" post="by several health authorities in Europe and North America.5,"/>
   <result pre="is unknown. Kawasaki disease is an acute febrile systemic childhood" exact="vasculitis" post="that affects medium and small-sized blood vessels with a"/>
   <result pre="The disease is one of the leading causes of acquired" exact="heart disease" post="in industrialised countries.12, 13 No specific test exists to"/>
   <result pre="changes in the peripheral extremities or perineal area, and cervical" exact="lymphadenopathy" post="of 15 mm or larger. Patients who meet the"/>
   <result pre="before this study The rapid spread of COVID-19 caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) has led to a global pandemic."/>
   <result pre="of Kawasaki disease was observed in December, 2009, during the" exact="influenza" post="A H1N1 pandemic. To our knowledge, this is the"/>
   <result pre="the peak of Kawasaki disease that occurred after the 2009" exact="influenza" post="A H1N1 pandemic, providing evidence of the role of"/>
   <result pre="A correlation between this bimodal seasonality and viruses such as" exact="influenza" post="and respiratory syncytial virus in winter and respiratory enteroviruses"/>
   <result pre="coronavirus HKU, coronavirus NL63, coronavirus OC43, metapneumovirus, rhinovirus or enterovirus," exact="influenza" post="A, influenza B, parainfluenza (types 1–4), respiratory syncytial virus,"/>
   <result pre="coronavirus NL63, coronavirus OC43, metapneumovirus, rhinovirus or enterovirus, influenza A," exact="influenza" post="B, parainfluenza (types 1–4), respiratory syncytial virus, Bordetella parapertussis,"/>
   <result pre="respiratory virus pandemic identified over the study period was the" exact="influenza" post="A H1N1 pandemic in 2009. Thus, another dummy variable"/>
   <result pre="in the model to allow for the immediate effect of" exact="influenza" post="A H1N1 on Kawasaki occurrence in December, 2009. The"/>
   <result pre="the model estimates based on the quasi-Poisson regression model. The" exact="influenza" post="A H1N1 outbreak occurred November to December, 2009, and"/>
   <result pre="years. Six (60%) children had cardiac abnormalities, including one major" exact="coronary aneurysm" post="(Z score=12) and five with myocarditis. Six (60%) patients"/>
   <result pre="Myocarditis No No Coronary dilatation (Z=12) No Myocarditis Myocarditis Myocarditis," exact="pericarditis" post="Myocarditis No First-line treatment IVIg IVIg None IVIg IVIg"/>
   <result pre="the Paris region, France, and in Bergamo, Italy, during the" exact="influenza" post="A H1N1 epidemics and outside of major viral epidemics"/>
   <result pre="believed to include features of Kawasaki disease (complete or incomplete)," exact="toxic shock syndrome," post="and myocarditis.4, 11, 27 Paediatric and scientific societies in"/>
   <result pre="patients with severe Kawasaki disease with cardiac involvement (abnormal echocardiography," exact="coronary aneurysm," post="or myocarditis), intensive care unit admissions, inotrope requirement, and"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling studyLancet Infect Dis12201268769522738893"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7338960/results/search/disease/results.xml">
   <result pre="little is known, the first recorded epidemic was the Justinian" exact="plague" post="which started in 540 AD, lasted for 2 centuries,"/>
   <result pre="Ages [4-6]. which also originated in Asia, and lastly the" exact="bubonic plague" post="pandemic, the third largest recorded, which originated in Yunnan"/>
   <result pre="[4-6]. which also originated in Asia, and lastly the bubonic" exact="plague" post="pandemic, the third largest recorded, which originated in Yunnan"/>
   <result pre="reaction. For example, during the 16th century, the French called" exact="syphilis" post="‘Spanish smallpox,’ the Spanish called it the ‘malady of"/>
   <result pre="a Venetian trading post on the Black Sea [2]. The" exact="plague" post="took advantage of the Genoese galleys' return to Europe"/>
   <result pre="court of King Louis XIII, and was developed during the" exact="plague" post="of 1619 which decimated Paris. In the 1890s the"/>
   <result pre="to 100%, was a resurgence of the 1894 Hong Kong" exact="plague" post="which gave the Frenchman Alexandre Yersin an opportunity to"/>
   <result pre="epidemic will also lead to scientific progress in terms of" exact="viral disease" post="management and that the economic consequences of confinement will"/>
   <result pre="the royal attorney for the commune of Remoulin, during the" exact="plague" post="of Marseille in 1720. Fig. 2. First mask used"/>
   <result pre="Marseille in 1720. Fig. 2. First mask used during the" exact="plague" post="of Paris in 1619. The mask is filled with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7341712/results/search/disease/results.xml">
   <result pre="columns. Important here are a set of individual-level characteristics (including" exact="obesity" post="and undernutrition) that we now know will determine the"/>
   <result pre="that overlaps and interacts with these three long-wave crises. Take" exact="obesity" post="for example – we know that the obesity epidemic"/>
   <result pre="crises. Take obesity for example – we know that the" exact="obesity" post="epidemic is being driven, in part, by the accessibility"/>
   <result pre="Tan et al. 2020). Evidence is also mounting on how" exact="obesity" post="confers a greater risk of poor outcomes of COVID-19"/>
   <result pre="2020). Compounding this, lockdowns are contributing to a rise in" exact="obesity" post="due to reduced physical activity and difficulties in sourcing"/>
   <result pre="Effects of COVID-19 lockdown on lifestyle behaviors in children with" exact="obesity" post="living in Verona, Italy: A Longitudinal Study.Obesity, 2020; 10.1002/oby.22861."/>
   <result pre="Longitudinal Study.Obesity, 2020; 10.1002/oby.22861. RauberFSteeleEMLouzadaMCMillettCMonteiroCALevyRBUltra-processed food consumption and indicators of" exact="obesity" post="in the United Kingdom population (2008-2016)PLoS One2020155e023267610.1371/journal.pone.023267632357191 RobertsonTCarterEDChouVBStegmullerARJacksonBDTamYSawadogo-LewisTWalkerNEarly estimates"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7361333/results/search/disease/results.xml">
   <result pre="Med Virol. 2020;1–3. 10.1002/jmv.2623331502247 1 INTRODUCTION The worldwide spread of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS‐CoV‐2), the novel human pathogen, first detected"/>
   <result pre="infected people develop rapidly a severe disease characterized by interstitial" exact="pneumonia" post="and acute respiratory distress syndrome that can ultimately lead"/>
   <result pre="develop rapidly a severe disease characterized by interstitial pneumonia and" exact="acute respiratory distress syndrome" post="that can ultimately lead to death. This is particularly"/>
   <result pre="1KsiazekTG, ErdmanD, GoldsmithCS, et al. A novel coronavirus associated with" exact="severe acute respiratory syndrome." post="N Engl J Med. 2003;348(20):1953‐1966.12690092 2KuikenT, FouchierRA, SchuttenM, et"/>
   <result pre="et al. Newly discovered coronavirus as the primary cause of" exact="severe acute respiratory syndrome." post="Lancet. 2003;362(9380):263‐270.12892955 3DrostenC, GüntherS, PreiserW, et al. Identification of"/>
   <result pre="et al. Identification of a novel coronavirus in patients with" exact="severe acute respiratory syndrome." post="N Engl J Med. 2003;348(20):1967‐1976.12690091 4de GrootRJ, BakerSC, BaricRS,"/>
   <result pre="to a predictive framework. Science. 2013;341(6145):514‐519.23908230 26ShamanJ, KohnM.Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. Proc Natl Acad Sci USA."/>
   <result pre="USA. 2009;106(9):3243‐3248.19204283 27LowenAC, SteelJ.Roles of humidity and temperature in shaping" exact="influenza" post="seasonality. J Virol. 2014;88(14):7692‐7695.24789791 28TangX, WuC, LiX, et al."/>
   <result pre="32MenacheryVD, Yount BLJr, JossetL, et al. Attenuation and restoration of" exact="severe acute respiratory syndrome" post="coronavirus mutant lacking 2′‐o‐methyltransferase activity. J Virol. 2014;88(8):4251‐4264.24478444 33ArmengaudJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7365411/results/search/disease/results.xml">
   <result pre="grown during previous outbreaks [1–3]. Despite the informative role that" exact="infectious disease" post="models played in the recent DRC outbreak [4–7], cross-talk"/>
   <result pre="played in the recent DRC outbreak [4–7], cross-talk within the" exact="infectious disease" post="modeling community and between infectious disease modelers and model"/>
   <result pre="[4–7], cross-talk within the infectious disease modeling community and between" exact="infectious disease" post="modelers and model stakeholders, such as health agencies, may"/>
   <result pre="an informal modeling research coordination group to align efforts around" exact="infectious disease" post="modeling of the outbreak (Fig 1). Each month, two"/>
   <result pre="stakeholders, with the goal of enabling more efficient and effective" exact="infectious disease" post="modeling relevant to this particular outbreak. Although preprint servers"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7365643/results/search/disease/results.xml">
   <result pre="that this needs to facilitate ongoing improved coordination for future" exact="infectious disease" post="epidemics and pandemics. Two research funder coordination groups, the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7373336/results/search/disease/results.xml">
   <result pre="was identified as the infectious agent causing an outbreak of" exact="viral pneumonia" post="(coronavirus disease 2019, COVID-19) in Wuhan, China (Li et"/>
   <result pre="identified as the infectious agent causing an outbreak of viral" exact="pneumonia" post="(coronavirus disease 2019, COVID-19) in Wuhan, China (Li et"/>
   <result pre="Chinese Preventive Medicine Association 2020). COVID-19, which is a new" exact="infectious disease," post="is highly contagious and spread quickly to other provinces"/>
   <result pre="Medicine AssociationAn update on the epidemiological characteristics of novel coronavirus" exact="pneumonia" post="(COVID-19)Chin J Epidemiol20204113914410.3760/cma.j.issn.0254-6450.2020.02.002 World Health Organization (2020) Poverty. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7376323/results/search/disease/results.xml">
   <result pre="[2], grid.24696.3f0000 0004 0369 153XDepartment of Critical care medicine of" exact="liver disease," post="Beijing You’an Hospital, Capital Medical University, epub: 2020-7-7pmc-release: 2020-7-7collection:"/>
   <result pre="people may still be vulnerable to viral infection or subsequent" exact="bacterial pneumonia" post="than the general population. Further studies and data collection"/>
   <result pre="may still be vulnerable to viral infection or subsequent bacterial" exact="pneumonia" post="than the general population. Further studies and data collection"/>
   <result pre="had a history of fever and had CT findings of" exact="viral pneumonia." post="COVID-19 was diagnosed by the positive result of RT-PCR."/>
   <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(Full version)New Med2020303564 8.MaoZQWanRHeLYHuYCChenWThe enlightenment from two cases of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7392634/results/search/disease/results.xml">
   <result pre="pandemic. Since its emergence in Wuhan, China, in late 2019," exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has"/>
   <result pre="to, COVID-19. Introduction Late in 2019, a cluster of acute" exact="respiratory disease" post="in Wuhan, China, was attributed to a new coronavirus,1–3"/>
   <result pre="Wuhan, China, was attributed to a new coronavirus,1–3 later named" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2).4 It was soon discovered that the"/>
   <result pre="December 2019–May 2020 Month Key events December 2019 Clusters of" exact="pneumonia" post="of unknown origin in Wuhan, China. Human infection probably"/>
   <result pre="table 2. Table 2 Contextual variables potentially influencing transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2 Variable Elements Range (variation/extremes) Population density People"/>
   <result pre="Ebola, that have obvious similarities in transmission patterns such as" exact="influenza" post="and measles, or that are closely related such as"/>
   <result pre="other coronaviruses. Emerging viral respiratory pathogens Respiratory viruses such as" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and"/>
   <result pre="syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and" exact="avian influenza" post="A and also Ebola have originated from animal hosts"/>
   <result pre="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and avian" exact="influenza" post="A and also Ebola have originated from animal hosts"/>
   <result pre="SARS-CoV Bat First emerged in China in November 2002.76 Causes" exact="severe acute respiratory syndrome" post="(SARS). Transmission through superspreading events in healthcare facilities.77 8422"/>
   <result pre="outbreak in South Korea (2015). 2502 cases; CFR: 34%79 Avian" exact="influenza" post="A (H5N1 and H7N9) Birds/poultry Subtypes of influenza viruses"/>
   <result pre="34%79 Avian influenza A (H5N1 and H7N9) Birds/poultry Subtypes of" exact="influenza" post="viruses detected in birds (having killed millions of poultry)"/>
   <result pre="pathogen sustain continuous human-to-human transmission. Other viral diseases such as" exact="measles" post="and influenza are ‘old’ diseases; they have been studied"/>
   <result pre="continuous human-to-human transmission. Other viral diseases such as measles and" exact="influenza" post="are ‘old’ diseases; they have been studied in great"/>
   <result pre="and influenza: the importance of context It is thought that" exact="measles" post="emerged thousands of years ago in the Middle East."/>
   <result pre="cross-over occurred from the rinderpest virus,31 to become the human" exact="measles" post="virus. Measles has since spread around the globe in"/>
   <result pre="human-to-human transmission. When measles, along with other viruses such as" exact="smallpox" post="and influenza, was introduced in the Americas by European"/>
   <result pre="often not identified as influenza. Such different epidemic patterns of" exact="influenza" post="are still incompletely understood but thought to be associated"/>
   <result pre="such as indoor crowding.35 But, in contrast to SARS-CoV-2, the" exact="influenza" post="virus is not new. Influenza is a very old"/>
   <result pre="also mutates, giving rise to a new dominant strain every" exact="influenza" post="season. Influenza is every year a slightly different virus"/>
   <result pre="is that older persons had some protective cross-immunity from previous" exact="influenza" post="outbreaks while younger persons did not. H1N1 continued to"/>
   <result pre="persons did not. H1N1 continued to circulate along with seasonal" exact="influenza" post="viruses, often recombining to produce more severe local outbreaks,"/>
   <result pre="resulted from an antigenic shift and caused the 2009 H1N1" exact="influenza" post="pandemic. The 2009 H1N1 virus originated in pigs in"/>
   <result pre="to cytokine storms.87 A role of protective cross-immunity from previous" exact="influenza" post="strains in older persons has been suggested. After August"/>
   <result pre="A(H1N1)pdm09 virus appeared to have integrated with circulating strains of" exact="influenza" post="and continues to cause localised seasonal influenza outbreaks worldwide.88"/>
   <result pre="circulating strains of influenza and continues to cause localised seasonal" exact="influenza" post="outbreaks worldwide.88 A major difference between COVID-19 and influenza"/>
   <result pre="seasonal influenza outbreaks worldwide.88 A major difference between COVID-19 and" exact="influenza" post="is that SARS-CoV-2 is a new pathogen and influenza"/>
   <result pre="and influenza is that SARS-CoV-2 is a new pathogen and" exact="influenza" post="is not. At the time of writing (May 2020),"/>
   <result pre=" A dominant way of studying the transmission dynamics of an" exact="infectious disease" post="such as COVID-19, and predicting the amplitude and peak"/>
   <result pre="why? Case fatality rate (CFR) Initial estimates CFR: 2%–3%; comparisons:" exact="influenza" post="0.1%; common cold: 0%; SARS: 9%–10%; MERS: 30%.97 Calculated"/>
   <result pre="ventilation, requiring sophisticated equipment and highly skilled personnel. Like COVID-19," exact="measles" post="and influenza have different epidemic patterns in different contexts."/>
   <result pre="sophisticated equipment and highly skilled personnel. Like COVID-19, measles and" exact="influenza" post="have different epidemic patterns in different contexts. This also"/>
   <result pre="this is not the case in very remote communities, where" exact="measles" post="transmission had been interrupted for extended periods (such as"/>
   <result pre="epidemic’.40 41 The latest stages of the global dissemination of" exact="measles" post="have been well documented, including in Australia, the Fiji"/>
   <result pre="occurred in the 19th and the mid-20th centuries.32 42 Fortunately," exact="measles" post="infection creates robust protective immunity and after a first"/>
   <result pre="affecting only those without any prior immunity.43 Human-to-human transmission of" exact="measles" post="virus in a community stops when the virus cannot"/>
   <result pre="the so-called herd immunity is reached.44 45 But transmission of" exact="measles" post="continues elsewhere on the planet from where it can"/>
   <result pre="enough to allow human-to-human transmission again. The epidemic patterns of" exact="measles" post="are easily understood as measles is highly infectious, creates"/>
   <result pre="again. The epidemic patterns of measles are easily understood as" exact="measles" post="is highly infectious, creates disease in almost every infected"/>
   <result pre="immunity and having lost maternal antibodies.46 These diverse patterns of" exact="measles" post="epidemics have been fundamentally changed by variable coverage of"/>
   <result pre="measles epidemics have been fundamentally changed by variable coverage of" exact="measles" post="vaccination. They can still help us make sense of"/>
   <result pre="similar for COVID-19. But it took thousands of years for" exact="measles" post="to reach all human communities while SARS-CoV-2 spread to"/>
   <result pre="spread to all countries in only a few months, despite" exact="measles" post="being much more transmissible than SARS-CoV-2. Factors such as"/>
   <result pre="The other four (HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63) cause the" exact="common cold" post="or diarrhoea and continuously circulate and mutate frequently.47 48"/>
   <result pre="trigger intensive dissemination. Table 6 Knowns, uncertainties and unknowns about" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), as of May 2020 Factor Available"/>
   <result pre="vaccine rather than a new vaccine every year like the" exact="influenza" post="vaccine.135 Ten different circulating clades (nextstrain.org; www.gisaid.org),136 as of"/>
   <result pre="identical or mutated form. For the current first wave, using" exact="influenza" post="and the common cold as reasonable comparisons, it is"/>
   <result pre="form. For the current first wave, using influenza and the" exact="common cold" post="as reasonable comparisons, it is possible that the major"/>
   <result pre="additional data are available. References References 1LuH, StrattonCW, TangYi‐WeiOutbreak of" exact="pneumonia" post="of unknown etiology in Wuhan, China: the mystery and"/>
   <result pre="and the miracle. J Med Virol2020;92:401–2. 10.1002/jmv.2567831950516 2XinhuanetNew-type coronavirus causes" exact="pneumonia" post="in Wuhan: expert; 9 January 2020, 2020 Available: http://www.xinhuanet.com/english/2020-01/09/c_138690570.htm"/>
   <result pre="3ZhuN, ZhangD, WangW, et al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med Overseas Ed2020;382:727–33."/>
   <result pre="5XuZ, ShiL, WangY, et al.Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome." post="Lancet Respir Med2020;8:420–2. 10.1016/S2213-2600(20)30076-X32085846 6DingQ, LuP, FanY, et al.The"/>
   <result pre="Med2020;8:420–2. 10.1016/S2213-2600(20)30076-X32085846 6DingQ, LuP, FanY, et al.The clinical characteristics of" exact="pneumonia" post="patients coinfected with 2019 novel coronavirus and influenza virus"/>
   <result pre="characteristics of pneumonia patients coinfected with 2019 novel coronavirus and" exact="influenza" post="virus in Wuhan, China. J Med Virol2020;382. 10.1002/jmv.25781. [Epub"/>
   <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–Infected" exact="pneumonia" post="in Wuhan, China. JAMA2020;323:106110.1001/jama.2020.1585 8LiQ, GuanX, WuP, et al.Early"/>
   <result pre="Infect Dis202010.1016/S1473-3099(20)30314-5 17ChanJF-W, YuanS, KokK-H, et al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="and the world. Respirology2003;8 Suppl:S2–5. 10.1046/j.1440-1843.2003.00516.x15018125 31FuruseY, SuzukiA, OshitaniHOrigin of" exact="measles" post="virus: divergence from rinderpest virus between the 11th and"/>
   <result pre="Open Res2020;5:8310.12688/wellcomeopenres.15889.232656368 36TaubenbergerJKThe origin and virulence of the 1918 &quot;Spanish&quot;" exact="influenza" post="virus. Proc Am Philos Soc2006;150:86–112.17526158 37AltmannDM, DouekDC, BoytonRJWhat policy"/>
   <result pre="protective immunity. Lancet2020;395:1527–9. 10.1016/S0140-6736(20)30985-532353328 38PanumPLObservations made during the epidemic of" exact="measles" post="on the Faroe Islands in the year 1846. New"/>
   <result pre="York: Delta Omega Society, 1940. 39RhodesCJ, AndersonRMA scaling analysis of" exact="measles" post="epidemics in a small population. Philos Trans R Soc"/>
   <result pre="Available: http://applications.emro.who.int/docs/EMCSR246E.pdf?ua=1 [Accessed 17 Apr 2020]. 80collab: World Health OrganizationPandemic" exact="influenza" post="risk management, 2017 Available: https://apps.who.int/iris/bitstream/handle/10665/259893/WHO-WHE-IHM-GIP-2017.1-eng.pdf?sequence=1 [Accessed 17 Apr 2020]."/>
   <result pre="81collab: World Health OrganizationWHO Risk Assessment of Human infections with" exact="avian influenza" post="A(H7N9) virus, 2015 Available: https://www.who.int/influenza/human_animal_interface/influenza_h7n9/RiskAssessment_H7N9_23Feb20115.pdf?ua=1 [Accessed 17 Apr 2020]."/>
   <result pre="World Health OrganizationWHO Risk Assessment of Human infections with avian" exact="influenza" post="A(H7N9) virus, 2015 Available: https://www.who.int/influenza/human_animal_interface/influenza_h7n9/RiskAssessment_H7N9_23Feb20115.pdf?ua=1 [Accessed 17 Apr 2020]."/>
   <result pre="[Accessed 17 Apr 2020]. 82collab: World Health OrganizationHuman infection with" exact="avian influenza" post="A(H5N1) virus - update (9 January 2014), 2014 Available:"/>
   <result pre="17 Apr 2020]. 82collab: World Health OrganizationHuman infection with avian" exact="influenza" post="A(H5N1) virus - update (9 January 2014), 2014 Available:"/>
   <result pre="85TrifonovV, KhiabanianH, RabadanRGeographic dependence, surveillance, and origins of the 2009" exact="influenza" post="A (H1N1) virus. N Engl J Med2009;361:115–9. 10.1056/NEJMp090457219474418 86DawoodFS,"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect"/>
   <result pre="2009 Influenza, BautistaE, ChotpitayasunondhT, et al.Clinical aspects of pandemic 2009" exact="influenza" post="A (H1N1) virus infection. N Engl J Med2010;362:1708–19. 10.1056/NEJMra100044920445182"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7395586/results/search/disease/results.xml">
   <result pre="and viral transmission, with a greater persistence and infectivity of" exact="influenza" post="A virus at cold temperatures and low relative humidity.6"/>
   <result pre="respiratory viruses, including respiratory syncytial virus (RSV), human rhinovirus, and" exact="avian influenza" post="virus.7 A recent systematic analysis of 37,335 studies reported"/>
   <result pre="viruses, including respiratory syncytial virus (RSV), human rhinovirus, and avian" exact="influenza" post="virus.7 A recent systematic analysis of 37,335 studies reported"/>
   <result pre="of 37,335 studies reported on seasonal patterns among 4 viruses:" exact="influenza" post="virus, RSV, parainfluenza virus (PIV), and human metapneumovirus (hMPV).8"/>
   <result pre="between seasonality and temperature and relative humidity was different for" exact="influenza" post="virus and RSV. Lower temperature was associated with higher"/>
   <result pre="both viruses; however, higher relative humidity was associated with increased" exact="influenza" post="virus activity if temperature was above average. In contrast,"/>
   <result pre="J Hyg Environ Health2213201837639029398406 8LiY.ReevesR.M.WangX.Global patterns in monthly activity of" exact="influenza" post="virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7402518/results/search/disease/results.xml">
   <result pre="at determining the prevalence of the dengue, rift valley and" exact="chikungunya" post="among humans in two geo ecologically distinct sites. The"/>
   <result pre="al.Early appearance of neutralizing immunoglobulin G3 antibodies is associated with" exact="chikungunya" post="virus clearance and long-term clinical protection. Journal of Infectious"/>
   <result pre="KaayaRD, MwakalingaS, NdossiR, NdaroA, ChilongolaJO, et al.Prevalence of dengue and" exact="chikungunya" post="virus infections in north-eastern Tanzania: a cross sectional study"/>
   <result pre="Medical Research2017:1–7. 29MwanzivaC, ManjuranoA, MbugiE, MweyaC, MkaliH, KivuyoMP, et al.Defining" exact="malaria" post="burden from morbidity and mortality records, self treatment practices"/>
   <result pre="30MwanzivaCE, KitauJ, TunguPK, MweyaCN, MkaliH, NdegeCM, et al.Transmission intensity and" exact="malaria" post="vector population structure in Magugu, Babati District in northern"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7402651/results/search/disease/results.xml">
   <result pre="facilities and tracked time to ART initiation and viral load" exact="suppression" post="at 6 months and 12 months follow-up visits. Herce"/>
   <result pre="one viral load result documented, 262 (97%) had achieved viral" exact="suppression" post="(&amp;lt;1000 copies per mL) at 6 months. Through early"/>
   <result pre="the proportion of the prison cohort who achieved viral load" exact="suppression" post="was similar to that observed in other African community-based"/>
   <result pre="outside of prison walls. References References 1DolanKWirtzALMoazenBGlobal burden of HIV," exact="viral hepatitis," post="and tuberculosis in prisoners and detaineesLancet38820161089110227427453 2collab: UNAIDSGlobal AIDS"/>
   <result pre="walls. References References 1DolanKWirtzALMoazenBGlobal burden of HIV, viral hepatitis, and" exact="tuberculosis" post="in prisoners and detaineesLancet38820161089110227427453 2collab: UNAIDSGlobal AIDS update 2018:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7402669/results/search/disease/results.xml">
   <result pre="Successes include eSwatini and Switzerland, which have achieved 85% viral" exact="suppression" post="among people living with HIV, the target under the"/>
   <result pre="Africa where just 49% of men with HIV have viral" exact="suppression" post="compared with 67% of women. Worldwide, 62% of new"/>
   <result pre="of disruptions to prevention and treatment for HIV, tuberculosis, and" exact="malaria" post="in low-income and middle-income settings. The researchers predict that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7404095/results/search/disease/results.xml">
   <result pre="the pathologist Rudolf Virchow did his path-breaking investigation of the" exact="typhus" post="epidemic in Upper Silesia. Due to the current pandemic’s"/>
   <result pre="habitats have happened in China with the previous coronavirus in" exact="severe acute respiratory syndrome" post="(SARS); Ebola in Africa; Zika in Africa, Latin America,"/>
   <result pre="of swine flu, avian flu, and a variety of emerging" exact="influenza" post="viruses.2–5 Deemphasis on Agriculture in Public Health Do sources"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7409732/results/search/disease/results.xml">
   <result pre="measures 10 nanometres and its genome contains only one gene:" exact="hepatitis" post="delta virus (which, moreover, is considered to be a"/>
   <result pre="moreover, is considered to be a satellite virus of the" exact="hepatitis" post="B virus, as it can only replicate in a"/>
   <result pre="it can only replicate in a patient already infected with" exact="hepatitis" post="B virus or in the presence of simultaneous contamination"/>
   <result pre="B virus or in the presence of simultaneous contamination with" exact="hepatitis" post="B virus and hepatitis D virus) [5]. One of"/>
   <result pre="the presence of simultaneous contamination with hepatitis B virus and" exact="hepatitis" post="D virus) [5]. One of the largest known viruses,"/>
   <result pre="genome and capsid of an enveloped virus, such as the" exact="influenza" post="virus, self-assembles into nucleocapsids underneath the cytoplasmic membrane before"/>
   <result pre="replaced by viral proteins. In certain viruses, such as the" exact="hepatitis" post="B virus, the fraction of viral proteins inserted into"/>
   <result pre="known to man since ancient times [2]. The Chinese identified" exact="smallpox" post="2500 years ago and knew that it was transmitted"/>
   <result pre="course, attributing the disease to a virus. Sexual transmission of" exact="syphilis" post="had been known since the 15th century, but Treponema"/>
   <result pre="Roux easily demonstrated, even without identifying the causative agent, that" exact="rabies" post="was a specific infectious disease probably caused by a"/>
   <result pre="without identifying the causative agent, that rabies was a specific" exact="infectious disease" post="probably caused by a microbe too small to be"/>
   <result pre="(a single gene, as in the case of the satellite" exact="hepatitis" post="D virus) or hundreds or thousands of functional units"/>
   <result pre="tous les savoirs – La vie2002Odile Jacob 4BaltimoreD.Viruses, polymerases, and" exact="cancer" post="(Nobel lecture)Science192197663263657644 5RizzettoM.Hepatitis D: thirty years afterJ Hepatol5020091043105019285743 6La"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7413401/results/search/disease/results.xml">
   <result pre="single-room assignment among patients admitted through the emergency department during" exact="influenza" post="epidemics Single room assignment for ED patients, during Influenza"/>
   <result pre="ChristopheConceptualizationMethodologySupervisionValidationWriting – review &amp;amp; editing16collab: on behalf of the ED" exact="influenza" post="management study group¶[1], IAME, INSERM, Université de Paris, Paris,"/>
   <result pre="that no competing interests exist. ¶ Membership of the ED" exact="influenza" post="management study group list in the Acknowledgments. * E-mail:"/>
   <result pre="to Bichat-Claude Bernard Hospital through the ED and tested for" exact="influenza" post="by PCR (GenXpert, Cepheid) or (FilmArray, BioMérieux) on a"/>
   <result pre="BioMérieux) on a nasopharyngeal swab were retrospectively included during three" exact="influenza" post="seasons (2015–2018. Results Of 1,330 included patients, 278 (20.9%)"/>
   <result pre="assigned a single room. Among patients with positive and negative" exact="influenza" post="PCR, 22.3% and 16.7% were assigned a single room"/>
   <result pre="excluding the third epidemic because of the concomitant use of" exact="influenza" post="immune-chromatic test. Only level 1 of the Emergency severity"/>
   <result pre="95%CI, 1.0–1.4; p = 0.07). Conclusion A PCR positive for" exact="influenza" post="was not significantly associated with single-room assignment. Less than"/>
   <result pre="significantly associated with single-room assignment. Less than one quarter of" exact="influenza" post="patients were adequately assigned a single room, likely due"/>
   <result pre="000 deaths every year worldwide [1]. Annual winter epidemics of" exact="influenza" post="also cause a large number of hospitalization, about 140,000"/>
   <result pre="the hospital management. Though most people recover within few days," exact="influenza" post="can cause various and serious respiratory, cardiac or neurological"/>
   <result pre="assessing the relationship between admission to double-occupancy rooms and hospital-acquired" exact="influenza" post="showed a higher risk of acquiring influenza among patients"/>
   <result pre="rooms and hospital-acquired influenza showed a higher risk of acquiring" exact="influenza" post="among patients admitted in a double-occupancy room compared to"/>
   <result pre="In another study, the same team estimated that the hospital-acquired" exact="influenza" post="risk was largely increased when the roommate presented an"/>
   <result pre="patients assigned to a single room among patients positive for" exact="influenza" post="or respiratory syncytial virus was higher, although not significantly,"/>
   <result pre="assignment. Our main objective was to assess the association of" exact="influenza" post="PCR and disease severity on single-room assignment, during the"/>
   <result pre="48 hours of admission, for patients seeking the ED during" exact="influenza" post="epidemics. Methods We conducted a retrospective study at the"/>
   <result pre="admitted to the hospital through the ED and tested for" exact="influenza" post="PCR during three consecutive influenza epidemics between 2015 and"/>
   <result pre="the ED and tested for influenza PCR during three consecutive" exact="influenza" post="epidemics between 2015 and 2018 were included. During the"/>
   <result pre="8 a.m. to 1 p.m. on Saturday). The definition of" exact="influenza" post="epidemic periods was based on the French national surveillance"/>
   <result pre="1). A total of 278 patients (20.9%) tested positive for" exact="influenza" post="with PCR. Fig 1 Study flowchart. The sex ratio"/>
   <result pre="during the second and third periods (p &amp;lt; 0.001); only" exact="influenza" post="type A virus was identified during the second period,"/>
   <result pre="A virus was identified during the second period, while both" exact="influenza" post="A and B were detected during the first and"/>
   <result pre="the 221 most severe patients (16.6%) with either hemodynamic or" exact="respiratory failure" post="was not statistically significant among the three periods (p"/>
   <result pre="During the third epidemic, ED physicians had access to an" exact="influenza" post="point of care test, which made this epidemic not"/>
   <result pre="OR,1.9; 95%CI, 1.3–2.8, p&amp;lt;0.01), while a positive PCR result for" exact="influenza" post="was not (aOR, 1.46; 95% CI, 1.0–1.9; p ="/>
   <result pre="Only 25.2% of admitted patients presenting a positive PCR for" exact="influenza" post="were assigned to a single room. These results underline"/>
   <result pre="that single-room assignment is efficient in reducing nosocomial infections, specifically" exact="influenza" post="[17,18], but the availability of single rooms is often"/>
   <result pre="of single rooms is often still beyond the needs during" exact="influenza" post="seasons [19]. Despite the fact that newly built hospitals"/>
   <result pre="the placement of patients with high-risk respiratory viral infection, notably" exact="influenza" post="infection, remains a challenge. In addition, the proportion of"/>
   <result pre="influenza infection, remains a challenge. In addition, the proportion of" exact="influenza" post="infections is usually low among patients presenting an ILI"/>
   <result pre="line with a recent randomised study that showed that performing" exact="influenza" post="PoC PCR improved the proportion of patients isolated with"/>
   <result pre="Further studies are required to evaluate the impact of PoC" exact="influenza" post="PCR and placement in single rooms. In the current"/>
   <result pre="the previous epidemics. In addition, a new algorithm for the" exact="influenza" post="diagnosis based on an immuno-chromatographic rapid influenza diagnostic test"/>
   <result pre="algorithm for the influenza diagnosis based on an immuno-chromatographic rapid" exact="influenza" post="diagnostic test (RIDT) was applied in the ED at"/>
   <result pre="to single-room assignment. We also did not know if some" exact="influenza" post="positive patients may have been rarely cohorted in double"/>
   <result pre="the PCR result. The proportion of patients with a positive" exact="influenza" post="PCR assigned to a single room remained low over"/>
   <result pre="greatly shortened for decision making of room assignment. Conclusion Hospital-acquired" exact="influenza" post="is an old and well-known threat that the physicians"/>
   <result pre="organisation, and improve isolation and droplet precautions during the overcrowded" exact="influenza" post="season. Supporting information S1 File (DOCX) LINK Click here"/>
   <result pre="department ESI Emergency severity index ICU Intensive care unit ILI" exact="influenza" post="like illness PCR Polymerase Chain Reaction POCT Point of"/>
   <result pre="Polymerase Chain Reaction POCT Point of care test RIDT Rapid" exact="influenza" post="diagnostic test References References 1Up to 650 000 people"/>
   <result pre="influenza-like illness in an acute health care setting during community" exact="influenza" post="epidemics in 2004–2005, 2005–2006, and 2006–2007: a prospective study."/>
   <result pre="Clinical and virologic factors associated with reduced sensitivity of rapid" exact="influenza" post="diagnostic tests in hospitalized elderly patients and young children."/>
   <result pre="2019. 10YouJHS, TamL-P, LeeNLS. Cost-effectiveness of molecular point-of-care testing for" exact="influenza" post="viruses in elderly patients at ambulatory care setting. PLoS"/>
   <result pre="Diagn2017; 19:460–467. 10.1016/j.jmoldx.2017.01.00928341587 13LacroixS, VrignaudB, AvrilE, et al.Impact of rapid" exact="influenza" post="diagnostic test on physician estimation of viral infection probability"/>
   <result pre="for clinical decisions on influenza-like illness in emergency department during" exact="influenza" post="a(H1N1)2009 pandemic. Biomarkers2018; 23:10–13. 10.1080/1354750X.2016.127662628010128 22CaseltonD, ArungaG, EmukuleG, et"/>
   <result pre="ArungaG, EmukuleG, et al.Does the length of specimen storage affect" exact="influenza" post="testing results by real-time reverse transcription-polymerase chain reaction? an"/>
   <result pre="results by real-time reverse transcription-polymerase chain reaction? an analysis of" exact="influenza" post="surveillance specimens, 2008 to 2010. Euro Surveill2014; 19. 23BrendishNJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7414693/results/search/disease/results.xml">
   <result pre="disease Stigma Key points •The opioid epidemic is fueling new" exact="infectious disease" post="epidemics, including human immunodeficiency virus (HIV), hepatitis C virus,"/>
   <result pre="fueling new infectious disease epidemics, including human immunodeficiency virus (HIV)," exact="hepatitis" post="C virus, and serious bacterial infections such as infective"/>
   <result pre="(HIV), hepatitis C virus, and serious bacterial infections such as" exact="infective endocarditis," post="across the United States among persons who use drugs."/>
   <result pre="be used to combat the current opioid epidemic and intertwined" exact="infectious disease" post="epidemics in the United States. Introduction When people typically"/>
   <result pre="to Wikipedia, an epidemic is &quot;the rapid spread of an" exact="infectious disease" post="to a large number of people in a given"/>
   <result pre="a short period of time.&quot; Although OUD is not an" exact="infectious disease," post="its &quot;transmission&quot; mimics infectious diseases and it is directly"/>
   <result pre="surge in infectious diseases such as human immunodeficiency virus (HIV)," exact="hepatitis" post="C virus (HCV), and serious bacterial infections such as"/>
   <result pre="hepatitis C virus (HCV), and serious bacterial infections such as" exact="infective endocarditis." post="&quot;Access to life-saving interventions must be improved in all"/>
   <result pre="who use drugs (PWUD). There seems to be a collective" exact="amnesia" post="about this earlier HIV epidemic and the well-documented relationship"/>
   <result pre="intertwined HIV, HCV, as well as invasive bacterial and fungal" exact="infectious disease" post="epidemics in this country. Background Current State of the"/>
   <result pre="related to illicit opioid and other drug use include HCV;" exact="hepatitis" post="B virus; HIV; and invasive bacterial and fungal infections,"/>
   <result pre="patients’ outcomes and to reduce the public health risk of" exact="infectious disease" post="transmission. Further, OUD affects everyone: people from urban, suburban,"/>
   <result pre="stigma,24 not only in the community but among providers, including" exact="infectious disease" post="physicians who were at the forefront of the epidemic;"/>
   <result pre="methamphetamine, which is causing even more overdose deaths and more" exact="infectious disease" post="outbreaks without any evidence of abating.9,29 The reason the"/>
   <result pre="suppression.39 In particular, it is well known that HIV viral" exact="suppression" post="not only reduces morbidity and mortality related to HIV-related"/>
   <result pre="this country. Programs that received Ryan White funding improved viral" exact="suppression" post="rates among PWH from 69.5% to 85.9% from 2010"/>
   <result pre="HIV and HCV33,52; buprenorphine and XR-NTX also improve HIV viral" exact="suppression" post="in PLWH,53, 54, 55 the gold standard of care"/>
   <result pre="treatment and how to quell the coalescing substance use and" exact="infectious disease" post="epidemics. A recent National Academy of Sciences, Engineering, and"/>
   <result pre="conducting interviews of programs across the country that were integrating" exact="infectious disease" post="and OUD prevention and treatment services.48,58 In addition, the"/>
   <result pre="directly end both the opioid and associated HIV and other" exact="infectious disease" post="epidemics.59 Such parallels of the opioid epidemic to the"/>
   <result pre="epidemics, as well as to prevent new HIV and other" exact="infectious disease" post="epidemics from occurring in this country, as identified earlier."/>
   <result pre="associated serious infections increased sharply, 2002-12Health Aff (Millwood)35201683283727140989 11FleischauerA.T.RuhlL.RheaS.Hospitalizations for" exact="endocarditis" post="and associated health care costs among persons with diagnosed"/>
   <result pre="Seattle, Washington, 2018MMWR Morb Mortal Wkly Rep68201934434930998671 16ZibbellJ.E.AsherA.K.PatelR.C.Increases in acute" exact="hepatitis" post="C virus infection related to a growing opioid epidemic"/>
   <result pre="2004 to 2014Am J Public Health108201817518129267061 17SchranzA.J.FleischauerA.ChuV.H.Trends in drug use-associated" exact="infective endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
   <result pre="to 2014Am J Public Health108201817518129267061 17SchranzA.J.FleischauerA.ChuV.H.Trends in drug use-associated infective" exact="endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
   <result pre="a study of statewide discharge dataAnn Intern Med17012018314030508432 18WurcelA.G.AndersonJ.E.ChuiK.K.Increasing infectious" exact="endocarditis" post="admissions among young people who inject drugsOpen Forum Infect"/>
   <result pre="Sciences, Engineering, and MedicineOpportunities to improve opioid use disorder and" exact="infectious disease" post="services: Integrating responses to a dual epidemicThe National Academies"/>
   <result pre="Correct Health Care212015122625559628 50SevalN.EatonE.SpringerS.A.Beyond antibiotics: a practical guide for the" exact="infectious disease" post="physician to treat opioid use disorder in the setting"/>
   <result pre="Infect Dis72020ofz53931993454 51SevalN.EatonE.SpringerS.A.Inpatient Opioid Use Disorder (OUD) treatment for the" exact="infectious disease" post="physicianNortonB.The opioid epidemic and infectious diseases1st edition2020Elsevier Inc.New York"/>
   <result pre="prevention of HIV infectionCochrane Database Syst Rev82011CD004145 53SpringerS.A.ChenS.AlticeF.L.Improved HIV and" exact="substance abuse" post="treatment outcomes for released HIV-infected prisoners: the impact of"/>
   <result pre="of buprenorphine treatmentJ Urban Health87201059260220177974 54SpringerS.A.Di PaolaA.AzarM.M.Extended-release naltrexone improves viral" exact="suppression" post="among incarcerated persons living with HIV with opioid use"/>
   <result pre="on buprenorphine is associated with high levels of maximal viral" exact="suppression" post="among HIV-infected opioid dependent released prisonersPLoS One72012e3833522719814 56SpringerS.A.KorthuisP.T.Del RioC.Integrating"/>
   <result pre="RioC.Integrating treatment at the intersection of opioid use disorder and" exact="infectious disease" post="epidemics in medical settings: a call for action after"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7414935/results/search/disease/results.xml">
   <result pre="14.8%, respectively. The mortality rate is higher in patients with" exact="cardiovascular disease," post="diabetes, chronic respiratory diseases, or hypertension.3 Clinical Symptoms and"/>
   <result pre="not have specific characteristic symptoms and is often diagnosed as" exact="bronchiolitis" post="or pneumonia, but infants tend to develop convulsions and"/>
   <result pre="lasts for 5–6 days. Classical symptoms include fever, coughing, and/or" exact="shortness" post="of breath, diarrhea, and other gastrointestinal symptoms. The disease"/>
   <result pre="and other gastrointestinal symptoms. The disease rapidly progresses to severe" exact="pneumonia" post="and causes respiratory failure, thrombocytopenia, and coagulation disorder. MERS-CoV"/>
   <result pre="symptoms. The disease rapidly progresses to severe pneumonia and causes" exact="respiratory failure," post="thrombocytopenia, and coagulation disorder. MERS-CoV infection tends to lead"/>
   <result pre="will experience dyspnea and/or hypoxemia, and critical patients will develop" exact="acute respiratory distress syndrome," post="septic shock, refractory metabolic acidosis, and coagulation disorders. Some"/>
   <result pre="patients will develop acute respiratory distress syndrome, septic shock, refractory" exact="metabolic acidosis," post="and coagulation disorders. Some SARS-CoV, MERS-CoV, and SARS-CoV-2 patients"/>
   <result pre="after a health certificate has been obtained. Staff with dysentery," exact="hepatitis" post="A and other digestive tract diseases, pulmonary tuberculosis, or"/>
   <result pre="Staff with dysentery, hepatitis A and other digestive tract diseases," exact="pulmonary tuberculosis," post="or exudative or purulent skin diseases should not be"/>
   <result pre="by the novel coronavirus is placed under the control of" exact="infectious disease" post="statutory. National Health Commission of the People’s Republic of"/>
   <result pre="et al. Target recombination demonstrates the spike gene of transmissible" exact="gastroenteritis" post="coronavirus is a determination of its tropism and virulence."/>
   <result pre="al. The membrane M protein carboxy terminal bind to transmissible" exact="gastroenteritis" post="coronavirus core and contribute to core stability. J Virol."/>
   <result pre="19.IzetaA, SmerdouC, AlonsoS, et al. Replication and packaging of transmissible" exact="gastroenteritis" post="coronavirus-derived synthetic minigenomes. J Virol. 1999;73:1535–1545. doi:10.1128/JVI.73.2.1535-1545.19999882359 20.SpaanWJM, DeliusH,"/>
   <result pre="YezliS, et al. Transmission of SARS and MERS coronaviruses and" exact="influenza" post="virus in healthcare settings: the possible role of dry"/>
   <result pre="coronavirus. Nature. 2003;426:450–454. doi:10.1038/nature0214514647384 31.WilliamsRK, JiangGD, HolmesKM. Receptor for mouse" exact="hepatitis" post="virus is a member of the carcinoembryonic antigen family"/>
   <result pre="ZhangD, WangW, et al. A novel coronavirus from patients with" exact="pneumonia" post="in China. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa200101731978945 46.ForniD,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7416915/results/search/disease/results.xml">
   <result pre="COVID-19, characterized by fever and cough that can lead to" exact="respiratory failure" post="and death [3, 4]. The virus appears to spread"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. 10.1016/S0140-6736(20)30211-732007143"/>
   <result pre="ChenYM, WangW, SongZG, et al.A new coronavirus associated with human" exact="respiratory disease" post="in China. Nature. 2020;579(7798):265–271. 10.1038/s41586-020-2008-332015508 3GoyalP, ChoiJJ, PinheiroLC, SchenckEJ,"/>
   <result pre="HunterJC, KirkingHL, ChristiansenD, JoshiK, et al.First known person-to-person transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137–1144. 10.1016/S0140-6736(20)30607-332178768"/>
   <result pre="YuanS, KokKH, ToKKW, ChuH, YangJ, et al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="CampbellPT, WuY, TongSYC, McVernonJ, GeardN. Implications of asymptomatic carriers for" exact="infectious disease" post="transmission and control. Royal Soc Open Sci. 2018;5(2):17234110.1098/rsos.172341 20WangJ,"/>
   <result pre="10.3934/mbe.201601927775386 22KucharskiAJ, FunkS, EggoRM, MalletHP, EdmundsWJ, NillesEJ. Pathology of human" exact="influenza" post="revisited. Plos Neg Trop Dis. 2016;10(5):e0004726. 23FraserC, RileyS, AndersonRM,"/>
   <result pre="Dis. 2016;10(5):e0004726. 23FraserC, RileyS, AndersonRM, NeilMF. Factors that make an" exact="infectious disease" post="outbreak controllable. Proc Natl Acad Sci USA. 2004;101(16):6146–6151. 10.1073/pnas.030750610115071187"/>
   <result pre="epidemiological and clinical features of the emerging 2019 novel coronavirus" exact="pneumonia" post="(COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–576."/>
   <result pre="in compartmental dynamic models using a computational approach: application to" exact="infectious disease" post="transmission models. Theor Biol Med Model. 2019;16:110.1186/s12976-018-0097-630642334 43HellewellJ, AbbottS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7419580/results/search/disease/results.xml">
   <result pre="due to secondary bacterial infections was observed for patients with" exact="pneumonia" post="(41 of 268). Most clinicians treated patients with SARS-CoV-2"/>
   <result pre="to 73.5% (n = 3,072) in all clinical reports of" exact="viral pneumonia" post="included in this review. For all cases of viral"/>
   <result pre="73.5% (n = 3,072) in all clinical reports of viral" exact="pneumonia" post="included in this review. For all cases of viral"/>
   <result pre="viral pneumonia included in this review. For all cases of" exact="viral pneumonia," post="a mortality rate of 10.9% due to secondary infections"/>
   <result pre="Staphylococcus aureus and Klebsiella pneumoniae. secondary bacterial infection pulmonary viruses" exact="viral pneumonia" post="SARS-CoV-2 COVID-19 influenza SARS antibiotic resistance fig-count: table-count: equation-count:"/>
   <result pre="aureus and Klebsiella pneumoniae. secondary bacterial infection pulmonary viruses viral" exact="pneumonia" post="SARS-CoV-2 COVID-19 influenza SARS antibiotic resistance fig-count: table-count: equation-count:"/>
   <result pre="pneumoniae. secondary bacterial infection pulmonary viruses viral pneumonia SARS-CoV-2 COVID-19" exact="influenza" post="SARS antibiotic resistance fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
   <result pre="result in respiratory tract infections. During the emergency of a" exact="viral disease," post="attention is initially focussed on clinical management of the"/>
   <result pre="(11, 12); infection with respiratory syncytial virus (RSV), rhinovirus and" exact="influenza" post="virus (all of which damage the mucosal layer), lead"/>
   <result pre="of SARS-CoV-2 infection typically include symptoms of mild fever and" exact="shortness" post="of breath (25). As the virus replicates in the"/>
   <result pre="pneumonia. In almost all severe cases, SARS-CoV-2 infection results in" exact="pneumonia" post="and the inflamed fluid-filled alveolar tissue now is an"/>
   <result pre="and challenges faced in treating SARS-CoV-2 infected patients. Patients with" exact="pneumonia" post="caused by other respiratory viruses or SARS-CoV-2 pneumonia patients"/>
   <result pre="Patients with pneumonia caused by other respiratory viruses or SARS-CoV-2" exact="pneumonia" post="patients were often prophylactically treated with broad-spectrum antibiotics, in"/>
   <result pre="viral respiratory illness but can rapidly progress to a fatal" exact="viral pneumonia" post="mostly complicated by ARDS (acute respiratory distress syndrome) and"/>
   <result pre="respiratory illness but can rapidly progress to a fatal viral" exact="pneumonia" post="mostly complicated by ARDS (acute respiratory distress syndrome) and"/>
   <result pre="and bilateral interstitial infiltrates in most cases, or ARDS. Nosocomial" exact="bacterial pneumonia" post="is however common among MERS patients with ventilator support."/>
   <result pre="bilateral interstitial infiltrates in most cases, or ARDS. Nosocomial bacterial" exact="pneumonia" post="is however common among MERS patients with ventilator support."/>
   <result pre="to cause seasonal flu every year and of the four" exact="influenza" post="types, type A and B are known to cause"/>
   <result pre="and B are known to cause seasonal epidemics (60). The" exact="influenza" post="A (H1N1) outbreak in 2009 had even developed into"/>
   <result pre="Secondary bacterial infections are one of the leading causes for" exact="influenza" post="associated deaths (62). According to the Center for Disease"/>
   <result pre="for Disease Control and Prevention (CDC), during the 2009 H1N1" exact="influenza" post="pandemic between 29 and 55% of mortalities were due"/>
   <result pre="due to secondary bacterial infections (63). The lethal synergism between" exact="influenza" post="virus and Pneumococcus strains accounts for the majority of"/>
   <result pre="for the majority of diseases as well as mortality during" exact="influenza" post="epidemics (64). Here, we summarize case studies that are"/>
   <result pre="(64). Here, we summarize case studies that are related to" exact="influenza" post="viruses and secondary bacterial infections (Supplementary File). Details on"/>
   <result pre="of a total of 910 patients that were infected with" exact="influenza" post="were reported in eight case studies (65–72). Five studies"/>
   <result pre="data regarding secondary bacterial infections following COVID-19, SARS, MERS and" exact="influenza" post="is surprising. In addition, precise numbers of clinical cases"/>
   <result pre="ill with pulmonary viral diseases. Similar to epidemics caused by" exact="influenza" post="viruses, during the current SARS-CoV-2 pandemic, antibiotic-resistant bacterial infections"/>
   <result pre="additional data file. References References 1.BradleyBTBryanA. Emerging respiratory Infections: The" exact="infectious disease" post="pathology of SARS, MERS, pandemic influenza, and Legionella. Semin"/>
   <result pre="Pathol. (2019) 36:152–9. 10.1053/j.semdp.2019.04.00631054790 2.MorrisDEClearyDWClarkeSC. Secondary bacterial infections associated with" exact="influenza" post="pandemics. Front Microbiol. (2017) 8:1041. 10.3389/fmicb.2017.0104128690590 3.WangHAnthonyDSelemidisSVlahosRBozinovskiS. Resolving viral-induced"/>
   <result pre="induces degradation of antimicrobial peptides and secondary bacterial infection in" exact="chronic obstructive pulmonary disease." post="Am J Respir Crit Care Med. (2012) 186:1117–24. 10.1164/rccm.201205-0806OC23024024"/>
   <result pre="the role of viral, host, and secondary bacterial factors in" exact="influenza" post="pathogenesis. Am J Pathol. (2015) 185:1528–36. 10.1016/j.ajpath.2014.08.03025747532 7.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.."/>
   <result pre="J Pathol. (2015) 185:1528–36. 10.1016/j.ajpath.2014.08.03025747532 7.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.. The role of" exact="pneumonia" post="and secondary bacterial infection in fatal and serious outcomes"/>
   <result pre="secondary bacterial infection in fatal and serious outcomes of pandemic" exact="influenza" post="a (H1N1) pdm09. BMC Infect Dis. (2018) 18:637. 10.1186/s12879-018-3548-030526505"/>
   <result pre="bacterial infections. Cell Host Microbe. (2011) 9:496–507. 10.1016/j.chom.2011.05.00621669398 9.JamiesonAMYuSAnnicelliCHMedzhitovR. Article" exact="influenza" post="virus-induced glucocorticoids compromise innate host defense against a secondary"/>
   <result pre="10.2147/TCRM.S8778926345407 11.NyangachaRMOdongoDOyiekeFOchwotoMKorirRNgetichRKet al.. Secondary bacterial infections and antibiotic resistance among" exact="tungiasis" post="patients in Western, Kenya. PLoS Neglect Trop D. (2017)"/>
   <result pre="Dis Rep. (2007) 9:186–92. 10.1007/s11908-007-0030-317430699 14.HandelALonginiIMAntiaR. Intervention strategies for an" exact="influenza" post="pandemic taking into account secondary bacterial infections. Epidem. (2009)"/>
   <result pre="(2002) 51:808–12. 10.1099/0022-1317-51-10-80812435058 17.BrookI. Microbiology of secondary bacterial infection in" exact="scabies" post="lesions. J Clin Microbiol. (1995) 33:2139–40. 10.1128/JCM.33.8.2139-2140.19957559963 18.MaharPDWasiakJClelandHPaulEGinDWattersDAet al.."/>
   <result pre="Burn Care Res. (2014) 35:518–24. 10.1097/BCR.000000000000006224988228 19.SmithAMMcCullersJASecondary bacterial infections in" exact="influenza" post="virus infection pathogenesis in influenza pathogenesis and control. Curr"/>
   <result pre="10.1097/BCR.000000000000006224988228 19.SmithAMMcCullersJASecondary bacterial infections in influenza virus infection pathogenesis in" exact="influenza" post="pathogenesis and control. Curr Top Microbiol Immunol. (2014) 385:327–56."/>
   <result pre="10.1097/IM9.0000000000000018 23.DuRHLiangLRYangCQWangWCaoTZLiMet al.. Predictors of mortality for patients with COVID-19" exact="pneumonia" post="caused by SARS-CoV-2: a prospective cohort study. Eur Respir"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet. (2020) 395:507–13."/>
   <result pre="Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study. Lancet"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected" exact="pneumonia" post="in Wuhan, China. JAMA. (2020) 323:1061–9. 10.1001/jama.2020.158532031570 29.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.First"/>
   <result pre="Med. (2020) 3:1–3. 10.1007/s00134-020-06028-z 32.WuCChenXCaiYZhouXXuSHuangHet al.. Risk factors associated with" exact="acute respiratory distress syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
   <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med. (2020) 180:1–11. 10.1001/jamainternmed.2020.099432167524"/>
   <result pre="patients assessed for COVID-19 infection; experience from a UK regional" exact="infectious disease" post="unit. Influenza Other Respir Viruses. (2020) 14:374–9. 10.1111/irv.1273932223012 37.ChenTWuDChenHYanWYangDChenGet"/>
   <result pre="at: http://www.who.int/csr/sars/country/table2004_04_21/en/ 42.Available, online at: http://www.who.int/csr/don/archive/disease/severe_acute_respiratory_syndrome/en/index.html 43.GuJKortewegCPathology and pathogenesis of" exact="severe acute respiratory syndrome." post="Am J Pathol. (2007) 170:1136–47. 10.2353/ajpath.2007.06108817392154 44.ChengVCChanJFToKKYuenKY. Clinical management"/>
   <result pre="(2013) 100:407–19. 10.1016/j.antiviral.2013.08.01623994190 45.ChongPYChuiPLingAEFranksTJTaiDYLeoYSet al.. Analysis of deaths during the" exact="severe acute respiratory syndrome" post="(SARS) epidemic in Singapore: challenges in determining a SARS"/>
   <result pre="10.1043/1543-2165(2004)128&amp;lt;195:AODDTS&amp;gt;2.0.CO;214736283 46.SoLKLauACYamLYCheungTMPoonEYungRWet al.. Development of a standard treatment protocol for" exact="severe acute respiratory syndrome." post="Lancet. (2003) 361:1615–7. 10.1016/S0140-6736(03)13265-512747883 47.LeeNHuiDWuAChanPCameronPJoyntGMet al.. A major outbreak"/>
   <result pre="Lancet. (2003) 361:1615–7. 10.1016/S0140-6736(03)13265-512747883 47.LeeNHuiDWuAChanPCameronPJoyntGMet al.. A major outbreak of" exact="severe acute respiratory syndrome" post="in Hong Kong. N Engl J Med. (2003) 348:1986–94."/>
   <result pre="(2003) 348:1986–94. 10.1056/NEJMoa03068512682352 48.TsangKWHoPLOoiGCYeeWKWangTChan-YeungMet al.. A cluster of cases of" exact="severe acute respiratory syndrome" post="in Hong Kong. N Engl J Med. (2003) 348:1977–85."/>
   <result pre="al.. Description and clinical treatment of an early outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in Guangzhou, PR China. J Med Microbiol. (2003)"/>
   <result pre="at: https://www.who.int/csr/don/24-february-2020-mers-saudi-arabia/en/ 53.CunhaCBOpalSMMiddle east respiratory syndrome (MERS) A new zoonotic" exact="viral pneumonia." post="Virulence. (2014) 5:650–4. 10.4161/viru.3207725089913 54.MemishZACottenMWatsonSJKellamPZumlaAAlhakeemRFet al.. Community case clusters"/>
   <result pre="62.McCullersJA. Effect of antiviral treatment on the outcome of secondary" exact="bacterial pneumonia" post="after influenza. J Infect Dis. (2004) 190:519–26. 10.1086/42152515243927 63.collab:"/>
   <result pre="Effect of antiviral treatment on the outcome of secondary bacterial" exact="pneumonia" post="after influenza. J Infect Dis. (2004) 190:519–26. 10.1086/42152515243927 63.collab:"/>
   <result pre="10, 2020). 64.McCullersJABartmessKC. Role of neuraminidase in lethal synergism between" exact="influenza" post="virus and Streptococcus pneumoniae. J Infect Dis. (2003) 187:1000–9."/>
   <result pre="clinical features among patients hospitalized in Wisconsin with 2009. H1N1" exact="influenza" post="A virus infections, April to August. 2009. Wisconsin Med"/>
   <result pre="al.. Clinical features of the hospitalized patients with 2009 pandemic" exact="influenza" post="A (H1N1) in Santa Fe, Argentina. Influenza Other Respir"/>
   <result pre="68.Abelenda-AlonsoGRombautsAGudiolCMeijeYOrtegaLClementeMet al.. Influenza and bacterial coinfection in adults with community-acquired" exact="pneumonia" post="admitted to conventional wards: risk factors, clinical features, and"/>
   <result pre="(2020) 7:ofaa066. 10.1093/ofid/ofaa06632206675 69.HughesJMWilsonMEHughesJMWilsonMELeeEHWuCet al.Fatalities associated with the 2009. H1N1" exact="influenza" post="A virus in New York city. Clin Infect Dis."/>
   <result pre="Clin Infect Dis. (2010) 50:1498–504. 10.1086/65244620420514 70.ShiehWJBlauDMDenisonAMDeLeon-CarnesMAdemPBhatnagarJet al.. 2009 pandemic" exact="influenza" post="A (H1N1): pathology and pathogenesis of 100 fatal cases"/>
   <result pre="25:1–3. 10.1038/modpathol.2011.18021874012 72.Perez-PadillaRDe La Rosa-ZamboniDPonce de LeonSHernandezMQuiñones-FalconiFBautistaEet al.. Pneumonia and" exact="respiratory failure" post="from swine-origin influenza A (H1N1) in Mexico. N Engl"/>
   <result pre="Rosa-ZamboniDPonce de LeonSHernandezMQuiñones-FalconiFBautistaEet al.. Pneumonia and respiratory failure from swine-origin" exact="influenza" post="A (H1N1) in Mexico. N Engl J Med. (2009)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7423094/results/search/disease/results.xml">
   <result pre="now and then Coronavirus disease 2019 (COVID-19) is a viral" exact="respiratory disease" post="that mysteriously emerged in late December 2019 in Wuhan"/>
   <result pre="novel coronavirus was identified as the etiologic agent and named" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the seventh coronavirus to infect humans"/>
   <result pre="used to treat a range of infectious diseases such as" exact="scarlet fever" post="and pneumococcal pneumonia. In 1890, the physiologists von Behring"/>
   <result pre="and Kitasato used blood serum from immunized animals to treat" exact="diphtheria" post="and tetanus [13]; subsequently, serum from recovered animals was"/>
   <result pre="used blood serum from immunized animals to treat diphtheria and" exact="tetanus" post="[13]; subsequently, serum from recovered animals was identified as"/>
   <result pre="degree of success to treat an array of diseases, including" exact="rheumatic fever" post="[16], scarlet fever [17], mumps [18], measles [18, 19],"/>
   <result pre="to treat an array of diseases, including rheumatic fever [16]," exact="scarlet fever" post="[17], mumps [18], measles [18, 19], chickenpox [18], and"/>
   <result pre="array of diseases, including rheumatic fever [16], scarlet fever [17]," exact="mumps" post="[18], measles [18, 19], chickenpox [18], and pneumococcal and"/>
   <result pre="diseases, including rheumatic fever [16], scarlet fever [17], mumps [18]," exact="measles" post="[18, 19], chickenpox [18], and pneumococcal and meningococcal infections"/>
   <result pre="fever [16], scarlet fever [17], mumps [18], measles [18, 19]," exact="chickenpox" post="[18], and pneumococcal and meningococcal infections [20] (Fig 1)."/>
   <result pre="convalescent plasma therapy was successfully employed during the H1N1 swine" exact="influenza" post="pandemic (2009), the H5N1 avian flu epidemic (2003), as"/>
   <result pre="the use of convalescent plasma during 2 previous coronavirus epidemics:" exact="severe acute respiratory syndrome" post="(SARS) in 2003, and Middle East respiratory syndrome (MERS)"/>
   <result pre="COVID-19, coronavirus disease 2019; MERS, Middle East respiratory syndrome; SARS," exact="severe acute respiratory syndrome." post="Buying time with the help of the convalescent The"/>
   <result pre="outcome (Treatment). CP, convalescent plasma; COVID-19, coronavirus disease 2019; SARS-CoV-2," exact="severe acute respiratory syndrome" post="coronavirus 2. Convalescent plasma with neutralizing antibodies is currently"/>
   <result pre="Arthritis. J Infect Dis. 1914;15(1):215–26. 17Smith DD. Serum treatment of" exact="scarlet fever" post="[doctoral thesis]. Omaha (Nebraska): University of Nebraska; 1934. 18The"/>
   <result pre="use of convalescent serum in the treatment of measles, chickenpox," exact="mumps" post="and whooping cough, including the prophylactic value of parental"/>
   <result pre="10.1016/S0097-0522(33)90316-0 PubMed PMID: S0097052233903160. 19KohnJL, KleinIF, SchwarzH. Treatment of preeruptive" exact="measles" post="with convalescent serum. JAMA. 1938;111(26):2361–4. 10.1001/jama.1938.02790520017004 20CasadevallA, ScharffMD. Serum"/>
   <result pre="al.Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="influenza" post="A (H1N1) 2009 virus infection. Clin Infect Dis. 2011;52(4):447–56."/>
   <result pre="multicenter double-blind randomized controlled trial for patients with severe 2009" exact="influenza" post="A(H1N1) infection. Chest. 2013;144(2):464–73. Epub 2013/03/02. 10.1378/chest.12-2907 .23450336 24Prevention"/>
   <result pre="al.Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study. Lancet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7423499/results/search/disease/results.xml">
   <result pre="their other colonies in Latin America, protecting the colonizers from" exact="malaria" post="as they pushed into the interior from all along"/>
   <result pre="the interior from all along the coast (Rutz 2018). Endemic" exact="malaria" post="has stopped many invasions in their tracks and ancient"/>
   <result pre="Dentinger 2013). It is no wonder then, that zoonotic emerging" exact="infectious disease" post="risk is elevated in high biodiversity regions experiencing anthropogenic"/>
   <result pre="value but also protracted human conflict, associated entrenched poverty, endemic" exact="infectious disease" post="burden and perpetual threat of emerging infections. The misfortunes"/>
   <result pre="there have been outbreaks of cholera (15,331 cases, 287 deaths)," exact="measles" post="(161,397 cases, 3,117 deaths) and malaria, the leading cause"/>
   <result pre="law2020BerlinSpringer7179 De VriesRPPengWGrantOCThompsonAJZhuXBouwmanKMde la PenaATTvan BreemenMJWickramasingheINAde HaanCAThree mutations switch H7N9" exact="influenza" post="to human-type receptor specificityPLoS Pathog201713100639010.1371/journal.ppat.1006390 DespommierDEllisBWilcoxBThe role of ecotones"/>
   <result pre="SARS-CoV-2 related coronaviruses in Malayan pangolinsNature202010.1038/s41586-020-2169-032555460 collab: MGE NetworkInsights into" exact="malaria" post="susceptibility using genome-wide data on 17,000 individuals from Africa,"/>
   <result pre="excelsior) dieback–a conservation biology challengeBiol Conserv2013158374910.1016/j.biocon.2012.08.026 PengJYangHJiangHLinY-xLuCDXuY-wZengJThe origin of novel" exact="avian influenza" post="A (H7N9) and mutation dynamics for its human-to-human transmissible"/>
   <result pre="dieback–a conservation biology challengeBiol Conserv2013158374910.1016/j.biocon.2012.08.026 PengJYangHJiangHLinY-xLuCDXuY-wZengJThe origin of novel avian" exact="influenza" post="A (H7N9) and mutation dynamics for its human-to-human transmissible"/>
   <result pre="of the sickle cell gene and geographical confirmation of the" exact="malaria" post="hypothesisNat Commun201011710.1038/ncomms110420975674 PyšekPHulmePESimberloffDBacherSBlackburnTMCarltonJTDawsonWEsslFFoxcroftLCGenovesiPScientists' warning on invasive alien speciesBiol Rev202010.1111/brv.1262732588508"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7427094/results/search/disease/results.xml">
   <result pre="variant (CVA24v) is a major causative agent of acute hemorrhagic" exact="conjunctivitis" post="outbreaks worldwide, yet the evolutionary and transmission dynamics of"/>
   <result pre="C), was first isolated from an outbreak of acute hemorrhagic" exact="conjunctivitis" post="(AHC) in Singapore in 1970. Afterwards, CVA24v has been"/>
   <result pre="other viruses causing major outbreaks or global spread such as" exact="influenza" post="A virus, HIV and EV-D6833,34. Our finding suggests that"/>
   <result pre="change of etiological agents and clinical signs of epidemic viral" exact="conjunctivitis" post="over an 18-year period in southern TaiwanGraefes Arch. Clin."/>
   <result pre="Arch. Clin. Exp. Ophthalmol.2003241755456010.1007/s00417-003-0680-212768288 4.LevequeNet al.Rapid diagnosis of acute hemorrhagic" exact="conjunctivitis" post="due to coxsackievirus A24 variant by real-time one-step RT-PCRJ."/>
   <result pre="phylogenetic study of coxsackievirus A24v causing outbreaks of acute hemorrhagic" exact="conjunctivitis" post="(AHC) in BrazilPLoS ONE20116e2320610.1371/journal.pone21858030 9.EnfissiaAJMDelaunebDDelpeyrouxbFRoussetaDBessaudbMCoxsackievirus A24 variant associated with"/>
   <result pre="in BrazilPLoS ONE20116e2320610.1371/journal.pone21858030 9.EnfissiaAJMDelaunebDDelpeyrouxbFRoussetaDBessaudbMCoxsackievirus A24 variant associated with acute haemorrhagic" exact="conjunctivitis" post="cases, French Guiana, 2017Intervirology20186027127510.1159/000489339 10.SousaIPJret al.Re-emergence of a coxsackievirus"/>
   <result pre="10.SousaIPJret al.Re-emergence of a coxsackievirus A24 variant causing acute hemorrhagic" exact="conjunctivitis" post="in Brazil from 2017 to 2018Arch. Virol.20191641181118510.1007/s00705-019-04157-530725183 11.Fragoso-FonsecaDEet al.Complete"/>
   <result pre="coxsackievirus type A24 variant causing an outbreak of acute haemorrhagic" exact="conjunctivitis" post="in southeastern Mexico in 2017Arch. Virol.20201651015101810.1007/s00705-020-04552-332052193 12.Ministerio de Salud"/>
   <result pre="of a variant of coxsackievirus A24J. Med. Virol.20016426927410.1002/jmv.104611424114 15.KosrirukvongsPKanyokRSitritantikornSWasiCAcute hemorrhagic" exact="conjunctivitis" post="outbreak in Thailand, 1992Southeast Asian J. Trop. Med. Public"/>
   <result pre="A 24 variant isolated from an epidemic of acute haemorrhagic" exact="conjunctivitis" post="in north India by RT-PCR using a novel primer"/>
   <result pre="Wkly. Rep.199847428999019810014 18.collab: Centers for Disease Control and PreventionAcute hemorrhagic" exact="conjunctivitis" post="outbreak caused by coxsackievirus A24—Puerto Rico, 2003MMWR Morb. Mortal."/>
   <result pre="Morb. Mortal. Wkly. Rep.20045363263415269699 19.MengRQiuYYanLStudy on etiology of acute hemorrhagic" exact="conjunctivitis" post="in Qingdao during 1997Zhonghua shiyan he linchuang bingduxue zazhi"/>
   <result pre="bingduxue zazhi Chin. J. Exp. Clin. Virol.1999132186187 20.MadhavanHNMalathyJPriyaKAn outbreak of" exact="acute conjunctivitis" post="caused by coxsackie virus A 24Indian J. Ophthalmol.200048215911116516 21.FonsecaMCet"/>
   <result pre="zazhi Chin. J. Exp. Clin. Virol.1999132186187 20.MadhavanHNMalathyJPriyaKAn outbreak of acute" exact="conjunctivitis" post="caused by coxsackie virus A 24Indian J. Ophthalmol.200048215911116516 21.FonsecaMCet"/>
   <result pre="21.FonsecaMCet al.Isolation of coxsackievirus A24 variant from patients with hemorrhagic" exact="conjunctivitis" post="in Cuba, 2008–2009J. Clin. Virol.2012531778110.1016/j.jcv.2011.10.00622074932 22.PAHO/OPS. Conjuntivitis hemorrágica aguda:"/>
   <result pre="immunocytochemical identification of coxsackievirus A-24 variant from the acute haemorrhagic" exact="conjunctivitis" post="outbreak in Taiwan in 2007Eye20102413113610.1038/eye.200919218990 24.WuBet al.Genetic characteristics of"/>
   <result pre="of the coxsackievirus A24 variant causing outbreaks of acute hemorrhagic" exact="conjunctivitis" post="in Jiangsu, China, 2010PLoS ONE20149e8688310.1371/journal.pone.008688324475191 25.ShuklaDKumarASrivastavaSDholeTNMolecular identification and phylogenetic"/>
   <result pre="coxsackievirus A24 variant isolated from an outbreak of acute hemorrhagic" exact="conjunctivitis" post="in India in 2010Arch. Virol201315867968410.1007/s00705-012-1520-723124888 26.DarribaDTaboadaGLDoalloRPosadaDjModelTest 2: more models,"/>
   <result pre="enterovirus 68J. Gen. Virol.201293Pt 91952195810.1099/vir.0.043935-022694903 35.DussartPet al.Outbreak of acute hemorrhagic" exact="conjunctivitis" post="in French Guiana and West Indies caused by coxsackievirus"/>
   <result pre="Asian importJ. Med. Virol.20057555956510.1002/jmv.2030415714481 36.ChansaenrojJet al.Epidemic outbreak of acute haemorrhagic" exact="conjunctivitis" post="caused by coxsackievirus A24 in Thailand, 2014Epidemiol. Infect.20151433087309310.1017/S095026881500064325824006 37.LaxmivandanaRYergolkarPRajeshwariMChitambarSDGenomic"/>
   <result pre="of coxsackievirus A24 variant isolates from a 2010 acute hemorrhagic" exact="conjunctivitis" post="outbreak in Guangdong, ChinaVirol. J.201294110.1186/1743-422X-9-4122336176 39.CabrerizoMEchevarriaJEOteroALucasPTralleroGMolecular characterization of a"/>
   <result pre="coxsackievirus A24 variant that caused an outbreak of acute haemorrhagic" exact="conjunctivitis" post="in Spain, 2004J. Clin. Virol.200843332332710.1016/j.jcv.2008.07.01718786853 40.NidairaMet al.Molecular evolution of"/>
   <result pre="coxsackievirus group A type 24 variant isolates from acute hemorrhagic" exact="conjunctivitis" post="in 2011 Okinawa, JapanMicrobiol. Immunol.20145822723810.1111/1348-0421.1214124517637 41.BessaudMJoffretMLBlondelBDelpeyrouxFExchanges of genomic domains"/>
   <result pre="&amp;amp; Wilkins490529 44.Yin-MurphyMSimple tests for the diagnosis of picornavirus epidemic" exact="conjunctivitis" post="(acute haemorrhagic conjunctivitis)Bull. World Health Organ.19765466756791088513 45.ChristopherSTheogarajSGodboleSJohnTJAn epidemic of"/>
   <result pre="haemorrhagic conjunctivitis)Bull. World Health Organ.19765466756791088513 45.ChristopherSTheogarajSGodboleSJohnTJAn epidemic of acute hemorrhagic" exact="conjunctivitis" post="due to coxsackievirus A24J. Infect. Dis.19821461161910.1093/infdis/146.1.166282991 46.GohKTOoiPLMiyamuraKOginoTYamazakiSAcute haemorrhagic conjunctivitis:"/>
   <result pre="hemorrágica, Cuba 1986Rev. Cub. Hig. Epidemiol.1989277179 49.RedonIALagoPJPerezLRPuentesPCorredorMBOutbreak of acute haemorrhagic" exact="conjunctivitis" post="in CubaMem. Inst. Oswaldo Cruz.199994446746810.1590/S0074-0276199900040000610446002 50.YanDet al.Molecular identification and"/>
   <result pre="analyses of coxsackievirus A24v causing an outbreak of acute hemorrhagic" exact="conjunctivitis" post="in Jiangxi, China, in 2010Bing Du Xue Bao201531325125726470530 51.ZhangLet"/>
   <result pre="2010Bing Du Xue Bao201531325125726470530 51.ZhangLet al.Molecular epidemiology of acute hemorrhagic" exact="conjunctivitis" post="caused by coxsackie A type 24 variant in China,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7427313/results/search/disease/results.xml">
   <result pre="ref-count: Since December 2019, Coronavirus disease 2019 (COVID-19), caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), emerged in the international scene as"/>
   <result pre="were multiple Flavivirus, such as Zika, Yellow fever or Japanese" exact="encephalitis" post="virus are circulating. The risk of false-positive results is"/>
   <result pre="care systems over the edgeTravel Med Infect Dis2020 4LorenzCAzevedoTSChiaravalloti-NetoFCOVID-19 and" exact="dengue fever" post="a dangerous combination for the health system in BrazilTravel"/>
   <result pre="PakistanAm J Trop Med Hyg20201031777832372752 11JoobBWiwanitkitVCOVID-19 can present with a" exact="rash" post="and be mistaken for dengueJ Am Acad Dermatol2020825e17732213305 12WuDLuJLiuQMaXHeWTo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7428060/results/search/disease/results.xml">
   <result pre="In Singapore, 2 clinical cases consisted of dengue-like syndromes with" exact="thrombocytopenia" post="and false immunoglobulin M (IgM) positives with 2 different"/>
   <result pre="Guiana and the Amazonian region of Brazil, the coinfection between" exact="malaria" post="and dengue is not exceptional [8,9]. Arboviral infections (Tonate,"/>
   <result pre="must be explored for both diseases. 10.1371/journal.pntd.0008426.t001Table 1 COVID-19 and" exact="dengue fever" post="similarities and differences. COVID-19 Dengue Symptoms and biological findings"/>
   <result pre="virus and Mayaro virus (French Guiana reports no case of" exact="chikungunya" post="virus infection from early 2016 and no case of"/>
   <result pre="to the context and clinical presentation, physicians may prescribe a" exact="malaria" post="test, blood and urine cultures, serologies, or molecular diagnosis"/>
   <result pre="arguably has the potential to give an edge to the" exact="dengue fever" post="vectors, Aedes aegypti. Population movements and the frequency of"/>
   <result pre="7PerdigãoACB, RamalhoILC, GuedesMIF, BragaDNM, CavalcantiLPG, MeloMEL de, et al.Coinfection with" exact="influenza" post="A (H1N1) pdm09 and dengue virus in fatal cases."/>
   <result pre="8EpelboinL, HanfM, DussartP, Ouar-EpelboinS, DjossouF, NacherM, et al.Is dengue and" exact="malaria" post="co-infection more severe than single infections? A retrospective matched-pair"/>
   <result pre="14210.1186/1475-2875-11-14222549018 9MagalhãesBML, SiqueiraAM, AlexandreMAA, SouzaMS, GimaqueJB, BastosMS, et al.P. vivax" exact="malaria" post="and dengue fever co-infection: a cross-sectional study in the"/>
   <result pre="SiqueiraAM, AlexandreMAA, SouzaMS, GimaqueJB, BastosMS, et al.P. vivax malaria and" exact="dengue fever" post="co-infection: a cross-sectional study in the Brazilian Amazon. PLoS"/>
   <result pre="10.4269/ajtmh.19-015631769401 11EpelboinL, ChesnaisC, BoulléC, DrogoulA-S, RaoultD, DjossouF, et al.Q fever" exact="pneumonia" post="in French Guiana: prevalence, risk factors, and prognostic score."/>
   <result pre="from: https://www.guyane.ars.sante.fr/system/files/2020-04/2020_04_PE_dengue_Guyane.pdf. 14EpelboinL, BoulléC, Ouar-EpelboinS, HanfM, DussartP, DjossouF, et al.Discriminating" exact="malaria" post="from dengue fever in endemic areas: clinical and biological"/>
   <result pre="14EpelboinL, BoulléC, Ouar-EpelboinS, HanfM, DussartP, DjossouF, et al.Discriminating malaria from" exact="dengue fever" post="in endemic areas: clinical and biological criteria, prognostic score"/>
   <result pre="VesinG, BidaudB, BlanchetD, DjossouF. Caractéristiques clinico-biologiques et score prédictif de" exact="chikungunya" post="vs. dengue. Médecine Mal Infect. 2017;47: S58–S59. 24FlamandC, BaillyS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7431640/results/search/disease/results.xml">
   <result pre="pmcid: 7431640 doi: 10.1111/irv.12744IRV12744 : Original Article: Original Articles Recent" exact="influenza" post="activity in tropical Puerto Rico has become synchronized with"/>
   <result pre="from the Sentinel Enhanced Dengue Surveillance System (SEDSS) to describe" exact="influenza" post="trends in southern Puerto Rico during 2012‐2018 and compare"/>
   <result pre="7 days presenting were enrolled. Nasal/oropharyngeal swabs were tested for" exact="influenza" post="A and B viruses by PCR. Virologic data were"/>
   <result pre="National Respiratory and Enteric Virus Surveillance System (NREVSS). We compared" exact="influenza" post="A and B infections identified from SEDSS and WHO/NREVSS"/>
   <result pre="time series decomposition methods, and analysed coherence of climate and" exact="influenza" post="trends by region. Results Among 23,124 participants, 9% were"/>
   <result pre="by region. Results Among 23,124 participants, 9% were positive for" exact="influenza" post="A and 5% for influenza B. Influenza A and"/>
   <result pre="participants, 9% were positive for influenza A and 5% for" exact="influenza" post="B. Influenza A and B viruses were identified year‐round,"/>
   <result pre="Puerto Rico. We observed high coherence between absolute humidity and" exact="influenza" post="A and B virus in HHS regions. In Puerto"/>
   <result pre="recommendations are for everyone 6 months and older to receive" exact="influenza" post="vaccination by the end of October seem appropriate for"/>
   <result pre="the end of October seem appropriate for Puerto Rico. COVID-19" exact="influenza" post="Puerto Rico synchrony trends United States Funding National Center"/>
   <result pre="fig-count: table-count: page-count: word-count: Paz–BaileyG, QuandelacyTM, AdamsLE, et al. Recent" exact="influenza" post="activity in tropical Puerto Rico has become synchronized with"/>
   <result pre="BACKGROUND Influenza is a significant public health problem globally. Seasonal" exact="influenza" post="has a high disease burden, reducing school attendance, increasing"/>
   <result pre="absenteeism and impacting daily productivity.1 Since 2010, CDC estimates that" exact="influenza" post="is associated with between 9.3‐49 million illnesses, 140 000‐960"/>
   <result pre="US Advisory Committee on Immunization Practices (ACIP) recommends routine annual" exact="influenza" post="vaccination for individuals, aged ≥6‐months who do not have"/>
   <result pre="As a US Territory, Puerto Rico follows the same seasonal" exact="influenza" post="vaccination recommendations as the continental US. However, given its"/>
   <result pre="public health measures, for example when to recommend the annual" exact="influenza" post="vaccine in Puerto Rico. In high‐income temperate countries, influenza"/>
   <result pre="annual influenza vaccine in Puerto Rico. In high‐income temperate countries," exact="influenza" post="has been well described. Most seasonal epidemics in temperate"/>
   <result pre="local rainy seasons,9 whereas others have semi‐annual epidemics or year‐round" exact="influenza" post="activity without well‐defined influenza seasons.10, 11 Influenza seasonality in"/>
   <result pre="others have semi‐annual epidemics or year‐round influenza activity without well‐defined" exact="influenza" post="seasons.10, 11 Influenza seasonality in tropical and subtropical regions"/>
   <result pre="tropical and subtropical regions is less understood.9 Few studies examined" exact="influenza" post="in Puerto Rico, and none examine Puerto Rico influenza"/>
   <result pre="examined influenza in Puerto Rico, and none examine Puerto Rico" exact="influenza" post="trends in relation to patterns in the continental United"/>
   <result pre="patterns in the continental United States. Comparing seasonal patterns of" exact="influenza" post="in Puerto Rico to seasonality in the continental United"/>
   <result pre="Rico during 2012 to 2018 to define typical periods of" exact="influenza" post="activity. To better understand the temporal dynamics of influenza"/>
   <result pre="of influenza activity. To better understand the temporal dynamics of" exact="influenza" post="epidemics and possible drivers, we used time series decomposition"/>
   <result pre="used time series decomposition methods to isolate seasonal oscillations of" exact="influenza" post="epidemics in Puerto Rico and to compare them to"/>
   <result pre="influenza epidemics in Puerto Rico and to compare them to" exact="influenza" post="epidemics in US Health and Human Service [HHS] regions"/>
   <result pre="regions (Figure S1). We also explored coherence between climate and" exact="influenza" post="trends for Puerto Rico and HHS regions, to determine"/>
   <result pre="HHS regions, to determine whether climatic differences explained differences in" exact="influenza" post="trends. 2 METHODS 2.1 Sentinel enhanced dengue surveillance system"/>
   <result pre="testing was performed. Upper respiratory tract specimens were tested for" exact="influenza" post="A and B viruses, adenovirus, respiratory syncytial virus (RSV),"/>
   <result pre="committees reviewed and approved the SEDSS study protocol. 2.2 US" exact="influenza" post="viral surveillance Virologic surveillance data from the 40th week"/>
   <result pre="number of respiratory specimens tested, and the number positive for" exact="influenza" post="types A and B viruses each week. Data were"/>
   <result pre="Washington. 2.3 Data analyses We compared the number of confirmed" exact="influenza" post="A and B cases in SEDSS to virologic surveillance"/>
   <result pre="WHO and NREVSS laboratories by HHS region. Weekly numbers of" exact="influenza" post="cases combined influenza A and B virus types. The"/>
   <result pre="laboratories by HHS region. Weekly numbers of influenza cases combined" exact="influenza" post="A and B virus types. The reporting period for"/>
   <result pre="A and B virus types. The reporting period for each" exact="influenza" post="seasons begin during week 40 and ends week 39"/>
   <result pre="cases. To compare the difference in timing (in weeks) of" exact="influenza" post="epidemics between SEDSS and HHS regions, we used continuous"/>
   <result pre="we calculated coherence and phase difference analyses between the seasonal" exact="influenza" post="A and B component from SEDSS to the seasonal"/>
   <result pre="influenza A and B component from SEDSS to the seasonal" exact="influenza" post="component of each HHS region.16 Coherence estimated the relatedness"/>
   <result pre="extract the major seasonal component (period: 40‐80 weeks) for weekly" exact="influenza" post="cases and the weekly mean absolute humidity, temperature and"/>
   <result pre="Overall, 14% of participants were positive for influenza; 9% for" exact="influenza" post="A and 5% for influenza B viruses. Although there"/>
   <result pre="positive for influenza; 9% for influenza A and 5% for" exact="influenza" post="B viruses. Although there were no differences by gender,"/>
   <result pre="by gender, the percentage of participants with positive results for" exact="influenza" post="A or B viruses differed by age (P &amp;lt;"/>
   <result pre="We compared the time series and peak timing of overall" exact="influenza" post="and type‐specific patterns in Puerto Rico to the HHS"/>
   <result pre="Puerto Rico to the HHS regions. In Puerto Rico (SEDSS)," exact="influenza" post="peaks varied substantially between 2013 and 2018 (Figure 1A)."/>
   <result pre="peaks varied substantially between 2013 and 2018 (Figure 1A). Specifically," exact="influenza" post="A virus had an atypical summer peak in 2013,"/>
   <result pre="in the HHS regions (Figure 1B). In the HHS regions," exact="influenza" post="peaked consistently during the winter months (December and January)"/>
   <result pre="winter months (December and January) throughout the study period. For" exact="influenza" post="B virus, long‐term patterns in SEDSS were less clear"/>
   <result pre="2017‐2018 appeared to be closely aligned with HHS regions, where" exact="influenza" post="B virus peaked in the winter and early spring"/>
   <result pre="confirmed these trends (Figure S2A‐C). Figure 1 A, Number of" exact="influenza" post="cases overall (1A‐C) and by type in the Sentinel"/>
   <result pre="(US WHO/NRVESS), (B). Coherence (1D‐F) comparing the similarity between the" exact="influenza" post="patterns in the US HHS regions with SEDSS (PR),"/>
   <result pre="(C). Phase differences (1G‐I) comparing the timing of SEDSS (PR)" exact="influenza" post="seasonal epidemics to those in each of the US"/>
   <result pre="differences, negative values indicate the seasonal pattern of SEDSS (PR)" exact="influenza" post="cases is behind US HHS regions, and positive values"/>
   <result pre="estimate the relatedness and relative timing (in weeks) of the" exact="influenza" post="time series in SEDSS, Puerto Rico to those in"/>
   <result pre="during 2013‐2015, and high coherence in 2016 (Figure 1D). Similarly," exact="influenza" post="A virus in SEDSS had high coherence with influenza"/>
   <result pre="Similarly, influenza A virus in SEDSS had high coherence with" exact="influenza" post="A virus in each HHS time series in later"/>
   <result pre="increased in 2016‐2017 (Figure 1F). The average annual coherence of" exact="influenza" post="was highest when comparing US HHS Region 2 (0.66)"/>
   <result pre="Puerto Rico (0.52), suggesting they do not have more similar" exact="influenza" post="patterns (Table S1). Similar coherence patterns are also observed"/>
   <result pre="S1). Similar coherence patterns are also observed when looking at" exact="influenza" post="A and B. From the phase analyses, the seasonal"/>
   <result pre="period (Figure 1G‐I). From 2013 to 2015, the SEDSS seasonal" exact="influenza" post="patterns lagged behind the HHS regions by as much"/>
   <result pre="SEDSS to HHS regions. The sporadic and off‐season dynamics of" exact="influenza" post="A virus in SEDSS in 2013‐2014 led to a"/>
   <result pre="However, those dynamics quickly changed beginning in 2014, with seasonal" exact="influenza" post="A having similar timing with HHS regions in early"/>
   <result pre="timing with HHS regions in early 2016 and onward. Seasonal" exact="influenza" post="B virus patterns in Puerto Rico lagged behind the"/>
   <result pre="with the HHS regions. To investigate possible climatic drivers of" exact="influenza" post="A and B epidemics patterns within each geographic region,"/>
   <result pre="coherence and phase differences between location‐specific climate variables and type‐specific" exact="influenza" post="incidence (Figure 2A‐I). In terms of the overall time"/>
   <result pre="we observed high coherence (range: 0.61‐0.99) between absolute humidity and" exact="influenza" post="A and B viruses within the HHS regions (Figure"/>
   <result pre="to similar levels as the HHS regions (range: 0.18‐0.94). Meanwhile," exact="influenza" post="B virus coherence was higher early in the time"/>
   <result pre="patterns were observed for coherence between mean weekly temperature and" exact="influenza" post="A and B viruses (Figure 2E, H). Coherence between"/>
   <result pre="and B viruses (Figure 2E, H). Coherence between precipitation and" exact="influenza" post="varied substantially for the HHS regions and Puerto Rico,"/>
   <result pre="phase difference analyses showed a high degree of asynchrony of" exact="influenza" post="patterns in Puerto Rico and patterns for climate variables"/>
   <result pre="climate variables (Figure S3C‐D). The seasonal precipitation patterns lagged behind" exact="influenza" post="A virus trends in SEDSS by 20 weeks, while"/>
   <result pre="temperature patterns led by about 25‐30 weeks (Figure S3C). For" exact="influenza" post="B virus, precipitation, absolute humidity and temperature seasonal components"/>
   <result pre="absolute humidity and temperature seasonal components were ahead of the" exact="influenza" post="B patterns by 15‐30 weeks (Figure S3D). The seasonal"/>
   <result pre="The seasonal wavelet decomposition for each HHS region showed that" exact="influenza" post="peaked when temperature and absolute humidity were low (Figure"/>
   <result pre="and absolute humidity were low (Figure S4A‐E and K‐O for" exact="influenza" post="A and Figure S5A‐E, K‐O for influenza B). For"/>
   <result pre="and K‐O for influenza A and Figure S5A‐E, K‐O for" exact="influenza" post="B). For each HHS region, influenza patterns consistently lagged"/>
   <result pre="Figure S5A‐E, K‐O for influenza B). For each HHS region," exact="influenza" post="patterns consistently lagged approximately 30 weeks for influenza A"/>
   <result pre="HHS region, influenza patterns consistently lagged approximately 30 weeks for" exact="influenza" post="A and 20 weeks influenza B compared with temperature"/>
   <result pre="lagged approximately 30 weeks for influenza A and 20 weeks" exact="influenza" post="B compared with temperature and absolute humidity patterns (Figure"/>
   <result pre="and US HHS regions (US WHO/NRVESS) and annual coherence for" exact="influenza" post="A (D, E, F) and B (G, H, I)."/>
   <result pre="series 4 DISCUSSION This is the first study comparing seasonal" exact="influenza" post="trends in Puerto Rico to trends in the US"/>
   <result pre="to trends in the US HHS regions, and we found" exact="influenza" post="trends between HHS regions and SEDSS, Puerto Rico varied"/>
   <result pre="synchrony in recent years. We observed distinct synchronization patterns by" exact="influenza" post="virus types, showing different dynamics for each type over"/>
   <result pre="different dynamics for each type over the time series. For" exact="influenza" post="A, the predominant type in Puerto Rico and the"/>
   <result pre="exhibited increased synchrony starting in the 2016‐2017 season. Relative to" exact="influenza" post="in the HHS regions, both virus types in Puerto"/>
   <result pre="differences in climate. Consistent with other studies, we found that" exact="influenza" post="incidence in HHS regions had high coherence with humidity"/>
   <result pre="regions, and only had higher coherence during the most recent" exact="influenza" post="seasons. The absence of high coherence between influenza peaks"/>
   <result pre="most recent influenza seasons. The absence of high coherence between" exact="influenza" post="peaks and temperature and humidity in Puerto Rico may"/>
   <result pre="in temperate regions. In vitro and animal model studies of" exact="influenza" post="transmission showed low absolute humidity favours virus survival and"/>
   <result pre="studies showed lower humidity is associated with the onset of" exact="influenza" post="epidemics in the United States.21 Increased proximity between susceptible"/>
   <result pre="weather is also frequently suggested as an important driver of" exact="influenza" post="seasonality.8 Seasonal variation in host immunity may also explain"/>
   <result pre="variation in host immunity may also explain the seasonality of" exact="influenza" post="in temperate countries. Studies also suggest an association between"/>
   <result pre="in temperate countries. Studies also suggest an association between increased" exact="influenza" post="activity and the rainy season in several tropical populations,22"/>
   <result pre="tropical populations,22 but seasonal precipitation also had low coherence with" exact="influenza" post="activity in Puerto Rico. While climatic conditions may likely"/>
   <result pre="activity in Puerto Rico. While climatic conditions may likely affect" exact="influenza" post="transmission in some locations, humidity, temperature and precipitation are"/>
   <result pre="humidity, temperature and precipitation are not the main drivers of" exact="influenza" post="in Puerto Rico. Other climatic factors not examined here,"/>
   <result pre="increased synchronization with HHS regions during recent years for both" exact="influenza" post="virus types. As described above, the climate analysis suggests"/>
   <result pre="influenced by other factors23 including travel and global and US" exact="influenza" post="viral introductions into Puerto Rico. For instance, a previous"/>
   <result pre="epidemics among highly connected populations in the United States, with" exact="influenza" post="viruses spreading from populous to less populous locations.17 It"/>
   <result pre="scales may be particularly important to the seasonal patterns of" exact="influenza" post="in smaller populations, or for locations that are characterized"/>
   <result pre="across the continent was a function of global introductions of" exact="influenza" post="viruses paired with domestic connectivity.26 Our study found that"/>
   <result pre="Rico. Similar coherence patterns are also observed when looking at" exact="influenza" post="A and B. This may be because even though"/>
   <result pre="such as Hawaii or American Samoa. The annual coherence of" exact="influenza" post="B increased from 2015 to the end of 2018."/>
   <result pre="in Puerto Rico. Though we did not have data on" exact="influenza" post="B lineages, there is evidence from other genomic analyses"/>
   <result pre="lineages, there is evidence from other genomic analyses that the" exact="influenza" post="B Victoria lineage had experienced high genetic reassortment in"/>
   <result pre="part explain the increase in coherence and phase of the" exact="influenza" post="B strains across the region. Increases in B Victoria"/>
   <result pre="large study with consistent recruiting and diagnostic testing over multiple" exact="influenza" post="seasons, yet still is subject to several limitations. First,"/>
   <result pre="SEDSS are only a snapshot of a long history of" exact="influenza" post="in Puerto Rico. For example, it is unclear if"/>
   <result pre="account for vaccine effects. While Puerto Rico generally has lower" exact="influenza" post="vaccination rates compared with US states,29 we did not"/>
   <result pre="could not assess its impact the local dynamics. Data on" exact="influenza" post="A virus subtypes or B virus lineages were not"/>
   <result pre="other locations, but are components that may contribute substantially to" exact="influenza" post="dynamics in Puerto Rico. Future studies could include phylogenetic"/>
   <result pre="studies could include phylogenetic analysis to confirm the timing of" exact="influenza" post="strains circulating in the continental United States compared with"/>
   <result pre="were similar to others. We did not have data on" exact="influenza" post="trends for all of Puerto Rico and were unable"/>
   <result pre="Puerto Rico.29 Our study highlights the poorly understood complexity of" exact="influenza" post="in tropical regions where climate is not a strong"/>
   <result pre="dynamics. It also broadens our understanding of the relationship between" exact="influenza" post="trends in the continental United States and Puerto Rico,"/>
   <result pre="and the role of climate. Currently in the United States," exact="influenza" post="vaccines are recommended to be received before the end"/>
   <result pre="to ensure that interventions, like vaccinations, are implemented appropriately for" exact="influenza" post="in Puerto Rico. CONFLICT OF INTEREST The authors report"/>
   <result pre="project. References REFERENCES 1TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ. Global" exact="influenza" post="seasonality: reconciling patterns across temperate and tropical regions. Environ"/>
   <result pre="Centers for Disease Control and Prevention . Disease burden of" exact="influenza" post="[Internet]. 2019 [cited 2019 Mar. 18]; Available from: https://www.cdc.gov/flu/about/burden/index.html"/>
   <result pre="3SamaanG, McPhersonM, PartridgeJ. A review of the evidence to support" exact="influenza" post="vaccine introduction in countries and areas of WHO's Western"/>
   <result pre="SokolowLZ, BroderKR, WalterEB, FryAM, JerniganDB. Prevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
   <result pre="CoxN, et al. Epidemiological, antigenic and genetic characteristics of seasonal" exact="influenza" post="A(H1N1), A(H3N2) and B influenza viruses: basis for the"/>
   <result pre="and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: basis for the WHO recommendation on the composition"/>
   <result pre="viruses: basis for the WHO recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 northern hemisphere season."/>
   <result pre="et al. Virologically confirmed population‐based burden of hospitalization caused by" exact="influenza" post="A and B among children in Hong Kong. Clin"/>
   <result pre="Infect Dis. 2009;49:1016‐1021.19722912 11DurandLO, ChengPY, PalekarR, et al. Timing of" exact="influenza" post="epidemics and vaccines in the American tropics, 2002–2008, 2011–2014."/>
   <result pre="Sao Paulo. 2013;55:432.24213199 14DareR, ZhuY, WilliamsJV, GriffinM, TalbotHK. Detection of" exact="influenza" post="by real time RT‐PCR is not affected by delays"/>
   <result pre="[cited 2019 Apr. 16]; Available from: https://www.esrl.noaa.gov/psd/ 19HoodAM. Infectivity of" exact="influenza" post="virus aerosols. J Hyg. 1963;61:331‐335.14066589 20LowenAC, MubarekaS, SteelJ, PaleseP."/>
   <result pre="and temperature. PLoS Pathog. 2007;3:1470‐1476.17953482 21ShamanJ, KohnM. Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. Proc Natl Acad Sci USA."/>
   <result pre="BoellePY, FlahaultA, FergusonNM. Estimating the impact of school closure on" exact="influenza" post="transmission from Sentinel data. Nature. 2008;452:750‐754.18401408 24AlthouseBM, FlascheS, ThiemVD,"/>
   <result pre="GogJR, et al. Urbanization and humidity shape the intensity of" exact="influenza" post="epidemics in U.S. cities. Science. 2018;362:75‐79.30287659 26GeogheganJL, SaavedraAF, DucheneS,"/>
   <result pre="SaavedraAF, DucheneS, SullivanS, BarrI, HolmesEC. Correction: continental synchronicity of human" exact="influenza" post="virus epidemics despite climatic variation. PLoS Pathog. 2018;14:e1006903.29414984 27VirkRK,"/>
   <result pre="2018;14:e1006903.29414984 27VirkRK, JayakumarJ, MendenhallIH, et al. Divergent evolutionary trajectories of" exact="influenza" post="B viruses underlie their contemporaneous epidemic activity. Proc Natl"/>
   <result pre="https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html 29collab: Centers for Disease Control and Prevention . 2013–14" exact="influenza" post="season vaccination coverage estimates for local areas and territories"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7435559/results/search/disease/results.xml">
   <result pre="boost health management. fig-count: table-count: page-count: word-count: 1 INTRODUCTION The" exact="severe acute respiratory syndrome" post="(SARS); a viral respiratory disease outbreak in Southern China"/>
   <result pre="1 INTRODUCTION The severe acute respiratory syndrome (SARS); a viral" exact="respiratory disease" post="outbreak in Southern China (between November 2002 and July"/>
   <result pre="viruses. For instance, the &quot;African swine fever (ASF) a viral" exact="hemorrhagic disease," post="caused by a large double‐stranded DNA virus with an"/>
   <result pre="A., &amp;amp; Dixon, L. (2018). African swine fever: A re‐emerging" exact="viral disease" post="threatening the global pig industry. The Veterinary Journal, 233,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7440033/results/search/disease/results.xml">
   <result pre="for containment of future outbreaks, epidemics or pandemics of any" exact="infectious disease" post="in Africa. Résumé La maladie du coronavirus 2019 (COVID-19)"/>
   <result pre="pandemic will not be the last global spread of an" exact="infectious disease" post="the world will experience, and the next one may"/>
   <result pre="its first report, the high morbidity and mortality associated with" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), the aetiological agent of COVID-19, pose"/>
   <result pre="because public health officials leveraged on the lessons learnt in" exact="poliomyelitis" post="response. In the same vein, but for initial delays"/>
   <result pre="epidemicNature538201619320010.1038/nature1979027734858 3PurohitV.KudaleA.SundaramN.JosephS.SchaettiC.WeissM.G.Public health policy and experience of the 2009 H1N1" exact="influenza" post="pandemic in Pune, IndiaInt J Health Policy Manag7201815416610.15171/ijhpm.2017.5429524939 4ChiaT.OyeniranO.I.Human"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7441048/results/search/disease/results.xml">
   <result pre="technical characteristics, clinical scenarios and requirements. Abstract The outbreak of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), which began in Wuhan, Hubei Province,"/>
   <result pre="diagnosis An outbreak of coronavirus disease 2019 (COVID-19) caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China, in"/>
   <result pre="sampling sites in SARS-CoV-2 detection. Since the initial cases of" exact="pneumonia" post="of unknown cause were first reported, viral culture and"/>
   <result pre="have an immediate impact on patient management and control of" exact="infectious disease" post="epidemics (Kozel and Burnham-Marusich, 2017). At the time of"/>
   <result pre="shedding of 2019-nCoV infectionsmedRxiv20202020.02.11.20021493 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019New Engl J Med2020PubMed PMID: 31978945 Appendix"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7445369/results/search/disease/results.xml">
   <result pre="copyright protections. Abstract The present outbreak caused by SARS-CoV-2, an" exact="influenza" post="virus with neurotropic potential, presents with neurological manifestations in"/>
   <result pre="postinfectious complications are also expected. Neurological disorders as sequelae of" exact="influenza" post="viruses have been repeatedly documented in the past and"/>
   <result pre="Wuhan, 11/221 patients with COVID-19 developed acute ischemic stroke, 1" exact="cerebral venous sinus thrombosis," post="and 1 cerebral hemorrhage. However, patients with these severe"/>
   <result pre="comorbidities, especially vascular risk factors such as hypertension [6]. Hypoxic" exact="encephalopathy" post="has been diagnosed in 20% of 113 deceased patients"/>
   <result pre="was identified as a risk factor along with hypertension, diabetes," exact="chronic obstructive pulmonary disease," post="and cardiovascular disease [9]. Other neurological features were observed"/>
   <result pre="factor along with hypertension, diabetes, chronic obstructive pulmonary disease, and" exact="cardiovascular disease" post="[9]. Other neurological features were observed in severe cases,"/>
   <result pre="of drug-induced neuromuscular blockade or early death. Acute inflammatory demyelinating" exact="polyneuropathy" post="[11] and Miller-Fisher syndrome [12] were also observed. The"/>
   <result pre="occurrence of cerebrovascular events in patients with arterial hypertension and" exact="cardiovascular disease" post="might be related to a direct effect of the"/>
   <result pre="[13]. Lessons from the Past Neurological complications as sequelae of" exact="influenza" post="infection have been documented for over a century. In"/>
   <result pre="Henry and coworkers [14] found that in a discussion on" exact="influenza" post="in 1919, the British Royal Society of Medicine established"/>
   <result pre="association between neurological disorders and the pandemic and postulated that" exact="influenza" post="&quot;attacked more particularly the nerve centres&quot; based on the"/>
   <result pre="the authors argued that the temporal relationship between outbreaks of" exact="influenza" post="and cerebrospinal fever (meningitis), poliomyelitis, and polio-encephalitis was more"/>
   <result pre="(meningitis), poliomyelitis, and polio-encephalitis was more than coincidence. Most importantly," exact="encephalitis" post="lethargica and postencephalitic Parkinsonism have been closely associated with"/>
   <result pre="been then associated with secondary Parkinsonisms. These include Coksackievirus; Japanese" exact="encephalitis" post="B, St. Louis, and West Nile viruses; and HIV"/>
   <result pre="eye infections [16]. Less frequently reported neurological complications include encephalitis/meningoencephalitis," exact="acute disseminated encephalomyelitis," post="myelitis, cerebrovascular diseases (ischemic infarction and vasculopathy), seizures and"/>
   <result pre="associated with severe neurological complications, including, in addition to HFMD," exact="aseptic meningitis," post="encephalitis, acute flaccid paralysis, and acute flaccid myelitis. Other"/>
   <result pre="Neurological Disorders Severe acute respiratory syndrome (SARS) is a zoonotic" exact="respiratory disease" post="caused by a coronavirus (SARS-CoV) starting in Southeast Asia"/>
   <result pre="induce several neurological diseases, including polyneuropathy, encephalitis, and aortic ischemic" exact="stroke" post="[25]. Autopsy studies demonstrated that signs of cerebral edema"/>
   <result pre="has been reported in a variety of neurological disorders, including" exact="encephalitis" post="[29], optic neuritis [30], multiple sclerosis [31], and Parkinson's"/>
   <result pre="reported in a variety of neurological disorders, including encephalitis [29]," exact="optic neuritis" post="[30], multiple sclerosis [31], and Parkinson's disease [32]. Neurological"/>
   <result pre="variety of neurological disorders, including encephalitis [29], optic neuritis [30]," exact="multiple sclerosis" post="[31], and Parkinson's disease [32]. Neurological Complications: Direct Viral"/>
   <result pre="1976 led to a debate on the possible link between" exact="influenza" post="vaccinations and GBS [33]. The reported relative risk was"/>
   <result pre="Between 1978 and 2009, several studies on the association between" exact="influenza" post="vaccination and GBS yielded conflicting results [34]. Although the"/>
   <result pre="remain unsettled [35], a study in mice [36] suggested that" exact="influenza" post="vaccine antigens may induce cross-reactive anti-ganglioside antibodies, eventually causing"/>
   <result pre="cross-reactive anti-ganglioside antibodies, eventually causing peripheral nerve damage. During the" exact="influenza" post="pandemic in 2009, the possible link between influenza vaccination"/>
   <result pre="During the influenza pandemic in 2009, the possible link between" exact="influenza" post="vaccination and GBS drew special attention due to the"/>
   <result pre="to the rapid development and implementation of vaccines against pandemic" exact="influenza" post="A/H1N1 virus. A case-control study was conducted in Italy"/>
   <result pre="October 2010 and May 2011 to explore the association between" exact="influenza" post="vaccination and GBS [34]. Influenza vaccination was associated with"/>
   <result pre="with the results of eight studies conducted during the 2009–2010" exact="influenza" post="vaccine campaign with a monovalent A/H1N1 vaccine, which showed"/>
   <result pre="those studies do not modify the risk-benefit profile of seasonal" exact="influenza" post="vaccination but call attention to the need to develop"/>
   <result pre="a number of infectious and immune-mediated inflammatory neurological diseases, including" exact="encephalitis" post="and aseptic meningitis [38], acute transverse myelitis [39], brachial"/>
   <result pre="of infectious and immune-mediated inflammatory neurological diseases, including encephalitis and" exact="aseptic meningitis" post="[38], acute transverse myelitis [39], brachial plexus neuropathy [40],"/>
   <result pre="infectious and immune-mediated inflammatory neurological diseases, including encephalitis and aseptic" exact="meningitis" post="[38], acute transverse myelitis [39], brachial plexus neuropathy [40],"/>
   <result pre="neurological diseases, including encephalitis and aseptic meningitis [38], acute transverse" exact="myelitis" post="[39], brachial plexus neuropathy [40], and GBS [41], and"/>
   <result pre="including encephalitis and aseptic meningitis [38], acute transverse myelitis [39]," exact="brachial plexus neuropathy" post="[40], and GBS [41], and calculate the excess number"/>
   <result pre="and aseptic meningitis [38], acute transverse myelitis [39], brachial plexus" exact="neuropathy" post="[40], and GBS [41], and calculate the excess number"/>
   <result pre="and proper treatment. This might have occurred for people with" exact="stroke" post="[42, 43] and can be expected for other conditions"/>
   <result pre="effects of control measures [45]. As taught by the 1918" exact="influenza" post="pandemic and the more recent occurrence of postinfectious neurological"/>
   <result pre="at risk of incurring the most severe complications of the" exact="infectious disease," post="and, conversely, the infection itself might be a source"/>
   <result pre="profound reflections on the management of acute neurological conditions like" exact="stroke" post="and chronic conditions like multiple sclerosis, neurodegenerative disorders, and"/>
   <result pre="of acute neurological conditions like stroke and chronic conditions like" exact="multiple sclerosis," post="neurodegenerative disorders, and myasthenia gravis. Furthermore, the implementation of"/>
   <result pre="stroke and chronic conditions like multiple sclerosis, neurodegenerative disorders, and" exact="myasthenia gravis." post="Furthermore, the implementation of social distancing and interruption of"/>
   <result pre="neuroinvasive potential of SARS-CoV2 may play a role in the" exact="respiratory failure" post="of COVID-19 patientsJ Med Virol2020Feb 27 2MichalicováABhideKBhideMKováčAHow viruses infiltrate"/>
   <result pre="infection: causality or coincidence?Lancet Neurol202019(5)383432246917 14HenryJSmeyneRJJangHMillerBOkunMSParkinsonism and neurological manifestations of" exact="influenza" post="throughout the 20th and 21st centuriesParkinsonism Relat Disord201016(9)5667120650672 15JangHBoltzDAWebsterRGSmeyneRJViral"/>
   <result pre="2)ii354020215134 19ChaconRMirzaSRodriguezDParedesAGuzmanGMorenoLet al.Demographic and clinical characteristics of deaths associated with" exact="influenza" post="A(H1N1) pdm09 in Central America and Dominican Republic 2009–2010BMC"/>
   <result pre="neuritisActa Neurol Scand1999100(2)889110442448 31SalmiAZiolaBHoviTReunanenMAntibodies to coronaviruses OC43 and 229E in" exact="multiple sclerosis" post="patientsNeurology198232(3)29256278362 32FazziniEFlemingJFahnSCerebrospinal fluid antibodies to coronavirus in patients with"/>
   <result pre="1976–1977Am J Epidemiol1979110(2)10523463869 34GaleottiFMassariMD'AlessandroRBeghiEChiòALogroscinoGet al.Risk of Guillain-Barré syndrome after 2010–2011" exact="influenza" post="vaccinationEur J Epidemiol201328(5)4334423543123 35SejvarJJBaughmanALWiseMMorganOWPopulation incidence of Guillain-Barré syndrome: a"/>
   <result pre="meta-analysisNeuroepidemiology201136(2)1233321422765 36NachamkinIShadomySVMoranAPCoxNFitzgeraldCUngHet al.Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other" exact="influenza" post="vaccines: insights into vaccine-associated Guillain-Barré syndromeJ Infect Dis2008198(2)2263318522505 37PoserCNeurological"/>
   <result pre="into vaccine-associated Guillain-Barré syndromeJ Infect Dis2008198(2)2263318522505 37PoserCNeurological complications of swine" exact="influenza" post="vaccinationActa Neurol Scand198266(4)413316128862 38BeghiENicolosiAKurlandLTMulderDWHauserWAShusterLEncephalitis and aseptic meningitis, Olmsted County,"/>
   <result pre="37PoserCNeurological complications of swine influenza vaccinationActa Neurol Scand198266(4)413316128862 38BeghiENicolosiAKurlandLTMulderDWHauserWAShusterLEncephalitis and" exact="aseptic meningitis," post="Olmsted County, Minnesota, 1950–1981: I. EpidemiologyAnn Neurol198416(3)283946148911 39BeghiEKurlandLTMulderDWIncidence of"/>
   <result pre="County, Minnesota, 1950–1981: I. EpidemiologyAnn Neurol198416(3)283946148911 39BeghiEKurlandLTMulderDWIncidence of acute transverse" exact="myelitis" post="in rochester, Minnesota, 1970–1980, and implications with respect to"/>
   <result pre="myelitis in rochester, Minnesota, 1970–1980, and implications with respect to" exact="influenza" post="vaccineNeuroepidemiology19821(3)17688 40BeghiEKurlandLTMulderDWNicolosiABrachial plexus neuropathy in the population of Rochester,"/>
   <result pre="1970–1980, and implications with respect to influenza vaccineNeuroepidemiology19821(3)17688 40BeghiEKurlandLTMulderDWNicolosiABrachial plexus" exact="neuropathy" post="in the population of Rochester, Minnesota, 1970–1981Ann Neurol198518(3)32032996415 41BeghiEKurlandLTMulderDWWiederholtWCGuillain-Barré"/>
   <result pre="Minnesota, 1970–1981Ann Neurol198518(3)32032996415 41BeghiEKurlandLTMulderDWWiederholtWCGuillain-Barré syndrome. Clinicoepidemiologic features and effect of" exact="influenza" post="vaccineArch Neurol198542(11)105374051833 42NaccaratoMScaliIOlivoSAjčevićMBuoite StellaAFurlanisGet al.Has COVID-19 played an unexpected"/>
   <result pre="of SARS-CoV-2 through the postpandemic periodScience2020May 22368(6493)860832291278 46SejvarJJPfeiferDSchonbergerLBGuillain-barré syndrome following" exact="influenza" post="vaccination: causal or coincidental?Curr Infect Dis Rep201113(4)3879821681501 47collab: IHME"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7448857/results/search/disease/results.xml">
   <result pre="ABSTRACT The emerging SARS-CoV-2 infection associated with the outbreak of" exact="viral pneumonia" post="in China is ongoing worldwide. There are no approved"/>
   <result pre="The emerging SARS-CoV-2 infection associated with the outbreak of viral" exact="pneumonia" post="in China is ongoing worldwide. There are no approved"/>
   <result pre="worldwide. There are no approved antiviral therapies to treat this" exact="viral disease." post="Here we examined the antiviral abilities of three broad-spectrum"/>
   <result pre="ref-count: page-count: Since the late 2019 when a cluster of" exact="pneumonia" post="associated with the emerging novel coronavirus, SARS-CoV-2 was reported"/>
   <result pre="RNA viruses which include Middle East respiratory syndrome coronavirus (MERS-CoV)," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) [4], Zika virus [5], influenza virus [6]"/>
   <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) [4], Zika virus [5]," exact="influenza" post="virus [6] and enterovirus. Gemcitabine inhibits both MERS-CoV and"/>
   <result pre="immunity, at least in the cases of enterovirus [7] and" exact="influenza" post="virus [6]. To examine whether it acts by the"/>
   <result pre="concentration of gemcitabine observed in patients with advanced non-small cell" exact="lung cancer" post="(NSCLC) could reach 17 µM after bronchial artery infusion or"/>
   <result pre="of gemcitabine observed in patients with advanced non-small cell lung" exact="cancer" post="(NSCLC) could reach 17 µM after bronchial artery infusion or"/>
   <result pre="assays have shown that oxysophoridine has various pharmacological activities, including" exact="suppression" post="of the growth of hepatocellular carcinoma [10] and colorectal"/>
   <result pre="has various pharmacological activities, including suppression of the growth of" exact="hepatocellular carcinoma" post="[10] and colorectal cancer cells [11] by regulating apoptosis"/>
   <result pre="including suppression of the growth of hepatocellular carcinoma [10] and" exact="colorectal cancer" post="cells [11] by regulating apoptosis associated with the Bcl-2/Bax/caspase-3"/>
   <result pre="suppression of the growth of hepatocellular carcinoma [10] and colorectal" exact="cancer" post="cells [11] by regulating apoptosis associated with the Bcl-2/Bax/caspase-3"/>
   <result pre="in Amaryllidaceae with a wide range of biological functions for" exact="cancer" post="and infectious diseases treatment [13]. Unlike oxysophoridine, lycorine has"/>
   <result pre="to exhibit antiviral activities against enterovirus, flaviviruses, HIV-1, SARS-CoV and" exact="hepatitis" post="C virus. Regarding the exact antiviral mechanism of lycorine,"/>
   <result pre="that lycorine was able to (i) inhibit the export of" exact="influenza" post="virus nucleoprotein from the nucleus [14], and (ii) downregulate"/>
   <result pre="ZhengXS, ZhaoK, ChenQJ, DengF, LiuLL, YanB, ZhanFX, WangYY, XiaoGF, ShiZL.2020A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="10.1016/j.antiviral.2016.12.02228049006 6DenisovaOV, KakkolaL, FengL, et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit" exact="influenza" post="a virus infection. J Biol Chem. 2012;287:35324–32. doi: 10.1074/jbc.M112.39214222910914"/>
   <result pre="and related active compounds: a review of their role on" exact="hepatitis" post="B virus infection. Drug Discov Ther. 2013;7:212–24. doi: 10.5582/ddt.2013.v7.6.21224423652"/>
   <result pre="10.5582/ddt.2013.v7.6.21224423652 10YaoXQ, ZhangYH, LongW, et al.Oxysophoridine suppresses the growth of" exact="hepatocellular carcinoma" post="in mice: in vivo and cDNA microarray studies. Chin"/>
   <result pre="in vitro induction of the apoptotic effects of oxysophoridine on" exact="colorectal cancer" post="cells via the Bcl-2/Bax/caspase-3 signaling pathway. Oncol Lett. 2017;14:8000–8006.29344242"/>
   <result pre="vitro induction of the apoptotic effects of oxysophoridine on colorectal" exact="cancer" post="cells via the Bcl-2/Bax/caspase-3 signaling pathway. Oncol Lett. 2017;14:8000–8006.29344242"/>
   <result pre="inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic" exact="avian influenza" post="virus H5N1. Infl Other Respir Viruses. 2013;7:922–31. doi: 10.1111/irv.12035"/>
   <result pre="nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian" exact="influenza" post="virus H5N1. Infl Other Respir Viruses. 2013;7:922–31. doi: 10.1111/irv.12035"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7454301/results/search/disease/results.xml">
   <result pre="two decades, several viral epidemics have been listed like the" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) in 2002/2003, the influenza H1N1 in 2009"/>
   <result pre="the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002/2003, the" exact="influenza" post="H1N1 in 2009 and recently the Middle East respiratory"/>
   <result pre="and HKU1-CoV result in simple respiratory marks like that in" exact="common cold," post="SARS-CoV and MERS-CoV cause dangerous and deadly respiratory tract"/>
   <result pre="2020. At the same time, the ICTV committee named it" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) [6, 10]. The danger of COVID-19"/>
   <result pre="et al. [25] employed both X-ray and CT images for" exact="bacterial pneumonia," post="coronavirus, COVID-19 and normal cases and used different deep"/>
   <result pre="https://www.ncbi.nlm.nih.gov/books/NBK554776/(updated Mar 20, 2020), 2020. 3.ZhouP, YangX, WangX, et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="9.WuF, ZhaoS, YuB, et al.A new coronavirus associated with human" exact="respiratory disease" post="in China. Nature2020;579:265–9. doi: 10.1038/s41586-020-2008-3.32015508 10.PanL, MuM, YangP, et"/>
   <result pre="doi: 10.1093/nar/gkl986.18073190 29.LewandowskiK, XuY, PullanST, et al.Metagenomic nanopore sequencing of" exact="influenza" post="virus direct from clinical respiratory samples. J Clin Microbiol2019;58:e00963–19.31666364"/>
   <result pre="nanopore and illumina sequencing for recovering whole genome sequences of" exact="chikungunya" post="and dengue viruses directly from clinical samples. Euro Surveill2018;23:1800228."/>
   <result pre="−19 in Australia. Med J Aust2020;212(10):459–62.32237278 32.DasJ, BarmanSBayesian fusion in" exact="cancer" post="gene prediction. Int J Comput Appl2014;1:5–10. 33.TradCH, FangQ, CosicIProtein"/>
   <result pre="wavelet transform approach. Protein Eng2002;15(3):193–203. doi: 10.1093/protein/15.3.193.11932490 34.GhoshA, BarmanSPrediction of" exact="prostate cancer" post="cells based on principal component analysis technique In: Procedia"/>
   <result pre="transform approach. Protein Eng2002;15(3):193–203. doi: 10.1093/protein/15.3.193.11932490 34.GhoshA, BarmanSPrediction of prostate" exact="cancer" post="cells based on principal component analysis technique In: Procedia"/>
   <result pre="47.Al BatainehAA comparative analysis of nonlinear machine learning algorithms for" exact="breast cancer" post="detection. Int J Mach Learn Comput2019;9(3):248–54. 48.FogliattoFS, AnzanelloMJ, SoaresF,"/>
   <result pre="BatainehAA comparative analysis of nonlinear machine learning algorithms for breast" exact="cancer" post="detection. Int J Mach Learn Comput2019;9(3):248–54. 48.FogliattoFS, AnzanelloMJ, SoaresF,"/>
   <result pre="Mach Learn Comput2019;9(3):248–54. 48.FogliattoFS, AnzanelloMJ, SoaresF, et al.Decision support for" exact="breast cancer" post="detection: classification improvement through feature selection. Cancer Control2019;26(1):1–8. doi:"/>
   <result pre="Learn Comput2019;9(3):248–54. 48.FogliattoFS, AnzanelloMJ, SoaresF, et al.Decision support for breast" exact="cancer" post="detection: classification improvement through feature selection. Cancer Control2019;26(1):1–8. doi:"/>
   <result pre="through feature selection. Cancer Control2019;26(1):1–8. doi: 10.1177/1073274819876598. 49.MedjahedSA, SaadiTA, BenyettouABreast" exact="cancer" post="diagnosis by using k-nearest neighbor with different distances and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7454384/results/search/disease/results.xml">
   <result pre="asymptomatic adults, but up to 30% of immunocompromised patients with" exact="respiratory disease." post="Half of reported Pan-CoV assays identify SARS-CoV-2 and with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7458341/results/search/disease/results.xml">
   <result pre="Methods : Immunologic Techniques : Immunoassays: Enzyme-Linked Immunoassays Epidemiology of" exact="dengue fever" post="in Guatemala Dengue in Guatemala Castillo SignorLeticia del CarmenConceptualizationData"/>
   <result pre="the twentieth century, possibly as a by-product of the national" exact="malaria" post="and yellow fever eradication campaigns [17]. However dengue viruses"/>
   <result pre="century, possibly as a by-product of the national malaria and" exact="yellow fever" post="eradication campaigns [17]. However dengue viruses were reported since"/>
   <result pre="cases. The laboratory has the capacity to test for dengue," exact="chikungunya" post="and Zika infections, with the aim of testing samples"/>
   <result pre="notably high in 2015 and 2016, coinciding with the large" exact="chikungunya" post="[35] and zika [36] epidemics in the country. These"/>
   <result pre="compatible with dengue in the Latin American region include leptospirosis," exact="typhoid fever," post="influenza, Rickettsiosis and less common arboviruses such as Oropouche"/>
   <result pre="and parallel epidemics are well documented. For example, dengue and" exact="chikungunya" post="co-circulated in Guatemala, with a report indicating that both"/>
   <result pre="Surveill. 2010;15(39):1967620929659 8Gjenero-MarganI, AlerajB, KrajcarD, LesnikarV, KlobucarA, Pem-NovoselI, et al.Autochthonous" exact="dengue fever" post="in Croatia, August-September 2010. Euro surveill. 2011;16(9). 9RadkeEG, GregoryCJ,"/>
   <result pre="Int J Infect Dis. 2016;44:44–9. 10.1016/j.ijid.2016.01.01526836763 15PaixãoES, TeixeiraMG, RodriguesLC. Zika," exact="chikungunya" post="and dengue: the causes and threats of new and"/>
   <result pre="Trioplex real-time RT-PCR assay for detection of Zika, dengue, and" exact="chikungunya" post="viruses. Nat Comms. 2018;9(1):1391. 21HunspergerEA, YoksanS, BuchyP, NguyenVC, SekaranSD,"/>
   <result pre="distribution of the association between El Nino South Oscillation and" exact="dengue fever" post="in the Americas: a continental analysis using geographical information"/>
   <result pre="10.1038/s41598-018-38034-z30760757 29SippyR, HerreraD, GausD, GangnonRE, PatzJA, OsorioJE. Seasonal patterns of" exact="dengue fever" post="in rural Ecuador: 2009–2016. PLoS Neglect Trop Dis. 2019;13(5):e0007360."/>
   <result pre="Infect. 2018;7(1):167. 35EdwardsT, SignorLD, WilliamsC, DonisE, CuevasLE, AdamsER. Co-infections with" exact="chikungunya" post="and dengue viruses, Guatemala, 2015. Emerg Infect Dis. 2016;22(11):2003–5."/>
   <result pre="PlassD, HavelaarAH, BrookeRJ, KramarzP, et al.Measuring underreporting and under-ascertainment in" exact="infectious disease" post="datasets: a comparison of methods. BMC public health. 2014;14:14710.1186/1471-2458-14-14724517715"/>
   <result pre="2011;84(2):200–7. 10.4269/ajtmh.2011.10-050321292885 42LasernaA, Barahona-CorreaJ, BaqueroL, Castañeda-CardonaC, RosselliD. Economic impact of" exact="dengue fever" post="in Latin America and the Caribbean: a systematic review."/>
   <result pre="review. PloS one. 2019;14(2):e021140110.1371/journal.pone.021140130785894 46RaclozV, RamseyR, TongS, HuW. Surveillance of" exact="dengue fever" post="virus: a review of epidemiological models and early warning"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7459150/results/search/disease/results.xml">
   <result pre="and the practice of economicsJ Econ Lit202058240541810.1257/jel.20191573 AlmondDIs the 1918" exact="influenza" post="pandemic over? Long-term effects of in utero influenza exposure"/>
   <result pre="the 1918 influenza pandemic over? Long-term effects of in utero" exact="influenza" post="exposure in the post-1940 US populationJ Polit Econ2006114467271210.1086/507154 FourcadeMOllionEAlganYThe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7461001/results/search/disease/results.xml">
   <result pre="language to explain and predict the behavior of the infectious" exact="viral disease." post="These models could be deterministic, non‐deterministic, or could contain"/>
   <result pre="could contain branching processes that aid the prediction of the" exact="infectious disease." post="2 MATHEMATICAL MODELS Mathematical models help to make mental"/>
   <result pre="It was developed by Kernack and McKendrick to describe an" exact="influenza" post="epidemic (Bauer, 2017). It assumes the introduction of an"/>
   <result pre="been used to explain the transmission and repeated outbreaks of" exact="measles" post="in New York between 1930 and 1962. The SIR"/>
   <result pre="has been widely applied for various disease epidemics such as" exact="chickenpox" post="and SARS, and its relevance has been advanced for"/>
   <result pre="potent tools for understanding the transmission dynamics of an infectious" exact="viral disease." post="In other climes, there is no gainsaying to aver"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7466926/results/search/disease/results.xml">
   <result pre="doi: 10.1007/s13337-020-00628-5 : Review Article A brief outline of respiratory" exact="viral disease" post="outbreaks: 1889–till date on the public health perspectives http://orcid.org/0000-0003-4837-221XNoorRashedrashednoor@iub.edu.bdManihaSyeda"/>
   <result pre="significant increase in deaths in the current days due to" exact="influenza" post="around the world started in 1889 is a continued"/>
   <result pre="style of pandemic outbreaks. An array of research on the" exact="influenza" post="viruses has been conducted especially pointing on (1) the"/>
   <result pre="viral epidemiology, and on (4) the protective immunity against the" exact="influenza" post="viruses. Current review briefly discussed the epidemic/ pandemic history"/>
   <result pre="viruses. Current review briefly discussed the epidemic/ pandemic history of" exact="influenza" post="and correlated with the current epidemiology, the possible preventive"/>
   <result pre="and pandemics (like the ongoing COVID-19 pandemic caused by the" exact="severe acute respiratory syndrome" post="coronavirus 2 or the SARS-CoV-2; and the Spanish influenza"/>
   <result pre="respiratory syndrome coronavirus 2 or the SARS-CoV-2; and the Spanish" exact="influenza" post="H1N1 in 1918–1920) are very well known terms for"/>
   <result pre="an outbreak, an epidemic is known to occur when an" exact="infectious disease" post="tends to spread more quickly among a huge number"/>
   <result pre="pandemic is simply known as global disease like the Spanish" exact="influenza" post="H1N1 (causing around 50 million people in 1918–1920), Hong"/>
   <result pre="H1N1 (causing around 50 million people in 1918–1920), Hong Kong" exact="influenza" post="H3N2, causing approximately 1 million people in 1968, Asian"/>
   <result pre="influenza H3N2, causing approximately 1 million people in 1968, Asian" exact="influenza" post="H2N2 (causing nearly 2 million deaths in 1957–1958), or"/>
   <result pre="(causing nearly 2 million deaths in 1957–1958), or the Russian" exact="influenza" post="H2N2 (causing more than 1 million deaths in 1889–1892)"/>
   <result pre="late 2019, has appeared no less dreadful than the Spanish" exact="influenza" post="in terms of morbidity and mortality [4]. COVID-19 is"/>
   <result pre="COVID-19 is already well known as the life threatening infectious" exact="respiratory disease" post="which actually shares the same routes and means of"/>
   <result pre="same routes and means of transmission as influenza; and hence" exact="influenza" post="can be correlated with COVID-19 disease which has been"/>
   <result pre="by the case of a patient co-infected with SARS-CoV-2 and" exact="influenza" post="A virus [6]. Therefore, measures taken for the influenza"/>
   <result pre="and influenza A virus [6]. Therefore, measures taken for the" exact="influenza" post="(and other infectious respiratory diseases) prevention and control may"/>
   <result pre="also serve effectively to combat the COVID-19 pandemic [4]. The" exact="influenza" post="pandemic is of significant public health importance since it"/>
   <result pre="irresponsible and close contact coughing and sneezing [3–6]. The 1918" exact="influenza" post="pandemic, the most severe one in the history, occurred"/>
   <result pre="common knowledge to be safe during a pandemic situation. Russian" exact="influenza" post="(La Grippe) H2N2 (1889–1892) Russian Flu, the first true"/>
   <result pre="noticed to be severely affected without any early symptoms of" exact="influenza" post="[5, 8]. Briefly it is to be noted that"/>
   <result pre="[4, 8–11]. There is an interesting factor to note that" exact="influenza" post="was attributed to a Bacillus species, and it was"/>
   <result pre="been recently inferred that the causative virus of the Russian" exact="influenza" post="could be of the H3Nx subtype which circulated up"/>
   <result pre="of the H3Nx subtype which circulated up to the 1918" exact="influenza" post="pandemic outbreak [9]. The logic behind such inference is"/>
   <result pre="event could be held between the avian-, swine- and human" exact="influenza" post="viruses, or it could be introduced by a direct"/>
   <result pre="[9, 11–14]. As a known information, it’s clear that the" exact="influenza" post="pandemics occurs when the hemagglutinin (HA, or H) with"/>
   <result pre="H) with or without neuraminidase (NA, or N) subtypes of" exact="influenza" post="viruses infect humans (with little or no immunity) with"/>
   <result pre="[15]. A simple illustration of the viral reassortment between the" exact="influenza" post="viruses is shown in Fig. 1. Fig. 1 Simple"/>
   <result pre="1. Fig. 1 Simple illustration of viral reassortment between the" exact="influenza" post="viruses. After the 1918–1920 Spanish influenza outbreak the 1918"/>
   <result pre="viral reassortment between the influenza viruses. After the 1918–1920 Spanish" exact="influenza" post="outbreak the 1918 A/H1N1 subtype (thought to be generated"/>
   <result pre="result of the numerous reassortments between avian-, swine-, and human" exact="influenza" post="viruses yy[20, 36–38]. This is to be noted that"/>
   <result pre="responses; PB1: Polymerase basic protein 1, a determinant of the" exact="influenza" post="virus virulence; HA hemagglutinin, a homotrimeric glycoprotein found on"/>
   <result pre="HA hemagglutinin, a homotrimeric glycoprotein found on the surface of" exact="influenza" post="viruses which is integral to its infectivity, and is"/>
   <result pre="cleaving sialic acid groups from glycoproteins and are required for" exact="influenza" post="virus replication; i.e., it is essential for release of"/>
   <result pre="virus particles from the surface of an infected cell Spanish" exact="influenza" post="H1N1 in 1918–1920 As stated above, the Spanish influenza"/>
   <result pre="Spanish influenza H1N1 in 1918–1920 As stated above, the Spanish" exact="influenza" post="pandemic was in three consecutive waves: spring 1918, autumn"/>
   <result pre="single-nucleotide polymorphisms (SNPs), co-infections with bacterial pathogens, and with the" exact="measles" post="and malaria causing agents; and finally the malnutrition or"/>
   <result pre="(SNPs), co-infections with bacterial pathogens, and with the measles and" exact="malaria" post="causing agents; and finally the malnutrition or obesity has"/>
   <result pre="measles and malaria causing agents; and finally the malnutrition or" exact="obesity" post="has been found to contribute to the high mortality"/>
   <result pre="to the 1918 H1N1 virus infection [9]. Though the 1918" exact="influenza" post="pandemic is known as the &quot;Spanish Flue&quot;; in real"/>
   <result pre="is known as the &quot;Spanish Flue&quot;; in real the 1918" exact="influenza" post="virus didn’t originate in Spain; rather it originated in"/>
   <result pre="viral vector (animal reservoir) became controversial. Being a segmented virus," exact="influenza" post="virus was capable of undergoing the reassortment process which"/>
   <result pre="the reassortment process which is known to occur when two" exact="influenza" post="virus strains co-infect the same cell, thereby triggering the"/>
   <result pre="Such an interesting mechanism between the avian- and the human" exact="influenza" post="viruses later gave rise to the 1957 and 1968"/>
   <result pre="influenza viruses later gave rise to the 1957 and 1968" exact="influenza" post="pandemics [9, 19]. Demolition of protective immunity during viral"/>
   <result pre="pro-inflammatory response was noticed to be triggered by the 1918" exact="influenza" post="virus, which in turn imparted severe lung lesions among"/>
   <result pre="or cross-reactive) as well as the shortage of the pre-existing" exact="influenza" post="virus specific CD8+ T cells among the young population"/>
   <result pre="[9, 21]. This is to be noted that the protective" exact="influenza" post="virus-specific antibody responses may be long-lived [9, 21, 22]."/>
   <result pre="shortfall underlies the fact that antibodies elicited by the seasonal" exact="influenza" post="vaccines cannot impart protection in the case of an"/>
   <result pre="cannot impart protection in the case of an antigenically distinct" exact="influenza" post="virus of a novel subtype [24]. More specifically, during"/>
   <result pre="interpandemic periods, the antigenic drift (mutations in the genes of" exact="influenza" post="viruses) variants may arise which in turn created difficulties"/>
   <result pre="has been noticed when a trivalent hemagglutinin DNA prime-trivalent inactivated" exact="influenza" post="vaccine (IIV3) boost regimen (the 2012/13 seasonal trivalent HA"/>
   <result pre="VRC-FLUDNA063-00-VP) was developed to cure the children suffering from seasonal" exact="influenza" post="in the US [25]. In healthy adults, such DNA"/>
   <result pre="influenza in the US [25]. In healthy adults, such DNA" exact="influenza" post="vaccines against the emerging subtypes of avian origin (including"/>
   <result pre="was observed to increase the overall antibody titers [25]. Asian" exact="influenza" post="H2N2 in 1957–1958 The H2N2 subtype influenza A virus"/>
   <result pre="titers [25]. Asian influenza H2N2 in 1957–1958 The H2N2 subtype" exact="influenza" post="A virus (consisting of the genes from an H2N2"/>
   <result pre="encoding H2 hemagglutinin and N2 neuraminidase) that originated from an" exact="avian influenza" post="A virus emerged in East Asia, which triggered another"/>
   <result pre="H2 hemagglutinin and N2 neuraminidase) that originated from an avian" exact="influenza" post="A virus emerged in East Asia, which triggered another"/>
   <result pre="June‐August 1957 [26]. Moreover, the mortality burden of the 1957" exact="influenza" post="pandemic in 39 countries was assessed with the WHO"/>
   <result pre="study revealed that only 5.6% of the adults having symptomatic" exact="influenza" post="A, developed the infection earlier during the pandemic, despite"/>
   <result pre="was much higher (55.2%) in the children having the symptomatic" exact="influenza" post="A. This finding clearly showed the accumulation of the"/>
   <result pre="sufficient attention for the development of vaccines [29]. Hong Kong" exact="influenza" post="H3N2 in 1968 The H1N1 subtype influenza A virus"/>
   <result pre="[29]. Hong Kong influenza H3N2 in 1968 The H1N1 subtype" exact="influenza" post="A virus causing the 1918 pandemic outbreak caused the"/>
   <result pre="outbreak caused the seasonal epidemics until 1957 when a new" exact="influenza" post="A virus of the H2N2 subtype emerged [28]. This"/>
   <result pre="subtype emerged [28]. This was referred to as the &quot;Asian&quot;" exact="influenza" post="virus, causing the second pandemic after the Spanish flue"/>
   <result pre="[29]. The H2N2 kept continuing the dissemination of the seasonal" exact="influenza" post="from 1957 to 1967; and in 1968 the third"/>
   <result pre="change during the evolution of H2N2 subtype [29]. The 1968" exact="influenza" post="A virus of H3N2 subtype, with the especial feature"/>
   <result pre="feature of antigenic drift, consisted of two genes from an" exact="avian influenza" post="A virus: a new H3 hemagglutinin (HA), and the"/>
   <result pre="of antigenic drift, consisted of two genes from an avian" exact="influenza" post="A virus: a new H3 hemagglutinin (HA), and the"/>
   <result pre="be noted that the World Health Organization (WHO) selects the" exact="influenza" post="candidate vaccine strains based only on the HA antigenicity"/>
   <result pre="NA. Thus the continued surveillance of the NA of circulating" exact="influenza" post="viruses and the subsequent of NA antigenicity to optimize"/>
   <result pre="viruses and the subsequent of NA antigenicity to optimize the" exact="influenza" post="vaccines has been suggested [30]. Severe acute respiratory syndrome"/>
   <result pre="[30]. Severe acute respiratory syndrome (SARS) in 2002–2003 SARS, the" exact="severe acute respiratory syndrome," post="caused by a novel coronavirus (termed as SARS-CoV, causing"/>
   <result pre="of novel coronavirus infection were reported in Arabian Peninsula with" exact="pneumonia" post="and acute kidney injury; and the virus was named"/>
   <result pre="patients were found to suffer from acute renal impairment and" exact="proteinuria" post="together with hematological abnormalities like thrombocytopenia and lymphopenia [34–36]."/>
   <result pre="acute renal impairment and proteinuria together with hematological abnormalities like" exact="thrombocytopenia" post="and lymphopenia [34–36]. In contrast the SARS-CoV-2 is principally"/>
   <result pre="the SARS-CoV-2 is principally causing headache, fever, sore throat, cough," exact="acute respiratory distress syndrome," post="acute cardiac injury, upper airway congestion, pharyngalgia, myalgia, and"/>
   <result pre="and even the secondary infections [37]. However, the onset of" exact="acute respiratory distress syndrome" post="(ARDS) by three β-coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV is"/>
   <result pre="since that old time the world has experienced three additional" exact="influenza" post="pandemics: the 1957 &quot;Asian&quot; influenza pandemic, the 1968 &quot;Hong"/>
   <result pre="world has experienced three additional influenza pandemics: the 1957 &quot;Asian&quot;" exact="influenza" post="pandemic, the 1968 &quot;Hong Kong&quot; influenza pandemic (described in"/>
   <result pre="pandemics: the 1957 &quot;Asian&quot; influenza pandemic, the 1968 &quot;Hong Kong&quot;" exact="influenza" post="pandemic (described in the descendent paragraphs) and the currently"/>
   <result pre="of the Coronavirus Disease 2019 (COVID-19) resulting in novel coronavirus-infected" exact="pneumonia" post="(NCIP) is the ongoing pandemics around the world which"/>
   <result pre="the symptoms nearly similar to those as seen during the" exact="common cold" post="or more severe respiratory syndromes [42]. Besides the running"/>
   <result pre="infected individual prone to the respiratory disorders [31]. The coronavirus" exact="pneumonia" post="develops within maximum 7 days with the early symptoms"/>
   <result pre="As discussed earlier, the high pathogenicity exerted by the 1918" exact="influenza" post="virus was due to the proteins encoded by the"/>
   <result pre="cell-mediated immunity are very important for the protective immunity against" exact="influenza" post="[31]. Besides, (1) the genetic factors such as single-nucleotide"/>
   <result pre="resistance, (7) climate change, etc. may influence the dreadfulness of" exact="influenza" post="virus infections [11]. Quick identification of suspect cases is"/>
   <result pre="the current time, the diagnosis of viral strains responsible for" exact="influenza" post="has spectacularly improved both in terms of accuracy, speed"/>
   <result pre="on especially the pathogenicity and epidemiology on the pandemics of" exact="influenza" post="viruses are now a days well available in a"/>
   <result pre="to develop different approaches prevent the circulation of the different" exact="influenza" post="subtypes and the dreadful β-coronaviruses; as well as to"/>
   <result pre="outbreaks. Current review is apparently devoid of new information on" exact="influenza" post="virus from the molecular point of virological research; nevertheless,"/>
   <result pre="standards Conflict of interest None declared. References References 1.KępińskaAPIyegbeCOVernonACYolkenRMurrayRMPollakTASchizophrenia and" exact="influenza" post="at the centenary of the 1918–1919 Spanish influenza pandemic:"/>
   <result pre="1.KępińskaAPIyegbeCOVernonACYolkenRMurrayRMPollakTASchizophrenia and influenza at the centenary of the 1918–1919 Spanish" exact="influenza" post="pandemic: mechanisms of psychosis riskFront Psychiatry2020117210.3389/fpsyt.2020.0007232174851 2.Ksiazek TG, Erdman"/>
   <result pre="Anderson LJ, SARS Working Group. A novel coronavirus associated with" exact="severe acute respiratory syndrome." post="N Engl J Med. 2003; 348(20):1953–66. 10.1056/nejmoa030781 3.LeungYToMLamTYauSLeungOChuangSEpidemiology of"/>
   <result pre="N Engl J Med. 2003; 348(20):1953–66. 10.1056/nejmoa030781 3.LeungYToMLamTYauSLeungOChuangSEpidemiology of human" exact="influenza" post="A(H7N9) infection in Hong KongJ Microbiol Immunol Infect201750218318810.1016/j.jmii.2015.06.00426220305 4.LinQZhaoSGaoDLouYYangSMusaSSWangMHCaiYWangWYangLHeDA"/>
   <result pre="three waves. https://www.cdc.gov/flu/pandemic-resources/1918-commemoration/three-waves.htm accessed on May 30, 2020. 6.WuDLuJMaXLiuQWangDGuYLiYHeWCoinfection of" exact="influenza" post="virus and severe acute respiratory syndrome Coronavirus 2 (SARS-COV-2)Ped"/>
   <result pre="accessed on May 30, 2020. 6.WuDLuJMaXLiuQWangDGuYLiYHeWCoinfection of influenza virus and" exact="severe acute respiratory syndrome" post="Coronavirus 2 (SARS-COV-2)Ped Infect Dis J202010.1097/INF.0000000000002688 7.VogelOAManicassamyBBroadly protective strategies"/>
   <result pre="Coronavirus 2 (SARS-COV-2)Ped Infect Dis J202010.1097/INF.0000000000002688 7.VogelOAManicassamyBBroadly protective strategies against" exact="influenza" post="viruses: universal vaccines and therapeuticsFront Microbiol202071113510.3389/fmicb.2020.00135 8.EwingETLa Grippe or"/>
   <result pre="de SandtCEBack to the future: lessons learned from the 1918" exact="influenza" post="pandemicFront Cell Infect Microbiol2018834310.3389/fcimb.2018.0034330349811 10.WuDLuJLiuYZhangZLuoLPositive effects of COVID-19 control"/>
   <result pre="Cell Infect Microbiol2018834310.3389/fcimb.2018.0034330349811 10.WuDLuJLiuYZhangZLuoLPositive effects of COVID-19 control measures on" exact="influenza" post="preventionInt J Infect Dis2020S1201–971220302253023310.1016/j.ijid.2020.04.009 11.CDC (Centers for Disease Control"/>
   <result pre="April 4, 2020. 13.van de SandtCEKreijtzJHGeelhoed-MierasMMNieuwkoopNJSpronkenMIvan de VijverDAFouchierRAOsterhausADRimmelzwaanGFDifferential recognition of" exact="influenza" post="a viruses by M158–66 epitope-specific CD8+ T cells is"/>
   <result pre="residuesJ Virol20169021009102210.1128/jvi.02439-1526537686 14.TaubenbergerJKThe origin and virulence of the 1918 &quot;Spanish&quot;" exact="influenza" post="virusProc Am Philos Soc200615018611210.2807/esw.10.42.02812-en17526158 15.NeverovADLezhninaKVKondrashovASBazykinGAIntrasubtype reassortments cause adaptive amino"/>
   <result pre="Soc200615018611210.2807/esw.10.42.02812-en17526158 15.NeverovADLezhninaKVKondrashovASBazykinGAIntrasubtype reassortments cause adaptive amino acid replacements in H3N2" exact="influenza" post="genesPLoS Genet2014101e100403710.1371/journal.pgen.100403724415946 16.MurrayCJLopezADChinBFeehanDHillKHEstimation of potential global pandemic influenza mortality"/>
   <result pre="in H3N2 influenza genesPLoS Genet2014101e100403710.1371/journal.pgen.100403724415946 16.MurrayCJLopezADChinBFeehanDHillKHEstimation of potential global pandemic" exact="influenza" post="mortality on the basis of vital registry data from"/>
   <result pre="1918–20 pandemic: a quantitative analysisLancet200636895542211221810.1016/s0140-6736(06)69895-417189032 17.CollinsSDAge and sex incidence of" exact="influenza" post="and pneumonia morbidity and mortality in the epidemic of"/>
   <result pre="a quantitative analysisLancet200636895542211221810.1016/s0140-6736(06)69895-417189032 17.CollinsSDAge and sex incidence of influenza and" exact="pneumonia" post="morbidity and mortality in the epidemic of 1928–29 with"/>
   <result pre="epidemicsPublic Health Rep1931461909193710.2307/458013919315308 18.BarryJMViboudCSimonsenLCross-protection between successive waves of the 1918–1919" exact="influenza" post="pandemic: epidemiological evidence from US Army camps and from"/>
   <result pre="from BritainJ Infect Dis2008198101427143410.1086/59245418808337 19.SchäferJRKawaokaYBeanWJSüssJSenneDWebsterRGOrigin of the pandemic 1957 H2" exact="influenza" post="A virus and the persistence of its possible progenitors"/>
   <result pre="its possible progenitors in the avian reservoirVirology1993194278178810.1006/viro.1993.13197684877 20.KobasaDTakadaAShinyaKHattaMHalfmannPTheriaultSSuzukiHNishimuraHMitamuraKSugayaNUsuiTMurataTMaedaYWatanabeSSureshMSuzukiTSuzukiYFeldmannHKawaokaYEnhanced virulence of" exact="influenza" post="A viruses with the haemagglutinin of the 1918 pandemic"/>
   <result pre="immunity and susceptibility to infectious diseases: lessons from the 1918" exact="influenza" post="pandemicNat Immunol20078111188119310.1038/ni153017952044 22.ReedCKatzJMSerological surveys for 2009 pandemic influenza A"/>
   <result pre="the 1918 influenza pandemicNat Immunol20078111188119310.1038/ni153017952044 22.ReedCKatzJMSerological surveys for 2009 pandemic" exact="influenza" post="A H1N1Lancet201037597201062106310.1016/s0140-6736(09)62194-220096449 23.KrammerFSmithGJDFouchierRAMPeirisMKedzierskaKDohertyPCPalesePShawMLTreanorJWebsterRGGarcía-SastreAInfluenzaNat Rev Dis Primers201810.1038/s41572-018-0002-y29955068 24.De JongJCRimmelzwaanGFFouchierRAMOsterhausADMEInfluenza virus:"/>
   <result pre="JE; VRC 702 Study Team. DNA vaccine priming for seasonal" exact="influenza" post="vaccine in children and adolescents 6 to 17 years"/>
   <result pre="PLoS One. 2018;13(11):e0206837. 10.1371/journal.pone.0206837 26.ChowellGSimonsenLFuentesRFloresJMillerMAViboudCSevere mortality impact of the 1957" exact="influenza" post="pandemic in ChileInfluenza Other Respir Viruses201711323023910.1111/irv.1243927883281 27.ViboudCSimonsenLFuentesRFloresJMillerMAChowellGGlobal mortality impact"/>
   <result pre="ChileInfluenza Other Respir Viruses201711323023910.1111/irv.1243927883281 27.ViboudCSimonsenLFuentesRFloresJMillerMAChowellGGlobal mortality impact of the 1957–1959" exact="influenza" post="pandemicJ Infect Dis2016213573874510.1093/infdis/jiv53426908781 28.EpsteinSLPrior H1N1 influenza infection and susceptibility"/>
   <result pre="impact of the 1957–1959 influenza pandemicJ Infect Dis2016213573874510.1093/infdis/jiv53426908781 28.EpsteinSLPrior H1N1" exact="influenza" post="infection and susceptibility of Cleveland Family Study participants during"/>
   <result pre="der VlietSBurkeDFLexmondPBestebroerTMSmithDJHerfstSKoelBFFouchierRAMThe Molecular basis for antigenic drift of human A/H2N2" exact="influenza" post="virusesJ Virol2019938e01907e191810.1128/JVI.01907-1830700609 30.WanHGaoJYangHYangSHarveyRChenYQZhengNYChangJCarneyPJLiXPlantEJiangLCouzensLWangCStrohmeierSWuWWShenRFKrammerFCipolloJFWilsonPCStevensJWanXFEichelbergerMCYeZThe neuraminidase of A (H3N2) influenza viruses"/>
   <result pre="human A/H2N2 influenza virusesJ Virol2019938e01907e191810.1128/JVI.01907-1830700609 30.WanHGaoJYangHYangSHarveyRChenYQZhengNYChangJCarneyPJLiXPlantEJiangLCouzensLWangCStrohmeierSWuWWShenRFKrammerFCipolloJFWilsonPCStevensJWanXFEichelbergerMCYeZThe neuraminidase of A (H3N2)" exact="influenza" post="viruses circulating since 2016 is antigenically distinct from the"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/s0140-6736(20)30211-732007143 38.ChafekarAFieldingBCMERS-CoV: understanding the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7467230/results/search/disease/results.xml">
   <result pre="drug use (IDU)-related infections such as human immunodeficiency virus (HIV)," exact="hepatitis" post="C virus (HCV), hepatitis B virus (HBV), and invasive"/>
   <result pre="such as human immunodeficiency virus (HIV), hepatitis C virus (HCV)," exact="hepatitis" post="B virus (HBV), and invasive bacterial and fungal infections,"/>
   <result pre="in injection opioids [5, 13] and hospitalizations for injection opioid-related" exact="endocarditis" post="have increased more than 12-fold in recent years [6,"/>
   <result pre="improve patients’ outcomes and reduce the public health risk of" exact="infectious disease" post="transmission. Nevertheless, a number of barriers to care in"/>
   <result pre="in the United States as well as reduce the other" exact="infectious disease" post="health outcomes. To address these barriers we recommend expanding"/>
   <result pre="[14, 15]; and buprenorphine and XR-NTX also improve HIV viral" exact="suppression" post="in people living with HIV, the gold standard of"/>
   <result pre="such as skin and soft tissue infections and risk of" exact="endocarditis" post="with a specific focus on criminal justice involved populations."/>
   <result pre="a specific focus on criminal justice involved populations. Abbreviations: HCV," exact="hepatitis" post="C virus; HIV, human immunodeficiency virus; IDU, injection drug"/>
   <result pre="34%, respectively [28]. SSPs also can facilitate vaccine uptake for" exact="hepatitis" post="A virus (HAV), HBV, influenza, and invasive pneumococcal disease,"/>
   <result pre="reduce progression to serious infections and reduce complications like wound" exact="botulism" post="or partial drainage of abscesses. Given the increased incidence"/>
   <result pre="either HIV or HCV who receive MOUDs have improved viral" exact="suppression" post="(HIV) [16, 17], achieve sustained virologic response/cure (HCV) [45,"/>
   <result pre="collaborative decisions on complex patients, such as those with recurrent" exact="endocarditis" post="following valve repair. Evaluation of the impact of these"/>
   <result pre="makes it difficult—if not impossible—to identify, predict, and prevent new" exact="infectious disease" post="epidemics related to substance use in the United States."/>
   <result pre="OUD leading to fatal overdose, progression of HIV, and HBV/HCV-induced" exact="liver disease" post="[66–68]. Additionally, overall infectious disease testing rates and rates"/>
   <result pre="progression of HIV, and HBV/HCV-induced liver disease [66–68]. Additionally, overall" exact="infectious disease" post="testing rates and rates of vaccination against HAV and"/>
   <result pre="against HAV and HBV are low [69, 70]. Integration of" exact="infectious disease" post="management with treatment for OUD in CJIP is an"/>
   <result pre="reducing these health inequities that will likely lead to improved" exact="infectious disease" post="outcomes and facilitates linkage to care postrelease [16, 17,"/>
   <result pre="decreases postrelease mortality [72, 73] and increases postrelease HIV viral" exact="suppression" post="[16, 17]. Clearly, prevention and treatment for OUD and"/>
   <result pre="also associated with suboptimal postrelease management of chronic conditions like" exact="liver disease" post="[82]. Increased flexibility of Medicaid, allowing initiation of insurance"/>
   <result pre="to IDU, such as skin and soft tissue infections or" exact="infective endocarditis." post="Despite increasing frequency of endocarditis in people with OUD/SUD"/>
   <result pre="soft tissue infections or infective endocarditis. Despite increasing frequency of" exact="endocarditis" post="in people with OUD/SUD [7], and high rates of"/>
   <result pre="HCV, and other IDU-related infections. As a result, we as" exact="infectious disease" post="specialists need a paradigm shift in our clinical approach,"/>
   <result pre="Wkly Rep2015; 64:443–4.25928470 5.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute" exact="hepatitis" post="C virus infection related to a growing opioid epidemic"/>
   <result pre="Health2018; 108:175–81.29267061 6.SchranzAJ, FleischauerA, ChuVH, WuLT, RosenDLTrends in drug use-associated" exact="infective endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
   <result pre="108:175–81.29267061 6.SchranzAJ, FleischauerA, ChuVH, WuLT, RosenDLTrends in drug use-associated infective" exact="endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
   <result pre="Ann Intern Med2018; 170:31–40.30508432 7.WurcelAG, AndersonJE, ChuiKK, et al.Increasing infectious" exact="endocarditis" post="admissions among young people who inject drugs. Open Forum"/>
   <result pre="Open Forum Infect Dis2016; 3:ofw157.27800528 8.FleischauerAT, RuhlL, RheaS, BarnesEHospitalizations for" exact="endocarditis" post="and associated health care costs among persons with diagnosed"/>
   <result pre="Wkly Rep2017; 67:257–8. 13.HarrisAM, IqbalK, SchillieS, et al.Increases in acute" exact="hepatitis" post="B virus infections—Kentucky, Tennessee, and West Virginia, 2006–2013. MMWR"/>
   <result pre="on buprenorphine is associated with high levels of maximal viral" exact="suppression" post="among HIV-infected opioid dependent released prisoners. PLoS One2012; 7:e38335.22719814"/>
   <result pre="7:e38335.22719814 17.SpringerSA, Di PaolaA, AzarMM, et al.Extended-release naltrexone improves viral" exact="suppression" post="among incarcerated persons living with HIV with opioid use"/>
   <result pre="Integrating responses at the intersection of opioid use disorder and" exact="infectious disease" post="epidemics: proceedings of a workshop. Washington, DC: National Academies"/>
   <result pre="RioCintegrating treatment at the intersection of opioid use disorder and" exact="infectious disease" post="epidemics in medical settings: a call for action after"/>
   <result pre="and meta-analysis. Addiction2018; 113:545–63.28891267 29.PeakCM, StousSS, HealyJM, et al.Homelessness and" exact="hepatitis" post="A—San Diego County, 2016–2018 [published online ahead of print"/>
   <result pre="35.MacArthurGJ, van VelzenE, PalmateerN, et al.Interventions to prevent HIV and" exact="hepatitis" post="C in people who inject drugs: a review of"/>
   <result pre="in Affordable Care Act qualified health plans’ association with viral" exact="suppression" post="[published online ahead of print 18 November 2019]. Clin"/>
   <result pre="Dis2019; 68:1935–7.30357363 45.AkiyamaMJ, NortonBL, ArnstenJH, AgyemangL, HeoM, LitwinAHIntensive models of" exact="hepatitis" post="C care for people who inject drugs receiving opioid"/>
   <result pre="trial. Ann Intern Med2019; 170:594–603.30959528 46.AkiyamaM, LipseyD, MoonseongH, et al.Low" exact="hepatitis" post="reinfection following direct acting antiviral therapy among people who"/>
   <result pre="50.TalalAH, AndrewsP, McleodA, et al.Integrated, co-located, telemedicine-based treatment approaches for" exact="hepatitis" post="C virus management in opioid use disorder patients on"/>
   <result pre="women and infants prenatally exposed to substances, including infants with" exact="neonatal abstinence syndrome." post="MMWR Morb Mortal Wkly Rep2019; 68:777–83.31513558 52.collab: American College"/>
   <result pre="2019. 53.collab: US Preventive Services Task Force. Draft recommendation statement" exact="hepatitis" post="C virus infection in adolescents and adults: screening. Rockville,"/>
   <result pre="MD: USPSTF, 2019. 54.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute" exact="hepatitis" post="C virus infection related to a growing opioid epidemic"/>
   <result pre="56.CottrellEB, ChouR, WassonN, RahmanB, GuiseJMReducing risk for mother-to-infant transmission of" exact="hepatitis" post="C virus: a systematic review for the U.S. Preventive"/>
   <result pre="38:1289–97. 59.BarocasJA, BeiserM, LeónC, GaetaJM, O’ConnellJJ, LinasBPExperience and outcomes of" exact="hepatitis" post="C treatment in a cohort of homeless and marginally"/>
   <result pre="2017. 63.HennesseyKA, KimAA, GriffinV, CollinsNT, WeinbaumCM, SabinKPrevalence of infection with" exact="hepatitis" post="B and C viruses and co-infection with HIV in"/>
   <result pre="and co-infection with HIV in three jails: a case for" exact="viral hepatitis" post="prevention in jails in the United States. J Urban"/>
   <result pre="co-infection with HIV in three jails: a case for viral" exact="hepatitis" post="prevention in jails in the United States. J Urban"/>
   <result pre="Public Health Rep2001; 116:203–9. 71.AkiyamaMJ, ColumbusD, MacDonaldR, et al.Linkage to" exact="hepatitis" post="C care after incarceration in jail: a prospective, single"/>
   <result pre="Infect Dis doi: 10.1093/cid/ciz383. 79.HeT, LiK, RobertsMS, et al.Prevention of" exact="hepatitis" post="C by screening and treatment in U.S. prisons. Ann"/>
   <result pre="BrockmannBW, VohrF, SpauldingA, MontagueBTA budget impact analysis of newly available" exact="hepatitis" post="C therapeutics and the financial burden on a state"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7467512/results/search/disease/results.xml">
   <result pre="reviewers. Studies involving non-clinical populations or patients diagnosed with a" exact="mental disorder" post="during a pandemic/epidemic will be excluded. We will include"/>
   <result pre="2015. After controlling for sex and age, having a premorbid" exact="mental disorder" post="increased the likelihood of persistent anxiety and anger at"/>
   <result pre="26 Although causality is difficult to establish, the 1918 Spanish" exact="influenza" post="coincided with a significant increase in the incidence of"/>
   <result pre="the effects of pandemics or epidemics on individuals with any" exact="mental disorder," post="not limited to individuals affected by psychosis, and will"/>
   <result pre="a hypothesis. Proposed subgroup analyses are as follows: Type of" exact="mental disorder." post="Identity factors (age, sex, gender, ethnicity, sexual orientation): We"/>
   <result pre="suffer from the physical and mental ramifications of a previous" exact="influenza" post="outbreak.34 Region. Specific pandemic (eg, COVID-19). Specific epidemic. Specific"/>
   <result pre="time frame for publication could range from the 1918 Spanish" exact="influenza" post="pandemic (considered to be the first pandemic in modern"/>
   <result pre="major depressi* disorder* or depression or major depressive episode* or" exact="postpartum depression" post="or ADHD or attention deficit disorder or attention deficit"/>
   <result pre="psychos?s or addiction* or neurobehavioural or emotions or psychiatr* or" exact="mood disorder" post="or adjustment disorder or somatic or somatoform or delusional"/>
   <result pre="or neurobehavioural or emotions or psychiatr* or mood disorder or" exact="adjustment disorder" post="or somatic or somatoform or delusional disorder or mani*"/>
   <result pre="mood disorder or adjustment disorder or somatic or somatoform or" exact="delusional disorder" post="or mani* or affective or suicid* or mental status"/>
   <result pre="or affective or depress* or anxi* or obsessive compulsive or" exact="panic disorder" post="or post-trauma* or posttrauma* or PTSD or neurosis or"/>
   <result pre="quotient or IQ or mental retardation or intellectual disability or" exact="learning disability" post="or autis* or asperger* or attention deficit or ADHD"/>
   <result pre="amnesia/ or exp catatonia/ or exp personality disorders/ or exp" exact="schizophrenia" post="spectrum/) and other psychotic disorders/) or exp mental disorders/"/>
   <result pre="major depressi* disorder* or depression or major depressive episode* or" exact="postpartum depression" post="or ADHD or attention deficit disorder or attention deficit"/>
   <result pre="psychos?s or addiction* or neurobehavioural or emotions or psychiatr* or" exact="mood disorder" post="or adjustment disorder or somatic or somatoform or delusional"/>
   <result pre="or neurobehavioural or emotions or psychiatr* or mood disorder or" exact="adjustment disorder" post="or somatic or somatoform or delusional disorder or mani*"/>
   <result pre="mood disorder or adjustment disorder or somatic or somatoform or" exact="delusional disorder" post="or mani* or affective or suicid* or mental status"/>
   <result pre="or affective or depress* or anxi* or obsessive compulsive or" exact="panic disorder" post="or post-trauma* or posttrauma* or PTSD or neurosis or"/>
   <result pre="quotient or IQ or mental retardation or intellectual disability or" exact="learning disability" post="or autis* or asperger* or attention deficit or ADHD"/>
   <result pre="amnesia/ or exp catatonia/ or exp personality disorders/ or exp" exact="schizophrenia" post="spectrum/) and other psychotic disorders/) or exp mental disorders/"/>
   <result pre="or psychos?s or addiction* or neurobehavioural or emotions orpsychiatr* or" exact="mood disorder" post="or adjustment disorder or somatic or somatoform ordelusional disorder"/>
   <result pre="addiction* or neurobehavioural or emotions orpsychiatr* or mood disorder or" exact="adjustment disorder" post="or somatic or somatoform ordelusional disorder or mani* or"/>
   <result pre="mood or affective or depress* or anxi* or obsessivecompulsive or" exact="panic disorder" post="or post-trauma* or posttrauma* or PTSD or neurosis or"/>
   <result pre="intelligence quotient or IQ or mental retardation or intellectualdisability or" exact="learning disability" post="or autis* or asperger* or attention deficit or ADHD"/>
   <result pre="major depressi* disorder* or depression or major depressive episode* or" exact="postpartum depression" post="or ADHD or attention deficit disorder or attention deficit"/>
   <result pre="psychos?s or addiction* or neurobehavioural or emotions or psychiatr* or" exact="mood disorder" post="or adjustment disorder or somatic or somatoform or delusional"/>
   <result pre="or neurobehavioural or emotions or psychiatr* or mood disorder or" exact="adjustment disorder" post="or somatic or somatoform or delusional disorder or mani*"/>
   <result pre="mood disorder or adjustment disorder or somatic or somatoform or" exact="delusional disorder" post="or mani* or affective or suicid* or mental status"/>
   <result pre="or affective or depress* or anxi* or obsessive compulsive or" exact="panic disorder" post="or post-trauma* or posttrauma* or PTSD or neurosis or"/>
   <result pre="quotient or IQ or mental retardation or intellectual disability or" exact="learning disability" post="or autis* or asperger* or attention deficit or ADHD"/>
   <result pre="amnesia/ or exp catatonia/ or exp personality disorders/ or exp" exact="schizophrenia" post="spectrum/) and other psychotic disorders/) or exp mental disorders/"/>
   <result pre="including study methodology and design, population demographics and sample size," exact="mental disorder" post="diagnosis, symptomatology measure (if applicable), study outcomes and findings,"/>
   <result pre="10.1016/S2215-0366(20)30171-132330430 4CheungYT, ChauPH, YipPSFA revisit on older adults suicides and" exact="severe acute respiratory syndrome" post="(SARS) epidemic in Hong Kong. Int J Geriatr Psychiatry2008;23:1231–8."/>
   <result pre="posttraumatic stress in Chinese university students during the 2009 H1N1" exact="influenza" post="pandemic. Med Sci Monit2011;17:PH60–4. 10.12659/MSM.88183621709644 9HolmesEA, O'ConnorRC, PerryVH, et"/>
   <result pre="Intern Med2020:M20-1083. 10.7326/M20-1083 18DouglasPK, DouglasDB, HarriganDC, et al.Preparing for pandemic" exact="influenza" post="and its aftermath: mental health issues considered. Int J"/>
   <result pre="Law Rev2015;12:227–80. 10.18060/18963 20BlakeKD, BlendonRJ, ViswanathKEmployment and compliance with pandemic" exact="influenza" post="mitigation recommendations. Emerg Infect Dis2010;16:212–8. 10.3201/eid1602.09063820113549 21JeongH, YimHW, SongY-J,"/>
   <result pre="JAMA Neurol2020:1127. 10.1001/jamaneurol.2020.1127 27McCallS, VilenskyJA, GilmanS, et al.The relationship between" exact="encephalitis" post="lethargica and influenza: a critical analysis. J Neurovirol2008;14:177–85. 10.1080/1355028080199544518569452"/>
   <result pre="Available: https://handbook-5-1.cochrane.org/chapter_9/9_6_2_what_are_subgroup_analyses.htm [Accessed 26 Jul 2020]. 34QuinnSC, KumarSHealth inequalities and" exact="infectious disease" post="epidemics: a challenge for global health security. Biosecur Bioterror2014;12:263–73."/>
   <result pre="10.1089/bsp.2014.003225254915 35TomesN&quot;Destroyer and teacher&quot;: Managing the masses during the 1918-1919" exact="influenza" post="pandemic. Public Health Rep2010;125 Suppl 3:48–62. 10.1177/00333549101250S30820568568 36collab: World"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7469891/results/search/disease/results.xml">
   <result pre="cases reopening SARS-CoV-2 schools transmission page-count: The unknown correlates of" exact="severe acute respiratory syndrome" post="coronavirus 2 transmission One of the key characteristics of"/>
   <result pre="syndrome coronavirus 2 transmission One of the key characteristics of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is high transmissibility which, fueled by"/>
   <result pre="gear and impromptu hospitals, reminiscent of historic epidemics like the" exact="influenza" post="of 1918, revived in response to this unprecedented for"/>
   <result pre="epidemic coronaviruses that can be fatal for humans, the first" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV-1) of 2002–2003 and the Middle East respiratory"/>
   <result pre="agencies transmission model originally proposed by William F Wells for" exact="tuberculosis" post="in the 1930s had suggested. Instead, according to the"/>
   <result pre="the USA and whether rates differ between children who have" exact="asthma" post="or other allergic conditions and children who do not"/>
   <result pre="distancing considering the recent advances in the biophysics of host-to-host" exact="respiratory disease" post="transmission, respiratory etiquette and masks for older children. Such"/>
   <result pre="York Times (2020). http://www.nytimes.com/2020/06/19/us/coronavirus-new-dangerous-phase.html 4.ZhouP , YangXL , WangXGet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet395(10223), 507–513 (2020).32007143"/>
   <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA323(11), 1061–1069 (2020). 27.LudvigssonJFSystematic review of"/>
   <result pre="ZhengX , RippeJ , PatelAB , KociolekLKAge-related differences in nasopharyngeal" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) levels in patients with mild to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7470771/results/search/disease/results.xml">
   <result pre="dynamics of spreading diseases should be studied and modeled. The" exact="bubonic plague" post="(Black Death), caused by bacillus pestis, a microorganism originating"/>
   <result pre="of spreading diseases should be studied and modeled. The bubonic" exact="plague" post="(Black Death), caused by bacillus pestis, a microorganism originating"/>
   <result pre="1 4 t h century. Nevertheless, at that time, the" exact="bubonic plague" post="was spreading up through Europe at a speed of"/>
   <result pre="4 t h century. Nevertheless, at that time, the bubonic" exact="plague" post="was spreading up through Europe at a speed of"/>
   <result pre="described in recent epidemiological studies pertaining to the propagation of" exact="tuberculosis" post="(Ackley et al., 2019, Lee et al., 2016). The"/>
   <result pre="of leaky Integrate-and-Fire neurons. Susceptible (S) individuals can contract an" exact="infectious disease" post="D, through contacts with infected individuals (I). Removed (R)"/>
   <result pre="a threshold mechanism, better describes the contagion dynamics of an" exact="infectious disease." post="In particular, case studies have shown that the infection"/>
   <result pre="particular, case studies have shown that the infection risk of" exact="tuberculosis" post="increases with multiple exposures to infected individuals following a"/>
   <result pre="of the external environment on the propagation dynamics of an" exact="infectious disease," post="we incorporate an additional term into the differential equation"/>
   <result pre="comes to implementing &quot;lockdown&quot; strategies for the containment of an" exact="infectious disease." post="The evidence obtained from the simulations that we discuss,"/>
   <result pre="the reliable estimation of the community transmission risk of an" exact="infectious disease," post="thus permitting the timely organization and implementation of containment"/>
   <result pre="the effectiveness of various prevention and control policies for an" exact="infectious disease," post="through simulations with real parameter values. The results of"/>
   <result pre="inhibitory spiking neuronsJournal of Computational Neuroscience83200018320810809012 ChanJ.F.-W.YuanS.KokK.-H.ToK.K.-W.ChuH.YangJ.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="neural systems2001MIT press Del ValleS.HethcoteH.HymanJ.M.Castillo-ChavezC.Effects of behavioral changes in a" exact="smallpox" post="attack modelMathematical Biosciences1952200522825115913667 DickisonM.HavlinS.StanleyH.E.Epidemics on interconnected networksPhysical Review E8562012066109"/>
   <result pre="Italy and FranceChaos, Solitons &amp;amp; Fractals1342020109761 FergusonN.M.CummingsD.A.FraserC.CajkaJ.C.CooleyP.C.BurkeD.S.Strategies for mitigating an" exact="influenza" post="pandemicNature4427101200644845216642006 GerstnerW.KistlerW.M.Spiking neuron models: Single neurons, populations, plasticity2002Cambridge university"/>
   <result pre="been linked to SARS-CoV-2 transmission clusters?Wellcome Open Research58320208332656368 LeeR.S.ProulxJ.-F.MenziesD.BehrM.A.Progression to" exact="tuberculosis" post="disease increases with multiple exposuresEuropean Respiratory Journal48620161682168927824599 LiuJ.LiaoX.QianS.YuanJ.WangF.LiuY.Community transmission"/>
   <result pre="disease increases with multiple exposuresEuropean Respiratory Journal48620161682168927824599 LiuJ.LiaoX.QianS.YuanJ.WangF.LiuY.Community transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2, shenzhen, China, 20202020 LiuY.YanL.-M.WanL.XiangT.-X.LeA.LiuJ.-M.Viral dynamics in mild"/>
   <result pre="complex socio-technical systemsNature Physics8120123239 WangY.LiuY.LiuL.WangX.LuoN.LiL.Clinical outcomes in 55 patients with" exact="severe acute respiratory syndrome" post="coronavirus 2 who were asymptomatic at hospital admission in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7472381/results/search/disease/results.xml">
   <result pre="resultsAm. J. Trop. Med. Hyg.19955348950610.4269/ajtmh.1995.53.4897485707 17.LordC.C.DayJ.F.Simulation studies of St. Louis" exact="encephalitis" post="in South FloridaVector. Borne. Zoon. Dis.2001129931610.1089/1530366016002592112653129 18.LordC.C.DayJ.F.Simulation studies of"/>
   <result pre="South FloridaVector. Borne. Zoon. Dis.2001129931610.1089/1530366016002592112653129 18.LordC.C.DayJ.F.Simulation studies of St. Louis" exact="encephalitis" post="and West Nile viruses: The impact of bird mortalityVector."/>
   <result pre="47.ZouacheK.FontaineA.Vega-RuaA.MoussonL.ThibergeJ.-M.Lourenco-De-OliveiraR.CaroV.LambrechtsL.FaillouxA.-B.Three-way interactions between mosquito population, viral strain and temperature underlying" exact="chikungunya" post="virus transmission potentialProc. Roy. Soc. B20142812014107810.1098/rspb.2014.107825122228 48.DubrulleM.MoussonL.MoutaillerS.VazeilleM.FaillouxA.-B.Chikungunya virus and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7482569/results/search/disease/results.xml">
   <result pre="the human population in the past two decades, following the" exact="severe acute respiratory syndrome" post="coronavirus SARS-CoV outbreak in 2002 and the Middle East"/>
   <result pre="two coronaviruses [2]. For example, in the first case of" exact="pneumonia" post="caused by this virus reported in USA, a 35-year-old,"/>
   <result pre="dry cough and low grade fever; he proceeded to develop" exact="pneumonia" post="5 days later, but quickly recovered [3]. This is"/>
   <result pre="medical conditions, including respiratory and cardiovascular diseases, as well as" exact="diabetes mellitus." post="For example, after the identification of an individual in"/>
   <result pre="and the lack of appropriate early international measures for the" exact="suppression" post="of its spread, it has now caused a pandemic."/>
   <result pre="serious global public health threat since the devastating 1918 H1N1" exact="influenza" post="pandemic. Justifiably, several countries have adopted draconian measures to"/>
   <result pre="learning network to make accurate predictions. References References 1ZhouPet al.2020A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="ThanosDSubmitted.Atmospheric conditions influencing the origin, transport and spread of major" exact="influenza" post="and coronavirus pandemics: a research rubric based on COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7494453/results/search/disease/results.xml">
   <result pre="2014) and survivors of infectious diseases have higher rates of" exact="post-traumatic stress disorder" post="(PTSD) (Hong et al., 2009). Recommendations around the use"/>
   <result pre="area but little is known about the psychological impact during" exact="infectious disease" post="outbreaks (Mak et al., 2009). Detrimental outcomes such as"/>
   <result pre="need for prompt and continuous psychiatric interventions in high mortality" exact="infectious disease" post="outbreaks (Lee et al., 2018; Wang et al., 2020;"/>
   <result pre="to people involved in response planning for future outbreaks of" exact="infectious disease" post="(Wu et al., 2009). 4.3 Strengths of studies The"/>
   <result pre="a case-control studyJ. Affect. Disord.275202021021532734910 ChanA.O.HuakC.Y.Psychological impact of the 2003" exact="severe acute respiratory syndrome" post="outbreak on health care workers in a medium size"/>
   <result pre="health science. The Lancet Psychiatry. HongX.Posttraumatic stress disorder in convalescent" exact="severe acute respiratory syndrome" post="patients: a 4-year follow-up studyGen. Hosp. Psychiatr.3162009546554 HongS.Immediate psychological"/>
   <result pre="health care providersCrit. Care Shock2004100106 KohD.Risk perception and impact of" exact="severe acute respiratory syndrome" post="(SARS) on work and personal lives of healthcare workers"/>
   <result pre="survivorsGen. Hosp. Psychiatr.3142009318326 MaunderR.G.Factors associated with the psychological impact of" exact="severe acute respiratory syndrome" post="on nurses and other hospital workers in TorontoPsychosom. Med.666200493894215564361"/>
   <result pre="nationwide observational studyIndian J. Psychol. Med.4242020353358 WongT.W.The psychological impact of" exact="severe acute respiratory syndrome" post="outbreak on healthcare workers in emergency departments and how"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugs_disease_country/PMC7499620/results/search/disease/results.xml">
   <result pre="Report: AcademicSubjects/MED00290 Non-pharmaceutical interventions used to control COVID-19 reduced seasonal" exact="influenza" post="transmission in China LeiHao1XuModi2WangXiao2XieYu2DuXiangjun2ChenTao3YangLei3WangDayan3ShuYuelong2[1], School of Public Health, Zhejiang"/>
   <result pre="implemented a set of non-pharmaceutical interventions (NPIs). Because COVID-19 and" exact="influenza" post="have similar means of transmission, it is hypothesized that"/>
   <result pre="it is hypothesized that NPIs targeting COVID-19 may also affect" exact="influenza" post="transmission. In this study, the extent to which NPIs"/>
   <result pre="the extent to which NPIs targeting COVID-19 have affected seasonal" exact="influenza" post="transmission was explored. Indicators of seasonal influenza activity in"/>
   <result pre="have affected seasonal influenza transmission was explored. Indicators of seasonal" exact="influenza" post="activity in the epidemiological year 2019/20 were compared with"/>
   <result pre="and 2018/19. Results show that the incidence rate of seasonal" exact="influenza" post="reduced by 64% in 2019/20 (p&amp;amp;0.001). These findings suggest"/>
   <result pre="that NPIs aimed at controlling COVID-19 significantly reduced the seasonal" exact="influenza" post="transmission in China. (105 words) Non-pharmaceutical interventions influenza COVID-19"/>
   <result pre="the seasonal influenza transmission in China. (105 words) Non-pharmaceutical interventions" exact="influenza" post="COVID-19 incidence"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
